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POST-TRANSCRIPTIONAL REGULATION OF ADDICTION-RELATED
BEHAVIORS: OPPOSING ROLES OF NUCLEUS ACCUMBENS MIR-495 AND
HUD

by

Robert Oliver
A.B. Biological Sciences, University of Chicago, 2011
PhD. Biomedical Sciences, University of New Mexico, 2017

ABSTRACT

Substance use Disorders (SUDs) are characterized by chronic relapse after periods
without symptoms. This has been hypothesized to stem from persistent alterations in
corticolimbic circuit function and structure caused by drug-induced alterations in
addiction-related gene (ARG) expression. Transcriptional and epigenetic regulation of
ARGs and addiction-like behaviors have been well characterized but the role of posttranscriptional regulation is an understudied, yet promising field. RNA binding proteins
(RBPs) are one post-transcriptional regulator of mRNA stability. HuD is a neuronal
specific RBP that stabilizes mRNAs and is regulated by neuronal activity and cocaine.
Another type of post-transcriptional regulator, microRNAs (miRNAs), are non-coding
RNAs that target specific mRNAs for degradation or translational repression. Since both
RBPs and miRNAs target the 3’UTR, this opens the possibility that these two classes of
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molecules could compete for access to a specific recognition site. We have found that
miR-495 and HuD target a set of shared mRNAs via binding to the same GUUUGUUUG
sequence. Many of these shared targets, including Bdnf and Camk2a mRNAs have been
implicated in addiction and are considered ARGs. This led to my hypothesis that cocaine
CPP differentially regulates HuD and miR-495 leading to a synergistic increase in ARG
expression and addiction-like behaviors. We found that miR-495 was significantly
decreased within the NAc while HuD protein and mRNA was significantly increased.
CaMKIIα and BDNF mRNA and protein levels were increased in a similar fashion.
Overexpression of HuD or miR-495 caused opposite effects on ARG expression and CPP
behavior. Finally, to determine the in vivo capability of these two regulators to compete
for behavior, we infused LV-miR-495 in HuDOE mice and trained them in CPP. We
found that HuDOE + LV-miR-495 completely blocked the development of CPP compared
to LV-GFP controls as well as diminishing expression of shared target mRNA and
protein. This suggests that miR-495 and HuD have bidirectional roles in the regulation of
CPP behavior. Further research on the role of post-transcriptional competition of shared
targets on cellular dynamics and behavior may inform new pharmacological treatments
that tip the balance of this post-transcriptional competition mechanism in the favor of
remission.
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CHAPTER 1: INTRODUCTION

1a. Overview of Substance Use Disorders

Substance use disorders (SUDs), or more colloquially known as drug addiction,
are a significant societal burden both financially, incurring an estimated $193 billion in
costs (www.justice.gov/ndic, 2011), and emotionally devastating to patients and their
families. In opposition to more controlled, casual drug use, SUDs are characterized by
uncontrollable bouts of drug consumption despite negative life consequences. Patients
with this disorder appear to lose interest in normal prosocial activities, instead directing
their energy towards the pursuit of these substances. Since addiction is a chronic,
relapsing condition, this disorder has been notoriously difficult to manage. The complete
understanding of the molecular, physiological, and behavioral mechanisms involved in
the disorder is necessary for the discovery and implementation of more effective
treatments.
The mesolimbic dopamine system is the most well studied and implicated circuit
associated with the disorder. Naturally, this neurocircuit may have evolved as an
information-processing center to direct behavior towards environmentally important
stimuli predicting the presence of vital resources, e.g. food and water. Synaptic plasticity
within these regions are implicated in associative learning of these stimuli to guide
behavior necessary to receive these rewarding resources. Depending on the frequency and
accuracy that a particular stimulus may predict a natural reward, goal-directed behavior
towards this stimulus with the intention of obtaining the reward may become habitual.
1

Thus, if an exogenous substance were to recruit this same neurocircuitry this may elicit
similar goal-directed behavior towards obtaining these compounds.
Structurally, drugs of abuse are highly varied and have many specific protein
targets within the body (for a review of pharmacological mechanisms of drugs of abuse
see, (Lüscher et al., 2006). However, all pharmacological mechanisms of drugs of abuse
cause excessive dopamine release in the ventral tegmental area and nucleus accumbens
(Figure. 1.1). Not only are these regions involved in this disorder, they also appear to be
crucial mediators of appropriate goal-directed behavior towards natural rewards.
Dopaminergic projections from VTA neurons are important in regulating motivation to
perform integral, evolutionarily-conserved behaviors such as feeding and reproduction
(Kelley et al., 2002; Bromberg-Martin et al., 2010). Drug-elicited synaptic plasticity also
occurs within this region, possibly through similar mechanisms as natural rewards.
Mirroring a classical symptom of addiction, the synaptic alterations induced by drugs of
abuse inhibit the ability of other non-drug related experiences to elicit synaptic plasticity
(Kolb et al., 2003; Hamilton et al., 2005). As such, it has been hypothesized that drugs of
abuse cause a heightened form of plasticity-dependent associative memory leading to
habit formation and addiction-like behaviors (Stuber et al., 2008).

1b. Animal models of Substance Use Disorders

Animal models of human SUDs, termed addiction-related behaviors, are
necessary to fully dissect the mechanisms of this disorder. Although we cannot study
many of the intricacies of the human aspects of these disorders, anthropomorphized
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rodent behavior has enabled the study of the long lasting constitutive changes and the
transient processes that are related to

Fig 1.1. Drugs of abuse cause dopamine release within the Nucleus Accumbens.
Through various interactions with specific cell types and receptors, drugs of abuse all
cause influx of dopamine within the NAc during intoxication. See Nestler, 2005 for
original publication.
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addiction (Scofield et al., 2016). As such, there are three main addiction-related
behaviors, locomotor sensitization, conditioned place preference (CPP), and selfadministration (SA). From these three main forms of addiction-related behavior, more
specific models of various aspects of human SUDs arise. These behaviors have been
found to involve encoding of contextual or cue associations, but only CPP and SA are
truly forms of Pavlovian conditioning. The encoding of these previous neutral stimuli
with the unconditioned stimulus of the subjective effects of the drug is a common aspect
of addiction-related behaviors in experimental animals and in human SUDs (Vezina et
al., 2009; Mayo et al., 2013). Overall, we can extrapolate features of addiction-related
behaviors in animal models to certain behaviors found in human SUDs.
Drugs of abuse are a form of reward. As such, rewards in general can be “liked”
and “wanted.” Thus, there are differences in neural systems that drive either of these
processes. After repeated exposure to drugs of abuse, the stimuli that are associated with
availability of the drug drive behavior or become more “salient”. This phenomenon has
been termed “incentive sensitization” (Robinson et al., 1993). This set of behavior is also
found in human patients with substance use disorders. This manifests itself as stimuli
such as drug paraphernalia or drug-paired environments become more stimulating to
these patients and drive their motivation towards acquisition of these drugs. This feature
of SUDs is modeled in the most basic forms of animal models of addiction-related
behaviors. Animals trained in these behavioral procedures will seek out drug-paired cues,
energize their drug-related responding in a cue-triggered fashion, and will work to be
presented these cues in the absence of drugs. The procedures that generate these three
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characteristics of incentive sensitization and how they are measured will be discussed
below.
Locomotor sensitization is the elevation of drug-induced locomotor activity
compared to the first drug administration, usually following repeated administration of
the drug with or without a withdrawal period (Vezina et al., 2009). This behavior is
correlated with an increase in dopamine influx within the NAc, suggesting that this may
be a mechanism involved in this phenotype (Kalivas et al., 1990). In contrast to
dopamine, enhanced NAc glutamate influx requires the presence of previously paired
environmental cues (Bell et al., 2000). Bell and colleagues also found that drug-paired,
cue-induced glutamate release coincides with the enhanced drug-induced dopamine
release. Though this was posited to be a mechanism for cue-induced craving in humans,
this was not the case, as dopamine was not elevated in humans and non-human primates
(Bradberry, 2007). Another caveat is that locomotor sensitization requires acute exposure
to the drug in the final stage of testing. This adds the confound of the effect of the drug
itself in the study of distinct mechanisms. In either case, locomotor sensitization is a
translatable behavioral procedure that may be involved in drug-cue pairing found in
human SUDs.
A more translatable model for drug-cue pairing is CPP. This is a classical form of
Pavlovian conditioning, in which the drug and vehicle are non-contingently administered
in the presence of two distinct environmental contexts (Tzschentke, 2007). Over time,
animals will pair this conditioned, environmental stimulus with the drug but not the
vehicle. This is assessed by allowing the animal to explore both environmental contexts,
in which the animal will seek out the drug-paired context in the absence of the drug itself.
5

Due to the volitional aspect of the procedure, it allows researchers to determine the
motivational value of seeking out these drug-paired cues. As such, this can be thought of
as a model to study motivation to acquire drugs or seek drugs. Additionally, this pairing
can be extinguished by exposure to both contexts in the absence of drugs, thus leading to
no preference to either context. If the animal is given the drug, it will reinvigorate
seeking for the previously drug paired environmental context (Mueller et al., 2000).
Thus, this CPP can be expanded to study the underlying mechanisms that mirror drug
craving and relapse. As mentioned previously, humans can also exhibit CPP behavior in
experimental contexts (Mayo et al., 2013). Overall, the motivation to acquire drugs or
seek out drug-associated contexts are important aspects of human SUDs.
Finally, the most translatable model used to study addiction is self-administration
of drugs (Roberts et al., 2007). In this model, an intravenous catheter will infuse cocaine
into the animal once it has completed a specific behavioral response, usually pressing an
active lever in opposition to an inactive lever that produces no effect. Usually, this is
done following a reinforcement schedule, in which the animal must complete the
“correct” instrumental response a certain number of times before the reinforcer is
dispensed. Once the animal has reached a determined set of criteria of correct lever
presses for drug, the animal has “acquired” SA. This can be combined with a “correct”
response cue, such as a light, to study Pavlovian association between this conditioned
stimulus cue and the unconditioned drug stimulus (Carroll et al., 1993). Presentation of
this cue can facilitate the learning of this instrumental responses, termed Pavlovianinstrumental transfer (Hall et al., 2001). Overall, acquisition of SA is comparable to
humans learning to take the drug.
6

In a progressive ratio schedule of reinforcement, the reinforcement schedule can
be made to progressively increase the number of correct responses required for the
reinforcer to be dispensed. Once the animal reaches an established criterion of reinforcer
received, the animal is termed to have reached a “break point.” This allows for
experimenters to measure the reinforcing efficacy of the drug, determined as the
maximum amount of effort the animal will undergo to maintain SA of the drug. Thus, the
maintenance of this behavior is comparable to the effort required for stable drug use in
humans.
In standard SA, animals are given a limited period to administer the drug.
However, when animals are given extended access to drugs of abuse in a selfadministration model, they undergo a specific behavioral pattern termed escalation of
drug use. This is hypothesized to be due to a change from goal-directed behavior towards
compulsive drug use, possibly due to less cortical control and more striatal control
(Kalivas et al., 2005). Uncontrollable, compulsive drug use is an important facet in the
human condition.
Mechanisms of abstinence can be assessed through removal of the drug. This can
be done by removal of the reinforcer for any instrumental action, termed extinction, or
forced abstinence through leaving the animal within its home cage. Although in both
models of abstinence, extinction requires new learning of the non-availability of the
reinforcer. This leads to the diminishment of active lever presses. In contrast, forced
abstinence recruits a separate phenomenon, incubation of craving. Animals that have
undergone forced abstinence will increase their active lever presses in response to
reintroduction of the operant chamber (Grimm et al., 2003). In the extinction model
7

active lever pressing can be reinvigorated through a non-contingent priming dose of the
drug, drug-associated cue, or stress. Similar to CPP, but more translatable to human
SUDs, these behaviors are measures of drug seeking. Overall, both reinstatement after
extinction and incubation of craving can be thought of as different models of relapse in
humans.

1c. Nucleus Accumbens plasticity associated with addiction-related behaviors

Although drug use is required for the development of addiction, it is most
certainly insufficient to cause this disorder. For example, around 176.6 million, of
Americans ages 12 and up drink alcohol but only 17 million are classified as having an
alcohol use disorder (SAMSHA, 2013). Drugs are metabolized and eventually cleared
from the body, thus, their pharmacological effect is not sufficient. In addition, SUDs are
classically characterized by chronic relapse after periods without symptoms (McLellan et
al., 2000). This may occur many years after a patient’s last reported use of a drug,
suggesting that some stable functional alteration has occurred within the brain. Repeated
drug exposure is required for an accumulation of molecular events that alter plasticity
within specific regions affecting the functioning of the entire circuit. These synaptic
alterations are persistent and similar to the chronic relapse state of patients with SUDs,
suggesting that reversing these processes may prevent relapse (McLellan et al., 2000;
Shen et al., 2009). Additionally, they appear to be protein-synthesis dependent forms of
plasticity (Hernandez et al., 2002; Scheyer et al., 2014). Thus, the molecular mechanisms
regulating gene expression may play a role in the etiology of this disorder, specifically
8

drug-induced alterations in addiction-related gene (ARG) expression leads to persistent
modifications in region-specific synaptic plasticity.
Long-term synaptic plasticity can take the form of potentiation (LTP) or
depression (LTD) of synaptic strength. Nearly every form of plasticity has been found to
occur within the NAc during various drug exposures or addiction-related behavioral
paradigms (Scofield et al., 2016). This may be due to different neuronal subtypes within
the region, such as dopamine receptor D1- or D2-containing medium spiny neurons
(MSNs), which are projection neurons and represent 95% of the neurons in the NAc, and
small number of interneurons. To add to this complexity, these neurons have different
downstream projections or upstream afferents. Thus, increased or decreased synaptic
strength may be required to cause orchestrated changes in other brain regions and
ultimately behavior.

1d. Molecular mechanisms of addiction-related behavior associated plasticity

Regulation of ARGs can occur at many different steps. The DNA in the genome
is organized into small compact three-dimensional units assembled by histones into
nucleosomes, which form the structure of chromatin. As such, basal transcription is
necessarily stagnant in the absence of regulation of gene accessibility. Modifications to
the accessibility of genes, by regulation of these structures is termed epigenetic regulation
and has also been found to be an integral component in the development of addiction.
Given that the epigenetic control of drug addiction has been elegantly reviewed in
previous works (Robison et al., 2011; Tuesta et al., 2014; Bastle et al., 2016; Cadet et al.,
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2016), this section will focus on other aspects of gene expression control starting at the
level of transcription.

i. Transcriptional Regulation of Addiction-Related Genes

Transcriptional regulation occurs through transcription factors, which respond to
intracellular changes leading to association with cis-regulatory elements (CREs) in the
promoter of target genes.

a. The Fos family transcription factors are differentially altered by drugs of abuse and
contribute to addiction-related plasticity and behavior

Although altered transcription of various genes had been suggested by earlier
work (E W Fleming et al., 1981; Eugene W Fleming et al., 1981), it was not until the
discovery that morphine caused increased striatal expression of, c-Fos, that it was shown
that transcription factors may regulate this drug-induced gene expression (Chang et al.,
1988). Although first found to be regulated by acute morphine treatment, it was found
that other drugs of abuse cause specific, dopamine-dependent, alterations in the
expression of this transcription factor within addiction-related regions (Graybiel et al.,
1990; Persico et al., 1993). Important for the study of relapse, it was found that c-Fos was
upregulated in mesolimbic structures following withdrawal, suggesting that it may play a
role in the intense drug craving present in this disorder (Hayward et al., 1990). c-FOS is
part of the Fos family of transcription factors, including FosB and ΔFosB, which all
heterodimerize with Jun to form the AP-1 complex (Milde-Langosch, 2005). This
10

complex then associates with its specific CRE, the AP-1 binding site, leading to increased
transcription of genes downstream of these sequences.
Fos genes are considered immediate early genes (IEG), or factors that are basally
expressed at low levels but elevated rapidly by specific stimuli (first reviewed in the
context of neuronal cells (Sheng et al., 1990). Since it was upregulated by other plasticity
and memory inducing events, it was hypothesized that c-Fos, and possibly other IEGs,
may alter gene expression involved in memory formation (Curran et al., 1987). As
expected, upregulation of c-Fos, FosB, ΔFosB and Jun lead to increased AP-1 mediated
transcription within addiction-related regions such as the NAc after acute drug
administration (Hope et al., 1992). Due to its regional specificity, it was hypothesized
that alterations in these genes may provide a mechanism for reorganization of functional
interactions between these regions in addiction (Moratalla et al., 1996). Although c-Fos
is rapidly upregulated and returns to basal levels quickly, AP-1 binding continued in the
absence of elevated c-Fos mRNA or protein expression suggesting that other Fos proteins
may replace c-Fos and accumulate during chronic use of drugs. This may provide a
molecular trace of chronic drug use in the absence of drug itself. This tolerance to initial
c-Fos upregulation appears to be drug agnostic, as acute alcohol exposure blocked the
previously observed acute cocaine upregulation of c-Fos, also suggesting that this
molecular trace persists for the use of different drugs (Torres, 1994).
To more specifically test the role of specific transcription factors in addiction,
transgenic mice with specific mutations were required. The first experiment to utilize this
approach used a transgenic mouse with a mutant fosB gene that prevented the production
of ΔFOSB. It is important to consider that this mutant fosB gene was not targeted to any
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specific cell type or even to the brain, but throughout the body. These mutant mice
showed attenuated chronic induction of AP-1 binding activity, suggesting that the
previously observed AP-1 binding without c-Fos upregulation was probably due to
ΔFOSB (Hiroi et al., 1997). Additionally, this study was the first to link transcriptional
regulation with altered addiction-like behavior. They used CPP to determine that fosB
mutant mice showed increased CPP compared to wild-type controls, suggesting that
normal ΔFOSB/AP-1 binding might be involved in a compensatory or adaptive response
to drugs. Fos family members have also been found to be upregulated after exposure to
drug-paired cues in the absence of the drug itself, suggesting this CPP effect may be due
to the interaction between drug and cues soliciting the availability of the drug, an
importance facet in addiction research (Schroeder et al., 2000).
Although certain molecular factors within one set of cells may cause increased
addiction-like behavior or plasticity, it may cause an opposite effect on these measures in
another set. Cellular specificity is an important facet of experimental neuroscience. In an
experiment complementary to that performed by Schroeder and colleagues, researchers
developed an inducible system to specifically overexpress ΔFosB within D1 neurons in
the striatum (Kelz et al., 1999). Neurons within the striatum are generally GABAergic
medium spiny neurons that mostly express D1 or D2 dopamine receptors. D1 receptors
are G-stimulatory (Gs) G-protein coupled receptors (GPCRs), which upon activation
increase the activity of the target neuron, leading to increased GABA release.
Conversely, D2 receptors are coupled to G-inhibitory (Gi) and are inhibited by dopamine
binding which lead to the opposite effect on these neurons. Since drugs of abuse increase
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dopamine levels within the striatum, both D1 and D2 containing neurons play important
but dissociable roles in the development of addiction.
Targeted ΔFosB overexpression in D1 neurons showed a similar effect on
increased CPP behavior at low doses (5 and 15 mg/kg), but normal CPP behavior at
higher doses (20 mg/kg). This suggests that that cocaine-induced ΔFosB expression
within these cells is necessary and sufficient to promote addiction-like behaviors.
Furthermore, GABAergic inhibition from these cells may play a role in CPP behavior.
Finally, this is physiologically relevant, as drugs of abuse and to a lesser extent natural
rewards cause upregulation of ΔFosB in this specific neuronal subtype (Nye et al., 1995;
Moratalla et al., 1996). In a similar experiment, non-specific deletion of ΔFosB
throughout the body caused the same behavioral alteration, increased CPP behavior to
lower doses of cocaine (Hiroi et al., 1997). Although this finding may seem
contradictory, when taken together with previous data, this points to the existence of
other regions or possibly neuronal subtypes that act in opposition to D1 neurons.
Following up on this, researchers overexpressed ΔFosB within D2 expressing neurons in
the striatum produced no effects, illustrating the cellular specificity of these drug-induced
alterations (Zachariou et al., 2006). Thus, ΔFosB within these regions and cells may not
play a role, or possibly inhibit, the plasticity required for the development of these
behaviors.
To study the role that ΔFosB may play in the motivation to consume drugs,
researchers utilized PR in a SA model. Animals with a similar inducible ΔFosB genotype
as used by Kelz and colleagues showed increased motivation to self-administer cocaine,
as they were found to have an increased PR (Colby et al., 2003). This was also the first

13

experiment to show that this alteration specifically affected motivation towards drugs and
not naturally rewards such as a food pellet.
Transcription factors elicit changes in expression of genes, thus this work
suggests that there must be some downstream targets of the FOS transcription factor that
are mediating these effects on addiction-related behavior. Kelz and colleagues first
described a downstream target that may alter plasticity involved in these behavioral
alterations (Kelz et al., 1999). Striatal neurons are normally quiescent, even with
dopamine input. Thus, glutamate is required to alter their firing. Speaking to integral role
of glutamate to MSN activity, it has been found to be an important neurotransmitter in
addiction-like behaviors (reviewed in (van Huijstee et al., 2015). Kelz and colleagues
found that ΔFosB overexpression caused an increase in a specific AMPAR subunit,
GluR2 which could lead to altered plasticity (Kauer et al., 2007). Additionally, they
could recapitulate their effects on behavior by viral mediated overexpression of this
subunit in the striatum. Overall, many ΔFOSB targets are genes encoding proteins that
appear to be previously linked to addiction-like behaviors such as CDK5 and NFKB.

b. CREB, a transcription factor well established in plasticity involved in learning and
memory, plays a role in addiction

Drugs of abuse can cause acute regulation of molecular signaling cascades that
can modify transcription factor activity. For example, many drugs of abuse can induce
acute upregulation of the second messenger cAMP within many addiction-associated
brain regions (Cole et al., 1995; Carlezon et al., 1998; Berke et al., 2000; Nestler, 2001;
Shaw-Lutchman et al., 2002, 2003; Walters et al., 2003). cAMP response element
14

binding protein (CREB) is phosphorylated in response to cAMP upregulation by a kinase
sensitive to cAMP, protein kinase A (PKA; (Shaywitz et al., 1999; Mayr et al., 2001) as
well as by CaMK and other kinases (Sheng et al., 1991). The role of CREB in other
forms of plasticity mediating memory have been well elucidated (Mayr et al., 2001).
Once phosphorylated CREB can enter the nucleus and bind to its response element, the
cyclic AMP response element (CRE). CREB was first implicated in drug-induced
alterations in response to acute and chronic morphine treatment within the locus
coeruleus, another region in the reward system projecting to the NAc and containing the
cell bodies of noradrenergic neurons (Guitart et al., 1992). Later it was found that
chronic, but not acute, morphine caused a decrease in CREB within the NAc (Widnell et
al., 1996). Cocaine self-administration was found to be sensitive to PKA inhibition, an
upstream regulator of CREB, by increasing lever pressing (Self et al., 1998b). Following
this experiment, it was later found that NAc overexpression of CREB caused a decrease
in cocaine-CPP behavior (Carlezon et al., 1998). Conversely, overexpression of a mutant
CREB containing a single point mutation, alanine for serine at residue 133, that prevents
its phosphorylation and blocks its ability to induced transcription acting as a dominant
negative form of CREB, caused an increase in cocaine-CPP behavior. Further correlating
the role of this transcription factor in the association of drug cues, researchers found that
re-exposure to the original drug-paired environment in CPP without drug caused
increased phosphorylation of CREB (Tropea et al., 2008). Highlighting the differences of
behavioral tasks, it was shown that NAc overexpression of CREB caused an increase in
self-administration behavior (Larson et al., 2011). This gene has also been studied in
human patients. Researchers found that opioid-dependent patients were more likely to
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have a polymorphism in a protein that associates with CREB, CREB binding protein,
within a region associated with its activation by phosphorylation (Kumar et al., 2011).
Altogether, it appears that CREB expression is involved in many aspects of addictionrelated behavior.
CREB is a nuclear transcription factor that binds to CRE upstream of target genes.
CREB regulation has been found to cause upregulation of ARG mRNA such as c-fos,
Fosb, Bdnf, and TrkB (for example in methamphetamine self-administration, (Krasnova
et al., 2013). BDNF and its receptor TrkB have a very long history in the study of
addiction-related behaviors as well as general plasticity occurring within the brain (Li and
Marina E Wolf, 2015). Further implicating CREB as a regulator of plasticity, it has been
found to be involved in late phase forms of long-term potentiation (LTP; (Barco et al.,
2002). As mentioned before, NAc neurons are normally quiescent and require glutamate
activation with or without dopamine stimulation to fire. CREB has been associated with
the regulation of this feature of NAc neuronal membrane excitability (Huang et al.,
2008). It was found that increased CREB activity leads to enhanced NMDAR mediated
currents, an important receptor for causing action potentials as well as for learning &
memory. This regulation increases NAc neuronal firing probability through enhancement
of the membrane excitability. This may partially explain the effect of NAc CREB on
behaviors such as self-administration. Thus, CREB regulates the expression of many
genes associated with plasticity and addiction-related behaviors.
CREB and ΔFOSB are very well documented addiction-related transcription
factors but, undoubtedly, there are many more transcriptional factors that alter addictionrelated plasticity and ultimately behavior. Myocyte enhancing factor 2 (MEF2) was found
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to be involved in cocaine-induced structural plasticity (Pulipparacharuvil et al., 2008).
Interestingly, it was necessary and sufficient to increase the number of dendritic spines,
or synapses. Structural plasticity or the alteration of the physical synaptic shape has been
associated with electrophysiological measurements of plasticity. Additionally, it was
found that MEF2 regulates a wide network of plasticity-associated genes allowing for
further exploration into its role in addiction-related plasticity and behavior (Flavell et al.,
2008). Overall, transcriptional regulation of ARG expression can lead to modifications in
drug-evoked synaptic plasticity and behavior (Persico et al., 1996; Nestler, 2012)s.

ii. Post-transcriptional regulation of plasticity and addiction-related gene mRNA can
promote addiction-like behaviors.

Post-transcriptional regulation occurs after mRNA transcription but before the
mRNA is translated into functional protein. Post-transcriptional regulation takes many
forms such as mRNA processing, splicing, editing, and stability. mRNA stability has
been the most well characterized post-transcriptional mechanism in plasticity, especially
in addiction. Additionally, it appears that mRNA stability may be especially important in
brain, as nearly 20% of brain expressed genes have been predicted to be controlled
through this mechanism (Bolognani et al., 2010).

a. miRNAs destabilize specific mRNAs which could lead to diminished expression of
genes involved in addiction
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Direct binding of factors to discrete recognition sites can influence mRNA
stability. One group of factors involved in this type of mRNA stability are small noncoding RNAs, termed microRNAs (miRNAs). miRNAs are ~20-22 oligonucleotide
molecules that are encoded within the genome and make up nearly 2-3% of transcribed
genes, but are not translated into protein. miRNAs target specific mRNAs through
binding of complementary sequences within the miRNA, termed seed regions, to the 3’
untranslated region (UTR) of the mRNA. Association of miRNAs with the 5’UTR of
mRNA has also been discovered (Panda et al., 2014) leading to different cellular effects,
but most studies within the brain have focused on the 3’UTR. Accordingly, the rest of
this section will focus on this mechanism.
Although the miRNA may associate directly with the mRNA target, the
regulatory effects of this binding are mediated through a large, supporting protein
complex, the RNA induced silencing complex or RISC. Through associating with the
RISC, a miRNA can target specific mRNAs for degradation or translational repression
(Bartel, 2004). This complex contains a multitude of auxiliary proteins, with the most
important being Argonaute (Ago; (Sontheimer, 2005). Ago is the component most
directly involved in regulating mRNA. There are many Ago isoforms, but generally, they
are separated into those containing nuclease “slicer” activity and those without. Thus,
Ago is important for the well-characterized miRNA induced destruction of mRNA.
mRNAs may have numerous sites complementary for multiple miRNAs. This
suggests that a single miRNA targets many mRNAs, affecting a myriad of cellular
processes and pathways. miRNAs may regulate a network of plasticity-associated genes.
For example, miR-9-3p was found to diminish Dmd and Sap97 mRNA (Sim et al., 2016).
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These genes are negatively associated with LTP expression, thus miRNA induced
silencing of these mRNAs would reverse this effect. A hippocampal LTP dependent
behavior, Morris water maze, was also found to be regulated by the expression of this
miRNA. Similar to a group of plasticity- and addiction-associated transcription factors,
miRNA expression patterns appear to be similar to IEGs in their temporal and activity
dependent regulation. As demonstrated before, many of these IEGs play integral roles in
general plasticity and addiction-related plasticity. Similar to IEGs, miRNAs have been
associated with neural development, synaptic plasticity, and even behavior.
The role of miRNA induced post-transcriptional regulation in addiction was first
studied in the regulation of the large-conductance-calcium-and-voltage-activated
potassium channel (BK). This channel is integral to plasticity by affecting excitability,
firing, and transmitter release from neurons (Storm, 1990). It is also one of the many
protein targets of alcohol within the brain, for the most part potentiating its conductance
(Butler et al., 1993). This channel has been well studied in its role in tolerance to alcohol
in the striatum, requiring larger amounts to exert similar effects (Pietrzykowski et al.,
2004). This seems to be mediated by decreased BK channel expression in the membrane.
A single gene can produce multiple mRNAs with the same coding region but with
different 3’UTRs through the inclusion or exclusion of different exons (Legendre et al.,
2006). Research has shown that the alpha subunit of this BK channel is alternatively
spliced both in the coding region and 3’ UTR in response to neuronal activity (Xie et al.,
1998; Pietrzykowski et al., 2004). These researchers also found that alcohol caused a
decrease in one specific BK mRNA that has a miR-9 binding site in its 3’ UTR. Given
that this isoform of the BK channel mRNA is the most abundant in the striatum and miR19

9 expression is increased by alcohol exposure, alcohol tolerance seems to be mediated at
least in part by this miRNA (Pietrzykowski et al., 2004). As mentioned before, miRNAs
target many mRNAs that contain a complementary sequence in the 3’UTR. Thus, these
authors also proposed that miR-9 targets many other mRNAs such as the beta subunit of
the GABA receptor, Gabrb2, and the Dopamine 2 Receptor, D2r. Overall, this suggests
that alcohol mediated upregulation of miR-9 leads to the development of an alcoholspecific regulation of mRNAs associated with plasticity and addiction.
Subsequent studies showed that miR-212 was upregulated in the dorsal striatum
of these animals after extended access (Im et al., 2010). These researchers found that
upregulation of miR-212 was associated with potentiated CREB signaling, possibly
through upstream cAMP pathways. RAF1 potentiates adenylyl cyclase activity, leading
to increased cAMP production. Various other factors can enhance or repress this action.
One of the targets of miR-212 is Sprout-related, EVH1 domain containing 1 (SPRED1), a
corepressor of RAF1. Thus, extended access to cocaine-induced upregulation of miR-212
led to decreased SPRED1 levels, leading to increased cAMP production and CREB
activity leading to increased miR-212 expression. When miR-212 was overexpressed
within the dorsal striatum, rats in extended access showed decreased levels of cocaine
infusions. With this, miR-212 upregulation was associated with an increase in CREB
expression. Oppositely, blocking of miR-212 by a locked nucleic acid (LNA) caused an
increase in cocaine infusions. Overall, this suggests miR-212 activates a compensatory
and protective pathway that leads to enhanced CREB signaling.
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b. RNA binding proteins bind to mRNAs and can bidirectionally regulate addictionassociated mRNA translation into protein

RNA binding proteins (RBPs) are another group of regulators of mRNA stability
and translation. Some RBPs recognize discrete sequences in the 3’UTR, such as the AUrich instability conferring elements (AREs; (Bakheet et al., 2006). As with miRNAs,
there is potential for a single RBP to affect multiple downstream processes leading to
miRNAs and RBP to be termed “master switches” of gene regulation (Deschênes-Furry
et al., 2006; Keene, 2007). Fragile x mental retardation protein (FMRP) is an RBP that
regulates the translation of nearly 850 brain mRNAs, many associated with synaptic
function (Darnell et al., 2011). One of its regulatory targets are the group I metabotropic
glutamate receptors mGluR1 and mGluR5 (Ceman et al., 2003; Narayanan et al., 2007;
Nalavadi et al., 2012). These receptors have been associated with cocaine-evoked
behaviors (Chiamulera et al., 2001; Olsen et al., 2010). Thus, Smith and colleagues tested
the role of FMRP in addiction-related behaviors (Smith et al., 2014). They found that
Fmr1 KO mice were deficient in cocaine locomotor sensitization and conditioned place
preference. The effect on conditioned place preference was reversed by genetic reduction
in mGluR5, suggesting that FMRP’s effect on drug-evoked behaviors was due to
mGluR5 activity. Finally, they found that FMRP caused a reduction in cocaine-induced
structural plasticity suggesting that these behavioral deficits may be caused by this
aberrant plasticity. Overall, post-transcriptional regulation may emerge as an important
player tying drug-evoked molecular alterations with behavior and will be discussed
extensively in this work.

21

c. mRNA editing can alter the sequence or expression of an addiction-related mRNA
leading to alterations in addiction-related plasticity and behavior

mRNA editing is another post-transcriptional regulatory mechanism. The most
common mechanism for RNA editing is through covalent modifications of a specific
nucleotide, without the alteration of the original DNA encoded gene. This would generate
multiple alternative forms of a protein which may be important in different cellular
contexts.
The most common mRNA modification leading to editing is the removal of an
amino group and its replacement with an oxygen, termed deamination. This occurs on the
N6 position of adenosine nucleotides, converting this nucleotide into an inosine. This
position directly contributes to conventional Watson-Crick base pairing, thus allowing
inosine to pair with cytosine similar to guanosine. Translationally, this leads to the
original adenosine to be read as a guanine, effecting causing an A-->G site-directed
mutagenesis. This modification is catalyzed by adenosine deaminase that acts on RNA
(ADAR) enzymes (Bass et al., 1988; Wagnert et al., 1989; Kim, Garner, et al., 1994;
Kim, Wang, et al., 1994; Melcher et al., 1996).
Specific mRNA editing in a neurophysiological context was first described in the
GluRA2 subunit of AMPAR (Lomeli et al., 1994). As mentioned before, editing of
mRNA is a rapid mechanism to generate multiple alternative forms of a protein
depending on environmental circumstances. These receptors are integral to excitatory
synaptic signaling, especially in plasticity. Thus, AMPAR editing generates channels that
are impermeable to calcium and display faster recovery rates from desensitization. In
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terms of drug-induced plasticity, a recent study demonstrated that GluA2 editing by
ADAR2 in the NAc of rats regulates cocaine seeking (Schmidt et al., 2015). These
researchers studied reinstatement, a specific stage of drug self-administration (Roberts et
al., 2007). Animals first need to learn the required instrumental behavior to receive a
reward in self-administration. When the animal reaches an experimenter determined
criterion, then the animal is said to have “acquired” self-administration behavior. If the
animal is then presented with the same context and levers, but rewards are withdrawn, the
animal will eventually override the previously learned reward driven behavior.
Eventually, the animal will no longer perform the task required for the reward, which is
termed extinction. Finally, when an animal is exposed to cues associated with the reward
or the reward itself, the animal will reinstate its behavior to receive the reward.
Reinstatement is thought to be analogous to relapse in human addiction patients. In this
study they found that abstinence from cocaine was associated with a decrease in NAc
edited calcium-impermeable AMPAR as well as ADAR2. Next, Schmidt and colleagues
overexpressed ADAR2 within the NAc. They found that this diminished cocaine-primed
reinstatement of self-administration behavior, suggesting that ADAR2 within the NAc is
important for the regulation of relapse-like behavior. Overall, there are many avenues for
mRNA editing in drug-induced plasticity and addiction-like behaviors (Rosenthal, 2015).
Another post-transcriptional mRNA modification is the covalent modification of
adenosine to N6-methyladenosine (m6A). This modification is carried out by a
methyltransferase complex, containing WTAP, METTL14, and KIAA1429. Hence, this
complex is usually thought of as the “writers” of m6A modifications. In opposition to the
activity of this complex, enzymes have been discovered that promote the demethylation
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of mRNA, or the “erasers” of these modifications. These modifications have been studied
for many years as a stable, unalterable modification. However, with the discovery of
m6A demethylases this shifted opinion to suggest that this modification is dynamic and
thus could be regulated by physiological conditions (reviewed in (Cao et al., 2016). For
example, it was reported that regulation of m6A was important to the normal functioning
of the circadian rhythm in mammals (Fustin et al., 2013). Thus, m6A is physiologically
relevant in behavior.
The first m6A demethylase to be discovered was the fat mass and obesity
associated protein (Fto). As the name suggests, it was identified as the strongest genetic
variation to predispose patients to obesity (Frayling et al., 2007). At the opening of this
chapter, evidence was presented to show that addiction-related neurocircuitry originally
evolved to elicit goal-directed behavior towards food, suggesting this gene may also be
involved in other forms of goal-directed behavior. The first study to link these findings
was performed in alcoholic patients, finding that a polymorphism in the Fto gene was
associated with obesity (rs9939609) was inversely correlated with general alcohol
consumption, measures of alcohol dependence, as well as cigarette use (Sobczyk-Kopciol
et al., 2011).
Later work found that this gene is expressed in dopaminergic neurons within the
midbrain and is increased by acute cocaine administration (20 mg/kg; (Hess et al., 2013).
Cocaine, and to a lesser extent amphetamines, inhibit the dopamine transporter (DAT),
leading to increased synaptic dopamine. This in turn leads to hyperactivation of
dopamine receptors on both sides of the synapse. The presynaptic terminal contains D2
and D3 receptors, which are inhibitory GPCRs. Thus, the presynaptic dopaminergic
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neuron will show increased suppression of firing in response to cocaine. In the next set of
experiments, these researchers found that Fto deficient dopaminergic neurons showed
diminished cocaine-induced suppression of firing rate, suggesting that signaling through
D2/D3 receptors is regulated by Fto. As expected, it was found that protein expression of
these downstream targets (DRD3, GIRK2, and NMDAR1) were reduced by Fto
deficiency. Functionally, Fto deficiency led to a reduction in GIRK currents, possibly
detailing a mechanism for the diminished cocaine-induced suppression of firing rate in
dopaminergic neurons. Finally, Fto deficient mice showed attenuated acute cocaineinduced locomotor activity, suggesting that these genetic and electrophysiological
measures translate into this behavioral modification.
As shown here, there are many avenues for regulation of ARGs at the
transcriptional or the post-transcriptional level. These regulatory mechanisms all have
been implicated in the development of this disorder and thus may be involved in the
vulnerability of some individuals to substance use disorders. Understanding the
regulation of addiction-related genes and their impact on synaptic plasticity and behavior
may inform new pharmacological treatments that reverse these aberrant drug-evoked
forms of plasticity in the favor of remission.

1e. Rationale for Nucleus Accumbens HuD and miR-495 involvement in addictionrelated processes

As mentioned previously, post-transcriptional regulation takes many forms such
as mRNA processing, splicing, editing, stability, and translation. Previous research in our
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laboratory has found that nearly 20% of brain expressed genes may be controlled through
mRNA stability (Bolognani et al., 2010). mRNA stability can be influenced by direct
binding of factors to discrete recognition sites. miRNAs are one such group and target
specific mRNAs through complementary regions within the miRNA, termed seed
regions, and the 3’ untranslated region (UTR) of the mRNA. Through associating with
the RNA-inducible silencing complex (RISC), a miRNA can target specific mRNAs for
degradation or translational repression (Bartel, 2004). Although one miRNA has one
specific seed region to bind to mRNAs, mRNAs may have numerous sites
complementary for multiple miRNAs. This suggests that a single miRNA targets many
mRNAs, affecting a myriad of cellular processes and pathways. As posited in the above
sections, many characteristics of miRNAs make them appealing targets for disorders such
as SUDs. Thus, we sought to identify a candidate miRNA that targets multiple addictionrelated genes (ARGs) and may provide a novel mechanism for - reverting drug-induced
aberrant gene expression.
RBPs are another group of regulators of mRNA stability. They too recognize
discrete sequences in the 3’UTR, such as the AU-rich instability conferring elements
(AREs; (Bakheet et al., 2006). As with miRNAs, there is potential for a single RBP to
affect multiple downstream processes leading to miRNAs and RBP to be termed “master
switches” of gene regulation (Deschênes-Furry et al., 2006; Keene, 2007). This is
especially important in the brain, as around 15-20% of brain specific transcripts contain
AREs suggesting these genes are regulated by this type of post-transcriptional regulation
(Bolognani et al., 2010). One such family of RBPs are the Hu, or Embryonic Lethal
Abnormal Vision like (ELAV-L) proteins. Hu proteins are primarily brain and neuronal
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specific and are homologous to the Drosophila protein ELAV (Szabo et al., 1991; Yao et
al., 1993). Similar to miRNAs, HuD expression and function is activity dependent,
suggesting it may regulate IEGs and other activity dependent genes associated with
plasticity (Tiruchinapalli, Ehlers, et al., 2008; Bolognani et al., 2010; Vanevski et al.,
2015). This activity dependence is compounded by evidence that this regulation of HuD
leads to association with plasticity associated mRNAs such as Homer1a and Camk2a.
Recent studies indicate that HuD also plays a role in translation and that PKC-mediated
phosphorylation of HuD increases local translation of BDNF, suggesting that HuD may
be involved in protein synthesis-dependent forms of plasticity. HuD is localized to the
dendritic compartment of hippocampal neurons (Bolognani et al., 2004), where it has
been implicated in activity-dependent synaptic tagging controlling CamkIIα mRNA
localization and translation (Sosanya et al., 2015a). In confirmation of this idea, our
laboratory has shown that HuD is critical for stabilizing U-rich containing mRNAs during
neuronal development and synaptic plasticity such as those encoding BDNF and
CaMKIIα (work from our laboratory reviewed in (Perrone-Bizzozero et al., 2002;
Bolognani et al., 2008, 2010; Allen et al., 2013; Sosanya et al., 2015a; Vanevski et al.,
2015). Moreover, HuD has been associated with hippocampal-dependent learning
(Bolognani et al., 2004; Pascale et al., 2004; Bolognani, Qiu, et al., 2007) and seizures
(Bolognani, Qiu, et al., 2007), suggesting it may be involved in other activity-dependent
regulatory networks. Thus, HuD is a critical regulator of multiple plasticity associated
genes, thus suggesting that it may be involved in addiction-related altered gene
expression, plasticity and ultimately behavior.
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Since many learning paradigms have been found to be protein synthesisdependent, RBPs that influence translation, such as HuD, may be involved. Substance use
disorders, and their animal model cognate, addiction-like behaviors, are aberrant forms of
learning that have been hypothesized to arise from similar molecular and
electrophysiological processes as those found in other forms of associative learning and
memory (Alkon et al., 1991; Ann E. Kelley, 2004; Hyman, 2005; Hyman et al., 2006;
Koob et al., 2010). The encoding of environmental cues predicting reward-availability is
a feature shared by both natural and drug-induced forms of learning and memory. These
strong associations with cues are thought to be involved in the chronic relapsing state of
patients with substance use disorders (Childress et al., 1999). CPP is an animal model
useful for studying learning and motivation acquired through associations between drug
effects and environmental cues present during the drug experience (see section 1b for a
more detailed explanation). Acquisition and expression of CPP is thought to recruit
protein-synthesis dependent mechanisms (Kuo et al., 2007; Robinson et al., 2007), which
are critical for forming the drug-cue associations that motivate approach and contact with
the cues (i.e., a model of conditioned drug-seeking behavior). Thus an RBP that regulates
mRNA levels and translation before or during translation may play an integral role in
SUDs.
Since both RBPs and miRNAs target the 3’UTR, this opens the possibility that
these two classes of molecules could compete for access to a specific recognition site
(Jing et al., 2005; Bhattacharyya et al., 2006; van Kouwenhove et al., 2011). We have
found a specific miRNA, miR-495, and HuD target a set of shared mRNAs through the
same GUUUGUUUG sequence (Bolognani et al., 2010); Gardiner et al., In prep.). Many
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of these shared targets, including Bdnf and Camk2a have been implicated in addiction
(Knowledgebase of addiction related genes, KARG, (Li et al., 2008). With this, we
hypothesized that the competition between miR-495 and HuD could inhibit or promote
the expression of ARG mRNA, respectively.
Alterations in dendritic and spine structural plasticity have been documented in
learning & memory, exposures to drugs of abuse, as well as addiction-related behavioral
paradigms (in general, (Alvarez et al., 2007); in addiction (Russo et al., 2010).
Alterations in these measures occur in other experience dependent situations, suggesting
that structural plasticity is a learning phenomenon (reviewed in (Alvarez et al., 2007).
Possibly mirroring a classical symptom of addiction, these structural alterations induced
by drugs of abuse inhibit the ability of other non-drug related experiences to elicit
structural plasticity (Kolb et al., 2003; Hamilton et al., 2005). These structural alterations
are very persistent similar to the chronically relapsing state of patients with addiction and
suggests that reversing these structural alterations may prevent this chronic relapsing
condition (McLellan et al., 2000; Shen et al., 2009). Additionally, multiple addictionrelated behaviors are associated with alterations in these measures. For example, place
preference to cocaine, but not home cage treatment, was correlated with NAcSh increases
in spine density, mostly by increases in thin spines (Marie et al., 2012). This suggests that
drug-evoked structural alterations of neurons within discrete regions may be involved in
addiction-related behaviors, especially in the NAcSh during CPP. More importantly, in
the context of my proposal, two of the shared targets of HuD and miR-495, BDNF and
CamKIIα, have been implicated both in CPP and in the increase in spine density and
change in spine morphology associated with these behaviors (Jourdain et al., 2003;
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Okamoto et al., 2007; Bahi et al., 2008; Orefice et al., 2013; Robison et al., 2013;
Yagishita et al., 2014). Thus, this suggests that miR-495 and HuD differentially affect
plasticity associated with the learning and memory found in addiction-related behaviors.

1f. Hypothesis
Combined, this led to the hypothesis that cocaine CPP differentially regulates HuD
and miR-495 leading to a synergistic increase in ARG expression and addiction-like
behaviors. This was tested utilizing two specific aims:

1. Test the hypothesis that HuD, miR-495 and targets within the NAc are
differentially regulated by cocaine CPP training
A) Determine expression of HuD and miR-495 and two of their shared
target mRNAs (Bdnf and CamK2a) after conditioned place preference
(CPP) by qRT-PCR
B) Western blots

2. Test the hypothesis that miR-495 and HuD have opposite roles in CPP
A) LV mediated OE of miR-495
B) Transgenic HuD Overexpressing animals (HuDOE)
C) Potential rescue of the increased CPP in HuDOE mice by LV-miR-495.
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Although the focus of this work is on the role of HuD and miR-495 within the context of
cocaine CPP, the findings related to this hypothesis as well as other supporting data
illustrating the role that HuD and miR-495 may play in addiction-related behaviors and
plasticity in general will be discussed in this work.
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Abstract
MicroRNAs (miRNAs) are important post-transcriptional regulators of gene
expression and are implicated in the etiology of several neuropsychiatric disorders,
including substance use disorders (SUDs). Using in silico genome-wide sequence
analyses, we identified miR-495 as a miRNA whose predicted targets are significantly
enriched in the Knowledgebase of Addiction-Related Genes (ARG) database (KARG;
http://karg.cbi.pku.edu.cn). This small non-coding RNA is also highly expressed within
the nucleus accumbens (NAc), a pivotal brain region underlying reward and motivation.
Using luciferase reporter assays, we found that miR-495 directly targeted the 3’UTRs of
Bdnf, Camk2a, and Arc. Furthermore, we measured miR-495 expression in response to
acute cocaine in mice and found that it is downregulated rapidly and selectively in the
NAc, along with concomitant increases in ARG expression. Lentiviral-mediated miR-495
overexpression in the NAc shell (NAcsh) not only reversed these cocaine-induced effects,
but also downregulated multiple ARG mRNAs in specific SUD-related biological
pathways, including those that regulate synaptic plasticity. miR-495 expression was also
downregulated in the NAcsh of rats following cocaine self-administration. Most
importantly, we found that NAcsh miR-495 overexpression suppressed the motivation to
self-administer and seek cocaine across progressive ratio, extinction, and reinstatement
testing, but had no effect on food reinforcement, suggesting that miR-495 selectively
affects addiction-related behaviors. Overall, our in silico search for post-transcriptional
regulators identified miR-495 as a novel regulator of multiple ARGs that play a role in
modulating motivation for cocaine.
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Introduction
Substance use disorder (SUD) is a chronic, debilitating condition characterized by
compulsive drug use despite negative consequences and a high recurrence of relapse even
after prolonged periods of abstinence (Leshner, 1997). SUD is believed to be a
dysfunction of neuroplasticity (Kalivas et al., 2008), whereby altered gene expression
impacts neuronal function and subsequent behavior (McClung et al., 2008). Drugs of
abuse cause widespread epigenetic changes to chromatin accessibility, thereby altering
the transcriptional activity of several genes (Robison et al., 2011; Feng et al., 2013;
Rogge et al., 2013). However, less is known about the post-transcriptional processes that
control mRNA dynamics and, ultimately, translation into functional proteins. Among the
non-coding RNAs, microRNAs (miRNAs) play a critical role in the post-transcriptional
control of a large number of transcripts. These small RNAs typically guide the RNAinduced silencing complex (RISC) through the binding of complementary sequences in
the 3’ untranslated region (3’UTR) of the target mRNAs, leading to mRNA degradation
or translational repression (Bartel, 2004). A single miRNA is predicted to target hundreds
of different mRNAs, and a single mRNA can be regulated by multiple miRNAs.
Therefore, dysregulation of these “master” regulators impacts several cellular processes
simultaneously and has been linked to many diseases and neurological disorder
(Kloosterman et al., 2006; Miller et al., 2010; Im et al., 2012; Sartor et al., 2012; Bali et
al., 2013).
Recent studies indicate that several drugs of abuse regulate miRNA expression in the
nucleus accumbens (NAc) and other regions of the brain reward pathway (Chandrasekar
et al., 2009; Nudelman et al., 2009; Schaefer et al., 2010; Eipper-Mains et al., 2011; Guo
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et al., 2012). In turn, in vivo manipulations of specific miRNAs or subsets of miRNAs
alter the development of addiction-like behaviors in rodents (Bahi et al., 2008; Hollander
et al., 2010; Schaefer et al., 2010; Chandrasekar et al., 2011; Tapocik et al., 2014). Thus,
we sought to identify a candidate miRNA that targets multiple addiction-related genes
(ARGs) and may provide a novel mechanism for - reverting drug-induced aberrant gene
expression. In this study, we used bioinformatics analyses of the 3’ untranslated regions
(3’UTRs) of transcripts in the Knowledgebase of Addiction-Related Genes database
(KARG;(Li et al., 2008) to identify miR-495, a miRNA that targets many ARGs in
regulatory networks previously implicated in SUDs. We found that miR-495 is enriched
within the NAc and is downregulated by acute cocaine administration and during cocaine
self-administration. Viral-mediated miR-495 overexpression not only robustly
downregulated ARG expression but more importantly, diminished motivation for
cocaine.
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Materials and Methods
Animals. Male 2-month-old C57BL/6J mice (Jackson Labs, Bar Harbor, ME, USA) and
adult 2-month-old Sprague Dawley rats (Charles River, San Diego, CA, USA) were
maintained on a 12-h and 14/10-h reverse light/dark cycle, respectively. Animal studies
were performed in accordance with NIH Animal Welfare guidelines under protocols
approved by the Institutional Animal Care and Use committees at the University of New
Mexico and Arizona State University.
Bioinformatics analyses. The lists for mouse, human, and rat ARGs were retrieved from
the KARG database (http://karg.cbi.pku.edu.cn, (Li et al., 2008). Lists of KARG genes
with evidence number scores ≥2 (Li et al., 2008) were used to acquire the 3'UTRs
sequences from ENSEMBL BioMart. The frequencies of predicted targets of miR-495
and two previously identified addiction-related miRNAs, let-7 and miR-212 (Hollander et
al., 2010; Chandrasekar et al., 2011), in these KARG lists vs. the respective genomes
were calculated using TargetScan 6.2 (http://www.targetscan.org) conserved sites. miR495 binding sites in the 3’UTR of the KARG/TargetScan dataset were further validated
using miRanda (Enright et al., 2003).
NAc shell (NAcsh) viral injections and cocaine self-administration, extinction, and
reinstatement. Rats were trained to self-administer cocaine, infused with lentiviruses
(LV) containing either green fluorescent protein (GFP; LV-GFP) or GFP+miR-495 (LVmiR-495) into the NAcsh, and then tested on a fixed ratio (FR) 5 and progressive ratio
(PR) schedule of cocaine reinforcement, as well as during extinction and cue and
cocaine-primed reinstatement, as described in Appendix C.
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Data Analysis. Power analyses were performed to determine adequate sample sizes
(PASS, NCSS software, Kaysville, UT, USA). Behavioral and biochemical measures
were analyzed using Student t tests or ANOVAs followed by tests for simple effects,
where appropriate, using SPSS 24.0 (IBM, Armonk, NY, USA). Adjustments to degrees
of freedom were made when unequal variances between groups existed (e.g., Welch’s
correction, Huynh-Feldt correction).
Full materials and methods for miRNA fluorescent in situ hybridization, dual luciferase
assays, acute cocaine treatment, reverse transcription and qPCR, western blotting,
intracranial virus injections, cocaine self-administration, food reinforcement, and
histology are provided in Appendix C.
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Results
In silico analyses identify miR-495 as a putative post-transcriptional regulator of
addiction-related genes in the nucleus accumbens

Initial bioinformatics analyses were aimed at identifying miRNAs that target
addiction-associated mRNAs expressed in the NAc. The 3’UTR sequences of mouse,
human, and rat gene sets of the KARG database (http://karg.cbi.pku.edu.cn) with
evidence scores ≥2 (Li et al., 2008) were used to determine the prevalence of miRNA
binding sites predicted by TargetScan (http://www.targetscan.org). Among the ARGtargeting miRNAs, we found that miR-495, a microRNA expressed in the adult rat
striatum (http://miRBase.org, (Landgraf et al., 2007; Kozomara et al., 2014), is predicted
to target several ARG mRNAs, such as Bdnf, Camk2a, Arc, and others (Table AC.1).
The percentage of mouse KARG genes containing conserved 3’UTR miR-495 binding
sites (7%, 70 genes) is significantly (p < 0.0001) higher than in the entire genome (2.5%),
and similar results were obtained using human or rat KARG gene sets (83 genes, 7.7%
and 55 genes, 5.6 %, respectively). To confirm this method, we assessed the proportion
of KARG gene targets of two miRNAs previously associated with cocaine addiction,
miR-212/-132 (Hollander et al., 2010) and let-7 (Chandrasekar et al., 2009, 2011). As
expected, both miRNAs targeted a higher % of KARG genes than in the genome (miR212/-132: 2.8%, p < 0.0001; let-7: 3%, p < 0.0001), confirming the utility of this
approach to identify miRNAs associated with addiction. Given that the frequency of
miR-495 targets in KARG was significantly higher (p < 0.001; ~2-fold) than those for
miR212/-132 and let-7 (Figure 2.1A, B), it is likely that miR-495 targets may impact a
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wider variety of functions involved in addiction than those that were established for miR212/-132 and let-7. Furthermore, the average evidence scores for miR-495 KARG targets
were significantly higher than those for the whole KARG set, suggesting the association
of predicted miR-495 KARG targets with addiction is heavily supported by previous
research (Figure AA.1, Mann-Whitney U, U = 36189). Using miRanda, we further
validated the presence of high affinity 3’UTR miR-495 binding sites (ΔG ≥ -15 kcal/mol)
in the mouse dataset, including Bdnf and Camk2a (Table AC.1; (Enright et al., 2003).
Fluorescent in situ hybridization (FISH) confirmed brain-wide miR-495 expression,
including the NAc and medial prefrontal cortex (mPFC), as previously reported in human
mPFC tissue (Figure 2.1C; scrambled locked nucleic acid (LNA) control in Figure
AC.2; (Mellios et al., 2008). Using qRT-PCR, we confirmed miR-495 expression in
these regions, with the highest expression within the NAc (Figure 2.1D). Thus, miR-495
is a candidate regulator of a set of ARGs conserved in mammals.

miR-495 directly targets the 3’UTRs of Bdnf, Camk2a, and Arc

To validate direct miR-495 binding to predicted target ARG mRNAs, we utilized
luciferase reporter constructs containing target mRNA 3’UTRs. Due to differential
poly(A) site usage, the predicted miR-495 target, Bdnf, is present in vivo as two different
transcripts with a short (Bdnf-S) or long 3’UTR (Bdnf-L) produced from the same
promoter. The long form contains more miR-495 binding sites (Figure 2.1E;
http://www.targetscan.org/mmu_50/), suggesting that miR-495 preferentially regulates
Bdnf-L. The binding sites within the 3’UTR at nucleotide (nt) positions 233, 565, 587,
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and 598 are highly conserved between mouse, rat and human, while the last binding site
at nt 2487 in mouse and rat or nt 2488 in human is partially conserved. Indeed, dualluciferase assays showed that miR-495 significantly reduced the activity of the reporter
containing the 3’UTR for Bdnf-L by ~50% and for Bdnf-S by ~20% (Figure 2.1F; F3, 7 =
39.4, p < 0.01 for Bdnf-L; F3,7 = 9.2, p < 0.05 for Bdnf-S). Given that these isoforms have
been hypothesized to have different functions and localization within the neuron, these
results suggest that miR-495 may preferentially regulate Bdnf-L and its associated
functions (An et al., 2008). Additionally, miR-495 significantly reduced the activity of
reporters containing the 3’UTRs of Camk2a and Arc by ~40% and 45%, respectively
(Figure 2.1G; F3, 7 = 156.3, p < 0.01 for Camk2a; F3,7 = 137.0, p < 0.01 for Arc). All
effects were blocked by anti-miR-495, and miR-495 had no effect on empty vectors
(Figure AC.3; F3,7 = 1.1, p = ns). These in vitro studies demonstrate that the predicted
miR-495 binding sites in these ARGs are indeed functional.

miR-495 and target mRNA expression in response to acute cocaine administration

The anatomical localization and targets of miR-495 suggest that it may play a role
in the post-transcriptional mechanisms underlying addiction-related plasticity. To
examine this further, we determined the effect of an acute cocaine injection (15 mg/kg,
i.p.) in mice on NAc miR-495 expression at different time points. NAc miR-495 was
significantly downregulated between 1-4 h post-injection (Figure 2.2A; F6,42 = 4.4, p <
0.01; 1h ps < 0.001, 2h ps < 0.05, 4h ps < 0.05). This effect was brain region-specific, as
miR-495 expression was not significantly altered by cocaine 2 h post-acute cocaine in the
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mPFC or dorsal striatum (Figure 2.2B, C; t(9) = 0.53, p = ns for mPFC; t(12) = 1.3, p =
ns).
Next, we assessed the expression of two luciferase validated miR-495 targets,
Bdnf and Camk2a, at the middle of this timeframe: 2 h post-injection. We found that both
NAc Bdnf-Pan mRNA, which is the sum of Bdnf-S and Bdnf-L isoforms, and Bdnf-L
mRNA were significantly increased 2 h post-injection (Figure AC.4; t(7) = 5, p < 0.01
for Bdnf-L; t(8) = 3.5, p < 0.01 for Bdnf-Pan). Although this demonstrates that Bdnf
mRNA is upregulated by acute cocaine, it does not point to the mechanism involved in
this cocaine-induced upregulation. Since both Bdnf transcripts originate from the same
promoter, differences between the two isoforms would suggest regulation at the posttranscriptional level. To evaluate the possibility, we calculated the ratio between Bdnf-L
and Bdnf-Pan and found that it was significantly increased by ~two-fold (Figure 2.2D;
t(7) = 2.4, p < 0.05), indicating that acute cocaine preferentially upregulates the long 3’
UTR variant that contains a greater number of miR-495 binding sites than the short form
(Figure 2.1E, F). Additionally, we found that both proBDNF and mature BDNF protein
were significantly increased within the NAc 2 h after cocaine treatment (Figure 2.2F, G;
t(12) = 2.8, p < 0.05 for proBDNF, t(13) = 2.4, p < 0.05 for matBDNF). Another
luciferase-validated miR-495 target, Camk2a, was found to be regulated 2 h postinjection within the NAc as both mRNA (Figure 2.2E; t(10) = 2.8, p < 0.05) and protein
(Figure 2.2H; t(10) = 4.8, p < 0.001) were increased. Thus, NAc miR-495 expression is
rapidly decreased by exposure to cocaine concomitantly with increased expression of its
ARG targets, Bdnf and Camk2a. This inverse relationship in cocaine-induced gene
expression suggests a functional link between miR-495 and its target ARGs in vivo.
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Overexpression of miR-495 within the NAc shell reverses cocaine-induced ARG
expression

To further examine the regulatory relationship between cocaine-induced NAc
miR-495 downregulation and upregulation of target ARG mRNAs, we next tested
whether these changes could be reversed by restoring miR-495 levels in the NAc with
viral-mediated overexpression. Lentivirus (LV) encoding pri-miR-495+GFP (LV-miR495) or GFP (LV-GFP) was infused into the NAc shell (NAcsh; Figure 2.3A) of male
Sprague-Dawley rats who were treated 2 weeks later with saline or cocaine (15 mg/kg,
i.p.). Cocaine-treated LV-GFP rats were found to express significantly lower NAc miR495 levels compared to saline-treated LV-GFP controls (Figure 2.3B; Virus, F1,33 = 4.5,
p < 0.05; Treatment, F1,33 = 70.1, p < 0.0001; Virus x Treatment, F1,33 = 4.6, p < 0.05;
Tukey HSD, q(33) = 4.2, p < 0.05 LV-GFP saline vs. LV-GFP cocaine), replicating the
cocaine-induced downregulation of NAc miR-495 in mice without lentiviral infusion
(Figure 2.2A). LV-miR-495 rats exhibited significantly greater NAc miR-495 expression
compared to LV-GFP-infused animals in either treatment group, effectively reversing the
cocaine-induced decrease in miR-495 (Figure 2.3B; Tukey HSD, LV-GFP saline vs. LVmiR-495 saline q(33) = 6.1, p < 0.001; LV-GFP Cocaine vs. LV-miR-495 Cocaine q(33)
= 10.7, p < 0.0001). Similarly, cocaine-treated LV-GFP rats were found to express
significantly higher levels of both Bdnf variants compared to saline treated LV-GFP
controls and LV-miR-495 animals in either drug treatment group (Figure 2.3C, D; For
Bdnf-Pan, Virus, F1,18 = 14.2, p < 0.01; Treatment, F1,18 = 12.5, p < 0.01; Virus x
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Treatment, F1,18 = 10.2, p < 0.01; Tukey HSD, LV-GFP saline vs. LV-GFP cocaine, q(18)
= 6.32, p < 0.01; LV-GFP cocaine vs. LV-miR-495 saline, q(18) = 8.2, p < 0.0001; LVGFP cocaine vs. LV-miR-495 cocaine, q(18) = 8.3, p < 0.0001; For Bdnf-L, Virus, F1,18 =
15.9, p < 0.01; Treatment, F1,18 = 17.0, p < 0.001; Virus x Treatment, F1,18 = 11.2, p <
0.001; Tukey HSD, LV-GFP saline vs. LV-GFP cocaine, q(18) = 7.0, p < 0.01; LV-GFP
cocaine vs. LV-miR-495 saline, q(18) = 9.1, p < 0.0001; LV-GFP cocaine vs. LV-miR495 cocaine, q(18) = 8.9, p < 0.0001). Thus, the ability of miR-495 overexpression to
reduce the cocaine-induced upregulation of both Bdnf transcripts suggests a functional
link between miR-495 and its targets in vivo.

Pathway analysis of mRNAs downregulated by miR-495 overexpression reveals
multiple regulatory networks involved in SUDs

Since multiple ARGs are predicted targets of miR-495 (Table AC.2), we used
microarray analysis to determine the global effects of NAcsh miR-495 overexpression on
mRNA expression in vivo. We found that 1027 mRNAs were significantly decreased
after LV-miR-495 treatment. Of the previously identified 691 miR-495 targets, 76 were
significantly downregulated by miR-495 overexpression, 15 of which, including Bdnf,
Camk2a, Arc, Gria3 and Stmn2, were also present in KARG (Table AC.2). A complete
list of miR-495 regulated transcripts on the arrays has been deposited in the Gene
Expression Omnibus (GEO) database (GSE85500).
Using Ingenuity Pathway Analysis (IPA), we searched for canonical pathways
enriched with NAc mRNAs downregulated by miR-495 overexpression. We found
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multiple pathways that were previously characterized in addiction-related behavior,
including GPCR signaling, cAMP-mediated signaling, synaptic long-term depression
(LTD) and potentiation (LTP), CREB, and PKA signaling (Figure 2.4A). The top
biological network of interacting molecules regulated by miR-495 contained 21 of the
original 76 molecules (selections in Figure 2.4B, for complete list see Table AC.3) with
functions related to drug-evoked synaptic plasticity (e.g., Gria3, Shank2, Arc, Ephb2,
Camk2a), transcription factors (e.g., Satb2, Per2), and chromatin remodeling (e.g.,
Satb2). Using qRT-PCR, we confirmed miR-495 overexpression decreased selected
target mRNAs (Figure 2.4C, Table AC.2). Altogether, these results indicate that miR495 regulates multiple target ARG mRNAs both in vitro (Figure 2.1F, G) and in vivo.

NAcsh miR-495 expression decreases following cocaine self-administration

Using qRT-PCR, NAc miR-495 expression was measured in rats that selfadministered cocaine for either 1 or 22 days (SA1 vs. SA22). The cocaine groups did not
differ in total cocaine infusions during the test session (Figure AC.5; t(6) = 0.46, p = ns
with Welch’s correction). Saline-yoked controls at each time point did not significantly
differ in NAcsh miR-495 and were combined. NAcsh miR-495 was significantly
decreased in the SA1 and SA22 group compared to the saline group (Figure 2.5A; F2,17 =
9.3, p < 0.01). Furthermore, a significant linear trend was found across time, where
NAcsh miR-495 levels decreased as the number of cocaine self-administration sessions
increased. Although baseline miR-495 expression in both NAc subregions are similar
(Figure AC.6; t(15) = 0.3, p = ns), no effect on miR-495 expression was found in the
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adjacent NAc core after short or long-term self-administration (Figure AC.7; F2,20 =
0.47, p = ns), demonstrating NAc subregion-specific effects.

miR-495 overexpression in the NAcsh reduces motivation to self-administer and seek
cocaine

To test the role of NAc miR-495 in models of addiction-related behavior, we next
examined the effect of NAcsh miR-495 overexpression on self-administration and
seeking behavior. Two weeks following NAcsh infusions of LV-miR-495 or LV-GFP
(Figure 2.5B), rats were given access to varying doses of cocaine delivered on a FR5 and
PR schedule of reinforcement. NAcsh miR-495 overexpression was persistent to the end
of our behavioral experiments (Figure 2.5C; t(6) = 3.7, p < 0.05). As such, NAcsh miR495 overexpression had no effect on responding or intake on the low effort FR5 schedule
of cocaine reinforcement (Figure AC.8; Virus, F1,20 = 1.1, p = ns). However, NAcsh
miR-495 overexpression significantly decreased responding and intake on the high effort
PR schedule compared to controls across all cocaine doses tested (Figure 3.5D, E;
Responding, Virus, F1,20 = 7.14, p < 0.05; Dose, F3,60 = 9, p < 0.01; Virus x Dose, F3,60 =
2.2, p = ns; Intake, Virus, F1,20 = 5.5, p < 0.05; Dose, F2.2,44.9 = 13.7, p < 0.01; Virus x
Dose, F2.2,44.9 = 0.65, p = ns), without effects on inactive lever pressing (Figure AC.9A).
The cumulative response records in Figure 2.5F show a lower break point in a
representative LV-miR-495 rat compared to a LV-GFP rat, consistent with a decrease in
motivation.
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Next, we tested the effect of NAcsh miR-495 overexpression on other measures
of motivation, including extinction and reinstatement. Before extinction testing, rats
received >3 sessions on an FR5 schedule of cocaine reinforcement on the training dose.
We found no group difference in active lever pressing during this baseline before
extinction (Figure 2.5G; t(17) = 0.7, p = ns). During extinction, NAcsh miR-495
overexpression decreased active lever pressing during the first 3 sessions compared to
LV-GFP controls (Figure 2.5G), without effects on inactive lever pressing (Figure
AC.9B). We then tested rats for both cue and cocaine-primed reinstatement of cocaine
seeking. While the virus groups did not differ in the degree of cue reinstatement (Figure
AC.10), the LV-miR-495 group exhibited significantly reduced cocaine-primed
reinstatement compared to the LV-GFP controls (Figure 2.5H; Virus, F1,20 = 6.6, p <
0.05; Day, F1,20 = 9, p < 0.001; Virus x Dose, F1,20 = 6.3, p < 0.05), without differences in
inactive lever pressing in either case (Figure AC9.C, D). To confirm the effect of miR495 overexpression on target regulation during drug-seeking behavior, we measured the
levels of Camk2a, Bdnf-L, and Bdnf-Pan mRNAs in the NAcsh of rats 1 week after
extinction and reinstatement experiments. As shown in Figures 2.5 I-K the levels of
these three target mRNAs were significantly decreased by miR-495 OE (Camk2a, t(12) =
3.3, p < 0.01; Bdnf-L, t(10) = 3.2, p < 0.01; Bdnf-Pan t(11) = 3.2, p < 0.01). Collectively,
these results suggest that NAcsh miR-495 overexpression decreases motivation to both
self-administer and seek cocaine. The additional decrease in target gene expression
suggests that the behavioral effect of miR-495 overexpression is mediated through these
ARGs.
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To test the specificity for cocaine and evaluate any potential locomotorsuppressing effects of miR-495 overexpression, a separate group of rats were trained to
lever press for food pellets while receiving either LV-GFP or LV-miR-495. LV-miR-495
had no effect on responding or intake on an FR5 schedule of food reinforcement (Figure
AC.11; Active lever, Virus, F1,14 = 1.16, p = ns; Day, F6,84 = 4.08, p < 0.01; Virus x Day,
F6,84 = 0.5, p = ns). To parallel differences in motivational value of low and high cocaine
doses on a PR schedule, we subjected rats to varying levels of food restriction. Rats that
had been food-restricted (18g/day) exhibited higher PR measures than those that had been
unrestricted, but both virus groups exhibited similar levels of motivation for food under
both feeding conditions (Figure 2.5L, Figure AC.12; For active lever, Virus, F1,14 =
0.02, p = ns; Food Restriction, F1,14 = 55.26, p < 0.001; Virus x Food Restriction, F1,14 =
0.003, p = ns). This suggests a selective effect of miR-495 overexpression on motivation
for cocaine.
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Discussion

Here we established NAc miR-495 as a novel post-transcriptional regulator of both
ARG expression and motivation for cocaine. Initial bioinformatics analyses identified
miR-495 as a miRNA with predicted targets enriched in the KARG database and with
preferential expression in the brain reward and motivation pathway. Among these, we
validated that miR-495 targeted Bdnf and Camk2a both in vitro and in vivo. Next, we
found that cocaine decreased miR-495 expression along with concomitant increases in
ARG targets in the NAc. When the cocaine-mediated miR-495 downregulation was
blocked by lentiviral-mediated overexpression, cocaine-induced upregulation of ARG
target mRNAs in the NAc was also prevented. From the miR-495 overexpression
microarray analysis, we found that several of the downregulated target genes formed
networks involved in receptor signaling, gene regulation, and synaptic plasticity.
Importantly, we found that NAc miR-495 overexpression reduced motivation to selfadminister and seek cocaine, without effects on food reinforcement, suggesting that NAc
miR-495 selectively regulates genes involved in motivation for cocaine. Given that
motivation for drug is a key factor involved in human drug relapse, miR-495 may have
translational value as a novel therapeutic target.
In contrast to other addiction-related miRNAs whose expression levels were
shown to increase in response to drugs of abuse (Chandrasekar et al., 2009; Nudelman et
al., 2009; Hollander et al., 2010; Schaefer et al., 2010), miR-495 expression in the NAc
decreased shortly after exposure to cocaine. This rapid downregulation could be due to
several factors. While miRNAs are stable in non-neuronal cell types, some miRNAs
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decay at faster rates in neurons via activity-dependent processes (Krol et al., 2010),
which could be triggered by cocaine administration. The decrease in miR-495 expression
may also be due to transcriptional repression. miR-495 is located within miRNA cluster
B of the Dlk1-Dio3 maternally imprinted region that is under the control of Methyl-CpGbinding protein 2 (MeCP2) and other transcription factors (Benetatos et al., 2013). Using
Mecp2-null mice, Wu and colleagues (Wu et al., 2010) demonstrated increased
expression of many of the miRNAs within this imprinted region, including miR-495.
However, given that not all of the miRNAs in this cluster are coordinately regulated (Wu
et al., 2010; Lempiäinen et al., 2013), other regulatory mechanisms such as pre-miRNA
processing and/or mature miRNA stability may play a role in controlling miRNA
expression profiles (Joilin et al., 2014). It is curious that we did not observe changes in
miR-495 in any other addiction-related brain region, especially in those that are also
innervated by ventral tegmental dopamine neurons (e.g., dorsal striatum, mPFC). One
possibility is that the relatively high basal expression levels of miR-495 in the NAc
allowed us to detect a decrease following cocaine administration. Another possibility is
that the NAc may have a more robust response to the acute and chronic effects of cocaine
resulting in decreases in miR-495 expression levels.
miRNAs play a role in fine-tuning gene expression involved in many cell
signaling pathways (Schratt, 2009; Feng et al., 2013). Here, we established that miR-495
directly targets and regulates the ARG Bdnf both in vitro and in vivo. Bdnf in the NAc
has been linked to several drug abuse-related behaviors, where BDNF expression levels
positively correlate with cocaine reward and motivation (Horger et al., 1999; Hall et al.,
2003; Graham et al., 2007, 2009; Bahi et al., 2008). Similarly, others have established
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that another miR-495 target, Camk2a, has a positive relationship between NAc levels and
psychostimulant abuse-related behavior (Anderson et al., 2008; J. A. Loweth et al.,
2010a; Wang et al., 2010; Kourrich et al., 2012a). Furthermore, CaMKII has been
identified in silico as a central node in positive feedback gene regulatory pathways
involved in addiction (Li et al., 2008). Therefore, regulation of both genes by miR-495
may coordinately affect several domains of addiction-related processes. Indeed, addiction
is hypothesized to be a dysfunction of neuroplasticity (Kalivas et al., 2008), and both
Bdnf and Camk2a genes encode for plasticity-related proteins. We found that many other
miR-495 targets we validated also form networks involved in LTP and LTD (Kauer et al.,
2007; Kasanetz et al., 2010; Russo et al., 2010), as well as other cell signaling cascades
relevant to addiction, such as PKA signaling Self, Boudreau (Self et al., 1998b; Boudreau
et al., 2009). Therefore, miR-495 may act as a mechanism to fine tune the molecular
response of multiple, interwoven pathways involved in the development of addiction.
Similar to acute cocaine administration, NAcsh miR-495 levels were also
decreased following both brief and prolonged cocaine self-administration. It is unknown
why this occurred exclusively in the NAc shell, and not the core, but this effect may be
due to the differential afferent projections into these subregions or the involvement of the
shell in the primary reinforcing and unconditioned effects of cocaine (Ito et al., 2004;
Yager et al., 2015). Interestingly, these effects are consistent with previous findings that
both BDNF and CaMKIIα involvement in cocaine abuse-related behavior is also specific
to the NAcsh, and not the core (Graham et al., 2007; Anderson et al., 2008; J. A. Loweth
et al., 2010b; Wang et al., 2010; Kourrich et al., 2012a; Robison et al., 2013).
Furthermore, the downward trend of NAcsh miR-495 expression as cocaine self-
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administration experience increased may be related to the theory of incentive
sensitization, where motivation to seek drug (i.e. ‘wanting’) increases over the course of
drug use (Robinson et al., 1993). Thus, decreases in NAcsh miR-495 expression may be
indicative of sensitized motivation.
To test this hypothesis, we examined the effect of NAcsh miR-495 overexpression
on cocaine self-administration and seeking behavior. We observed that NAcsh miR-495
overexpression decreased responding and intake when cocaine was available on the high
effort PR schedule, but did not alter intake in the low effort FR5 schedule. PR schedules
are believed to model an aspect of SUD related to an individual increasing time and
energy toward drug-seeking and -taking behavior (Roberts et al., 2007), thus alterations
in these behaviors closely model hallmark symptoms of human addiction. Furthermore,
NAc miR-495 overexpression did not alter PR measures in a similar procedure with a
natural food reinforcer. This suggests that miR-495 specifically influences motivation for
cocaine likely without impacting the reinforcing value of cocaine or food
reinforcement/motivation. Additionally, we found that NAcsh miR-495 overexpression
reduced cocaine-seeking behavior during extinction and reinstatement, further supporting
a selective reduction in motivation. We also confirmed that under these conditions, miR495 overexpression resulted in decreases in Bdnf and Camk2a expression. Closely
mirroring our effects, previous work has shown that NAcsh knockdown of Camk2a and
inhibition of NAcsh CAMKII reduces PR measures and reinstatement, respectively
(Anderson et al., 2008; Wang et al., 2010). Thus, CaMKIIα is an important regulatory
crux of many addiction-related molecular pathways (Wu et al., 2001; Anderson et al.,
2008; J. A. Loweth et al., 2010; Kourrich et al., 2012a; Robison et al., 2013). Although
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we did not detect a statistically significant effect during cue reinstatement (p = 0.06, onetailed), the pattern is very similar. The lack of a more robust effect on cue reinstatement
may highlight the more prominent role of the NAc core, rather than the shell, in
regulating cue reinstatement. Overall, our results suggest that miR-495 preferentially
regulates a network of ARG targets involved in the incentive motivational properties of
cocaine which are more critical for sustaining behavior under the high-effort PR schedule
of reinforcement than under the low-effort FR5 schedule of reinforcement.
In conclusion, we demonstrate a novel in silico method to identify potential
miRNAs that may be involved in SUD. Our findings suggest that miR-495 decreases
motivation for cocaine by targeting several ARGs and regulatory pathways in the NAc
involved in synaptic plasticity, PKA signaling, and other pathways associated with the
disorder. These results highlight the importance of moving drug abuse research from a
single gene focus to biological pathways in order to better understand the complexity of
the molecular networks associated with addiction. This discovery also opens new avenues
for future research on the specific factors controlling cocaine-induced decreases in miR495 and the role of miR-495 in regulating different forms of synaptic plasticity in the
NAc. Most importantly, this study is the first to identify a miRNA that specifically
regulates the incentive motivational properties for cocaine both during active drug taking
and following a period of abstinence. The latter finding is particularly compelling, as
preventing relapse is a primary objective for addiction translational research. The
possibility of globally targeting drug-induced changes in gene expression via miRNAs,
such as miR-495, may lead to new therapeutics that shift the balance of gene regulation
toward alleviating, rather than promoting, SUD-related behavior.
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Figures

Fig. 2.1. miR-495 targets several addiction-related genes (ARGs) and is expressed in
addiction-related brain regions. (A) Although the frequencies of miR-495, miR212/132 and let-7 putative targets are all enriched in the KARG database compared to the
entire genome, the frequency of miR-495 targets in KARG is significantly higher (~255

fold) than those of miR-212/132 and let-7. ****p < 0.0001 vs. genome, +++p < 0.001
miR-495 vs. miR-212/132 and # # # p< 0.001 miR-495 vs. let-7, two-tailed Chi square test.
(B) Number of genes with putative miR-495 target sites (miR-495 TG) in the mouse
KARG set. (C) Representative images of a coronal mouse brain section where miR-495
was visualized using fluorescent in situ hybridization at 4x (i), with insets at 10x focusing
on the PFC (ii) and the NAc (iii). Scale bars 500 μm in panel i and 200 μm in ii and iii.
(D) qRT-PCR analysis of miR-495 levels in different brain regions (n = 3). (E) Schematic
representation of the short and long 3’UTR transcripts of BDNF including the positions
of conserved and partially conserved miR-495 binding sites (M = Mus musculus, R =
Rattus norvegicus, H = Homo sapiens). For in vitro target validation, HeLa cells were
transfected with a firefly luciferase reporter containing the 3’UTR of Bdnf and Camk2a.
A Renilla vector was co-transfected with the firefly reporter. Pre-miR-495, anti-miR-495
and pre-miR™ miRNA precursor negative control #2 were transfected as described in
Supplementary Information. The alternative 3’UTRs of BDNF (F), as well as the 3’UTRs
of Camk2a and Arc, were assayed (G). n = 4 *p < 0.05, **p < 0.01. Error bars indicate
SEM. Ctx = neocortex, PyC = pyriform cortex, ac = anterior commissure. OFC =
orbitofrontal cortex, PFC = prefrontal cortex, NAc = nucleus accumbens, D-STR = dorsal
striatum, AMY = amygdala, DH = dorsal hippocampus, VH = ventral hippocampus, VTA
= ventral tegmental area, CBM = cerebellum.
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Fig. 2.2. Acute cocaine effects on NAc miR-495 and target mRNA expression. Male
C57Bl/6 mice received an acute injection of saline or cocaine (15 mg/kg, i.p.) and NAc
tissue was processed for qRT-PCR and Western blot. (A) NAc miR-495 levels were
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found to be downregulated rapidly after acute cocaine (0.5 h, n = 5; 1 h, n = 10; 2 h, n =
4; 4 h, n = 6; 24 h, n = 6; 48 h, n = 5). miR-495 expression was not altered by acute
cocaine 2h after within the medial prefrontal cortex (B; mPFC; coc n = 5, sal n = 6) or
dorsal striatum (C; DS; coc n = 6, sal n = 8). Acute cocaine increases expression of NAc
Bdnf-L relative to pan-Bdnf nearly two-fold, as measured by qRT-PCR (D; coc n = 4, sal
n = 5). (E) Acute cocaine also increased Camk2a mRNA at 2 h (n = 5). NAc pro-BDNF
(F), mature BDNF (G) and CaMKII (H) increases in protein levels were also found by
Western blot 2 h post-cocaine or saline injection, corrected for total protein by Coomassie
Brilliant Blue staining (proBDNF, coc n = 9, sal n = 7; matBDNF, coc n = 9, sal n = 8;
CaMKIIα n = 6/group, representative blot with each lane representing individual animals;
bars represent quantification of average density of each sample from duplicate blots).
Error bars indicate SEM. *p < 0.05, **p < 0.01 vs. saline.
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Fig. 2.3. NAc miR-495 overexpression counteracts cocaine-induced changes in gene
expression. Two weeks following infusion of either LV-GFP or LV-miR-495 into the
NAcsh (A), rats received an injection of saline or cocaine (15 mg/kg, i.p.). LV-miR-495
blocked the cocaine-induced decrease in NAc miR-495 expression 2-h post-injection (B)
and prevented the cocaine-induced increase in NAc pan-Bdnf (C) and Bdnf-L (D)
expression. LV-GFP-saline: n = 3; LV-miR-495-saline: n = 5; LV-GFP-cocaine: n = 8;
LV-miR-495-cocaine: n = 6. Error bars indicate SEM. *p < 0.05, ** < 0.01, *** < 0.001
vs. saline treated LV-GFP rats and ++++ p < 0.0001 vs. cocaine treated LV-GFP.
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Fig. 2.4. miR-495 regulates genes involved in several addiction-related networks.
Rats were infused with either LV-GFP or LV-miR-495 into the NAcsh and 1 week later
NAc RNA was collected for both microarray and qRT-PCR analysis (n = 5/group). (A)
Top canonical pathways enriched in genes downregulated by miR-495 overexpression
(vertical dotted line represents threshold, p < 0.01) were determined using Ingenuity
Pathway Analysis (IPA). (B) A graphical representation of the genes associated with the
top signaling network denotes the presence of predicted and validated miR-495 targets.
(C) LV-miR-495 infusion increased miR-495 expression and decreased expression of
several ARGs compared to LV-GFP controls (dotted line), as measured by qRT-PCR.
Error bars indicate SEM. *p < 0.05, **p < 0.01 compared to controls.
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Fig. 2.5. miR-495 overexpression in the NAcsh suppresses motivation to selfadminister and seek cocaine in rats. (A) Endogenous NAcsh miR-495 levels are
suppressed following 1 and 22 days of cocaine self-administration, as measured by qRTPCR (Saline: n = 7; SA1: n = 6; SA22: n = 7). *p < 0.05 vs. Saline-yoked. (B)
Histological verification of NAcsh cannula placement. (C) NAcsh miR-495 levels are
increased in the LV-miR-495 group compared to the LV-GFP group following behavioral
testing (n = 4/group). NAcsh miR-495 overexpression reduced responding (D) and intake
(E) on a PR schedule of cocaine reinforcement. (F) Cumulative response records of
representative rats tested at 1.5 mg/kg/infusion that were closest to their respective group
means. Dotted line represents the total number of lever presses emitted once break point
was achieved. (G) NAcsh miR-495 overexpression reduced cocaine-seeking behavior
during the first three 1-h extinction sessions. (H) NAcsh miR-495 overexpression reduced
cocaine-primed reinstatement during the 1-h test session (10 mg/kg, i.p.). LV-GFP: n =
12, LV-miR-495: n = 10. (I-K) Downregulation of Camk2a (LV-GFP: n = 7, LV miR495: n = 8, p < 0.01) and Bdnf-L and -Pan (n = 6/group, p < 0.01) in NAcsh of miR-495
OE animals after behavioral testing. (L) NAcsh miR-495 overexpression had no effect on
responding under a PR schedule of food reinforcement, regardless of whether the rats
were food restricted (18g/day) or not (n = 8/group). Error bars indicate SEM. Panels C-H:
*p < 0.05 vs. LV-GFP. +p < 0.05 vs. extinction baseline.
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Abstract
The neuronal RNA-binding protein HuD is involved in synaptic plasticity and
learning and memory mechanisms. These effects are thought to be due to HuD-mediated
stabilization and translation of target mRNAs associated with plasticity. To investigate
the potential role of HuD in drug addiction, we first used bioinformatic prediction
algorithms together with microarray analyses to search for specific genes and functional
networks upregulated within the forebrain of HuD overexpressing mice (HuDOE). When
this set was further limited to genes in the Knowledgebase of Addiction-related gene
databases (KARG) that contain predicted HuD-binding sites in their 3’ untranslated
regions (3’ UTR), we found that HuD regulates networks that have been associated with
addiction-like behavior. These genes included Bdnf and Camk2a, two previously
validated HuD targets. Since addiction is hypothesized to be a disorder stemming from
altered gene expression causing aberrant plasticity, we sought to test the role of HuD in
cocaine conditioned placed preference (CPP), a model of addiction-related behaviors.
HuD mRNA and protein were upregulated by CPP within the nucleus accumbens (NAc)
of wild type C57BL/6J mice. These changes were associated with increased expression of
Bdnf and Camk2a mRNA and protein. To test this further, we trained HuDOE animals and
wild type littermates in CPP and found that HuDOE mice showed increased cocaine CPP
compared to controls. This was also associated with elevated expression of HuD target
mRNAs and proteins, CaMKIIα and BDNF. These findings suggest HuD involvement in
addiction-related behaviors such as cocaine conditioning and seeking, through increased
plasticity-related gene expression.
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Introduction
Post-transcriptional mechanisms affect gene expression at multiple levels,
including the control of mRNA stability or ability of recently transcribed mRNA to be
translated into functional protein (Bevilacqua et al., 2003). This set of regulatory
mechanisms may be even more integral to neuronal physiology because many neuronal
proteins have a variety of isoforms generated through alternative splicing, the neuronal
structure requires long-distance transport of mRNAs, and de novo protein synthesis can
occur away from the cell body (Lee et al., 2003; Lipscombe, 2005; Sutton et al., 2006;
Hengst et al., 2007). Given the simultaneous influence over mRNA processing, stability
and protein translation, it is not surprising that post-transcriptional regulation plays a role
in many behaviors (Dracheva et al., 2009; Im et al., 2010; Lin et al., 2011; Tan et al.,
2013; Smith et al., 2014; Tapocik et al., 2014; Schmidt et al., 2015; Bastle et al., 2017;
Yan et al., 2017).
HuD is a neuronal RNA binding protein (RBP; (Perrone-Bizzozero et al., 2002)
that stabilizes specific target mRNAs, such as those encoding BDNF and CaMKIIα,
through direct interaction with their 3’UTRs (Bolognani et al., 2010; Allen et al., 2013;
Sosanya et al., 2015). HuD is localized to the dendritic compartment of hippocampal
neurons (Bolognani et al., 2004), where it has been implicated in activity-dependent
synaptic tagging controlling CamkIIα mRNA localization and translation (Sosanya et al.,
2015). Additionally, neuronal activity regulates HuD expression, localization, and
association with plasticity associated mRNAs such as Homer1a and Camk2a
(Tiruchinapalli, Ehlers, et al., 2008). Recent studies indicate that HuD also plays a role in
translation (Fukao et al., 2009) and that PKC-mediated phosphorylation of HuD increases
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local translation of BDNF (Vanevski et al., 2015), suggesting that HuD may be involved
in protein synthesis-dependent forms of plasticity. Additionally, HuD can regulate
alternative RNA processing and localization these mRNA transcripts (Sosanya, Peggy
P.C. Huang, et al., 2013). Therefore, HuD is involved in nearly every level of posttranscriptional regulation. Moreover, HuD has been associated with hippocampaldependent learning and seizures (Bolognani et al., 2004; Pascale et al., 2004; Bolognani,
Tanner, et al., 2007), suggesting it may be involved in other activity-dependent
regulatory networks. A single RBP, such as HuD, can associate with a number of target
mRNAs via binding to specific nucleotide sequences in the 3’ untranslated regions
(3’UTRs). In fact, HuD has been predicted to bind about 20% of the mouse forebrain
transcripts (Bolognani et al., 2010). Thus, HuD and related RBPs have been termed
“master switches” of gene regulation (Deschênes-Furry et al., 2006; Keene, 2007).
Substance use disorders, and their animal model cognate, addiction-like
behaviors, are aberrant forms of learning that have been hypothesized to arise from
similar molecular and electrophysiological processes as those found in other forms of
associative learning and memory (Alkon et al., 1991; Ann E Kelley, 2004; Hyman, 2005;
Hyman et al., 2006; Koob et al., 2010). The encoding of environmental cues predicting
reward-availability is a feature shared by both natural and drug-induced forms of learning
and memory. These strong associations with cues are thought to be involved in the
chronic relapsing state of patients with substance use disorders (Childress et al., 1999).
Drug-conditioned place preference (CPP) is an animal model useful for studying learning
and motivation acquired through associations between drug effects and environmental
cues present during the drug experience. Acquisition and expression of CPP is thought to
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recruit protein-synthesis dependent mechanisms (Kuo et al., 2007; Robinson et al., 2007),
which are critical for forming the drug-cue associations that motivate approach and
contact with the cues (i.e., a model of conditioned drug-seeking behavior; (Tzschentke,
2007). Since HuD mRNA targets have been suggested to play a role in general plasticity
and learning, as well as cocaine-induced behaviors (Graham et al., 2007; Anderson et al.,
2008), we hypothesized that HuD regulation of mRNAs, such as Camk2a and Bdnf, may
play a role in cocaine-CPP.
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Methods
Transgenic mice overexpressing HuD (HuDOE) under the Camk2a promoter were
generated and backcrossed to a C57BL/6J background for >20 generations (Bolognani,
Qiu, et al., 2007). Control animals were either wild type littermates or standard C57Bl/6
mice. Animals were maintained on a 12 h reverse light/dark cycle. Experiments were
performed in accordance with NIH Animal Welfare guidelines under protocols approved
by the Institutional Animal Care and Use committees at the University of New Mexico.
To identify the in vivo regulatory program induced by HuD, either directly or
indirectly, RNA samples from transgenic mice overexpressing HuD and control
littermates were run on Affymetrix 430 2.0 microarrays (n = 3/group). The forebrain,
which includes the cerebral cortex, basal ganglia, hypothalamus, thalamus, subthalamus,
and hippocampus, was isolated by removal of the olfactory bulb and cerebellum from the
entire brain. RNA was extracted from this tissue using a standard Trizol isolation
technique. Molecules that were upregulated by a fold change of ≥1.25 were selected as a
set of transcripts regulated by HuD. Within this set, putative HuD targets were identified
by searching for HuD binding sites found within the 3’UTR using Perl Biomodules as
described in (Bolognani et al., 2010). Briefly, to search for these motifs, we used a Perl
script to search for the following sequences, allowing for one mismatch:
[CG][CT][CT]TC[CT][CT]TC[TC]C[TC]C, [TG]TTTGTTT[TG][GT]TTT, and
TTTTTTTTT[TA]AAA, for motifs 1, 2 and 3, respectively.
Next, the list for mouse ARGs were retrieved from the Knowledgebase of
Addiction-Related Genes database (KARG; http://karg.cbi.pku.edu.cn; accessed in 2016
(Li et al., 2008). High confidence molecules are designated by the database through
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evidence score numbers, or number of evidences of their association with addiction from
categories such as microarray data and low-throughput evidence. Thus, high confidence
molecules from the mouse KARG database with evidence scores ≥2 were cross-analyzed
with the identified molecules regulated by HuD.
For mRNA analyses, brains from HuDOE mice were isolated and quickly frozen in
isopentane cooled at -40 C° by a methanol-dry ice bath. They were then dissected using a
brain matrix and the nucleus accumbens was punched using a 1.25 mm brain punch
(Harris Unicore™). Total RNA was isolated and mRNAs quantified using Power SYBR
Green PCR Master Mix (Life Technologies) as described previously (Bullock et al.,
2009), with primers designed against mouse HuD (Mansfield et al., 2012) and selected
target mRNAs (Bdnf-L: Forward TGGCCTAACAGTGTTTGCAG, Reverse
GGATTTGAGTGTGGTTCTCC; Camk2a: Forward
TATCCGCATCACTCAGTACCTG, Reverse GAACTGGACGATCTGCCATTT); and
compared to a reference transcript (Gapdh: Forward
TGTGATGGGTGTGAACCACGAGAA, Reverse
GAGCCCTTCCACAATGCCAAAGTT). Relative expression was determined using the
comparative 2-ΔCt method (Livak & Schmittgen 2001). A no reverse transcriptase (RT)
reaction was run for each sample and none of the no-RT controls amplified. qPCR
experiments were replicated on 2-3 separate occasions. Data collected from each run
were averaged together.
For protein analysis, NAc tissue was homogenized with lysis buffer (50 mM TrisHCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.1% Nonidet P-40) supplemented with fresh
protease inhibitors (cOmplete™ Mini, Roche, Indianapolis, IN, # 4693159001). Lysates
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were pre-cleared by centrifugation at 14,000 x g and then used for protein determination.
Aliquots containing 35 µg of total protein were diluted 1:1 in 2x Laemmli Sample Buffer
(Sigma, # S3401) and run on 4-15% SDS polyacrylamide gels (Bio-Rad, #4568086).
Western blots were performed as previously described (Tanner et al., 2008) using
antibodies to CaMKIIα (1:2000; Santa Cruz, Dallas, TX, USA, # sc-13141), mature
BDNF (1:1000; Icosagen, Õssu, Ülenurme, Tartumaa, Estonia, #327-100), proBDNF
(1:1000; Alomone, Jersusalem, Israel, #AGP-032), HuD (1: 2000 Santa Cruz, Dallas, TX,
USA, # sc-28299), or GAPDH(1:5000; Santa Cruz, Dallas, TX, USA # sc-32233).
Membranes were then incubated for 1 h in either secondary goat anti-mouse HRP
(1:5000; Santa Cruz, # sc-2005) or goat anti-guinea pig HRP (1:5000; Santa Cruz, # sc2438), respectively, and were developed with standard chemiluminescent reagents and
procedures (NEL103001EA, Perkin Elmer, Waltham, MA, USA). Each sample n is
exactly one animal with both hemispheres pooled together. Specific bands that
correspond to the correct molecular weight of the target (~14 kDa for mature BDNF, ~38
kDa for proBDNF, ~38 for GAPDH, ~50 for CaMKIIα) were quantified using
densitometric analysis in ImageJ and then standardized by pixel density to the Coomassie
Brilliant Blue stain of total protein as described previously (Tanner et al. 2008). Westerns
were replicated 2-3 times and data were averaged together.
For CPP, 2 month old Male C57Bl/6J mice (n = 20/group) underwent training as
previously described (Allan et al., 2001). The conditioning apparatus is a set of two
20x20x20 Plexiglass chambers connected by a 9x10x20 cm anteroom, with the walls
either entirely black or vertical black and white stripes in addition to either textured
plastic or metal lattice floors to allow for multidimensional discrimination between
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chambers. Experiments were performed under red light at 30-34 lux. On the first day,
animals received a saline injection and were allowed to roam throughout the apparatus
for 10 minutes to habituate to the chambers. Time spent in each chamber was recorded in
the habituation session with an Ethovision XT8 system calibrated for C57Bl/6J mice on
the chamber background. Data were recorded in the habitation session to determine if the
animals inherently preferred either chamber, confirming these mice showed no
preference for either chamber. Conditioning to non-contingent injections took place over
the next three days, and on each day animals were confined to one of the chambers for 30
min, and 5h later were confined to the other chamber for 30 min. Mice were returned to
their home cages between sessions. In one experiment, wild type mice were randomly
assigned to either a conditioned group that received cocaine immediately before
placement into the conditioned stimulus (Cs+) chamber and saline immediately before
placement into the other (Cs-) chamber, or a control group that received saline
immediately before placement into either chamber. In the subsequent experiment, wild
type mice were compared to HuDOE mice and all were cocaine-conditioned as above. The
chamber assigned as the Cs+ was randomly assigned assuring unbiased equal numbers
assigned to each chamber in each group. The session during which conditioned mice
received cocaine was counterbalanced across AM/PM sessions. Finally, on the 5th day,
animals were given a saline injection and allowed to freely explore the entire apparatus
for 20 minutes. Using the Ethovision XT8, preference was calculated by time spent in
CS+ versus CS-. The first 5 minutes of the test day was not analyzed to remove the
effects of the aversive injection, such as post-injection grooming. Animals were
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sacrificed 1 h following the saline injection. Behavioral and biochemical measures were
analyzed using Student t tests using SPSS 24.0 (IBM, Armonk, NY, USA).
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Results
Previously, it has been shown that HuD regulates a number of genes associated
with memory, learning, and plasticity through stabilization and translation of the mRNA
transcript (Tiruchinapalli, Ehlers, et al., 2008; Bolognani et al., 2010; Allen et al., 2013;
Sosanya et al., 2015; Vanevski et al., 2015). Due to the multiple sets of transcripts
regulated by HuD, the entire regulatory program induced by this RBP has not been fully
determined. Since we hypothesized that HuD may regulate mRNAs associated with
addiction-related behaviors, we sought to identify predicted targets of HuD in the
Knowledgebase of Addiction-related Genes database (KARG; http://karg.cbi.pku.edu.cn;
(Li et al., 2008), including those identified by expression patterns in microarray studies.
These analyses (Figure 3.1A) revealed that the KARG database set was significantly
enriched in genes containing any of the three consensus HuD binding motifs described in
forebrain neurons (***p<0.001 two-tailed χ2 test; (Bolognani et al., 2010) in their
3’UTRs. To identify which of the predicted targets were regulated by this RBP in vivo,
we used Affymetrix 430 2.0 microarrays to analyze forebrain samples from transgenic
animals overexpressing HuD and control littermates (n = 3/group). Transcripts that were
upregulated by a fold change of ≥1.25 relative to control mice were selected as putative
HuD-regulated targets. We then used KARG to refine our list to high confidence
addiction-related transcripts with evidence scores ≥2. The presence of predicted HuD
binding sites in this subset was confirmed upon 3’ UTR analyses as described before
(Bolognani et al., 2010) and in Supplementary Table 1 (available online). From these
bioinformatic analyses, we found 175 HuD-regulated genes were previously identified as
ARGs (Table 3.1). Finally, we used Ingenuity Pathway Analysis (IPA) to identify
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pathways, networks, and functions associated with this set of genes. Many of the HuDregulated ARGs have been implicated in behavior, neurological disease, cell morphology,
and psychological disorders as well as GPCR signaling, cAMP-mediated signaling, and
ERK/MAPK signaling (Figure 3.1B). Focusing on the 76 molecules specifically
associated with behavior (Table 3.1), we found that these molecules were enriched in top
canonical pathways associated with addiction such as GPCR signaling, cAMP-mediated
signaling, and synaptic long-term potentiation (LTP) (Figure 3.1C). Additionally, the top
network from these HuD-regulated and behavior-associated ARGs included many key
molecules in addiction-associated plasticity (complete network in Table 3.1; selections
shown in Figure 3.1D). Thus, we concluded that HuD induces a regulatory program that
controls the expression of many genes associated with drug addiction.
Since these HuD-regulated transcripts were previously identified as ARGs and
associated with behavior, we sought to determine whether HuD and its targets were
regulated during cocaine CPP. A group of 16 C57Bl/6J male mice were trained, as
previously described, with alternating cocaine or saline injections each paired with a
specific chamber, respectively, to form an association between the cocaine unconditioned
stimulus (US) and the environmental conditioned stimulus (CS+ or in the case of Saline,
CS-). A control group of 16 mice were trained in a similar fashion with saline paired with
both chambers, thus removing the associative learning between CS and US. On the test
day, animals received a saline injection and were allowed to freely roam between the
chambers. As described earlier, CPP was measured by time spent in the CS+ versus the
CS- chamber, thus scores >1 indicate preference for the CS+ chamber while scores ~1
suggest no preference for either chamber. As expected, mice trained with cocaine and
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saline showed CPP for the cocaine paired chamber (Figure 3.2A; t(28.47) = 4.05, p =
0.0004, with Welch’s Correction). Animals were sacrificed 1 h following the start of the
test day session and brains were flash frozen for RNA and protein analyses. We focused
on the NAc because this region is necessary and sufficient, specifically the shell, for
cocaine CPP as determined by lesion and region-specific cocaine injection experiments
(Liao et al., 2000; Sellings et al., 2006). We found that NAc HuD mRNA and protein
was significantly increased in those animals trained with cocaine (Figure 3.2B, C; t(10) =
2.5, p = 0.03; t(10) = 2.7, p <0.02). This suggests that NAc HuD upregulation is
associated with cocaine CPP.
Given that CPP was associated with an upregulation in NAc HuD, we expected
that HuD ARG targets may be upregulated as well. We assessed the expression of two
well validated HuD targets, Bdnf and Camk2a. As shown in Figures 3.2D and E, we
found that Camk2a mRNA and CaMKIIα protein were both upregulated within the NAc
after cocaine CPP training (t(5) = 2.8, p = 0.04; t(11) = 3.5, p = 0.005). The other
validated HuD target and ARG, Bdnf, can be transcribed from many promoters (Timmusk
et al., 1993). However, at the mRNA level, differential poly(A) site usage leads to two
different variants via alternative splicing. One variant is characterized by a shorter 3’UTR
(Bdnf-S) while the other has a longer 3’UTR (Bdnf-L). Since Bdnf-S and the initial
segment of Bdnf-L are identical, we could only reliably quantify total Bdnf mRNA (BdnfPan) from Bdnf-L. Thus, to fully evaluate the regulation of Bdnf mRNA, we assessed
both variants. As such, we found Bdnf-L and Bdnf-Pan mRNA were both upregulated by
cocaine CPP training (Fig. 3.2F, H; t(10) = 2.8, p = 0.02; t(11) = 2.2, p = 0.047). BDNF
protein also exists in two different forms, the unprocessed proBDNF and the smaller,
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processed mature BDNF (matBDNF; (Leibrock et al., 1989). These two forms of protein
have different receptors and cellular effects, so it is again important to assess both forms
of BDNF (Zanin et al., 2017). Both proBDNF and matBDNF were upregulated by
cocaine CPP training within the NAc (Fig. 3.2G, I; t(6) = 3.8, p = 0.009; t(6) = 2.8, p =
0.03). Taken together, this suggests that two independently-validated HuD ARG targets
that have been previously shown to be associated with addiction-related behaviors are
upregulated by cocaine CPP and associated with the upregulation of HuD after CPP
training.
To confirm our microarray analyses and further dissect the role of HuD-induced
upregulation of Camk2a and Bdnf in vivo specifically in the NAc, we used HuDOE
animals to determine if overexpression without training or drug treatment was sufficient
to elicit a similar effect on these two validated targets. Analysis of HuD expression in the
NAc of naïve HuDOE mice revealed that both the mRNA (Figure 3.3A; t(7) = 2.6, p =
0.04) and HuD protein (Figure 3.3B; t(7) = 3.2, p = 0.01) were overexpressed within this
region. We also found that Camk2a, Bdnf-L, and Bdnf-Pan mRNA were concomitantly
increased in HuDOE mice (Figures 3.3C, E, and G; t(6) = 2.5, p = 0.049; t(6) = 2.6, p =
0.04; t(6) = 2.6, p = 0.04). Additionally, NAc CaMKIIa, pro- and mat-BDNF proteins
were increased (Figures 3.4D, F, and H; t(5) = 9.9, p = 0.0002; t(11) = 2.2, p = 0.049;
t(5) = 2.7, p = 0.04). This suggests that in the absence of CPP training or cocaine
treatment, animals overexpressing HuD within the NAc show increased levels of HuD
and its plasticity associated targets.
To test the functional role of enhanced levels of HuD, we trained HuDOE mice and
wild type littermates in the same cocaine CPP procedure described above. Notably,
78

although all groups received cocaine during conditioning, HuDOE animals showed
increased CPP behavior compared to wild type controls (Figure 3.4A; t(25) = 2.6, p =
0.02). First, we confirmed that HuDOE animals indeed had elevated HuD in the NAc, as
found in Figures 3.3A and 3.3B in naive animals. Although we did not detect increased
expression of HuD mRNA, we did find increased HuD protein expression in HuDOE
animals that underwent cocaine CPP (Figures 5A, B, t(9) = 4.7; p = 0.47; t(5) = 3.5, p =
0.02). Additionally, HuDOE animals showed significantly higher expression of HuD ARG
target mRNA and protein (Figures 5C-H, t(5) = 2.9; p = 0.03; t(5) = 3.2, p = 0.02; t(4) =
4.0, p = 0.02; t(8) = 3.8, p = 0.005; t(7) = 2.5, p = 0.04; t(4) = 3.0, p = 0.04). To
determine the specificity of HuD overexpression, we assessed the expression of GAPDH
which is not predicted to be targeted by HuD. We found that Gapdh mRNA and protein
were not significantly different between controls and HuDOE animals (Figures 5I, J;
t(12) = 0.04, p = 0.97; t(7) = 0.9, p = 0.4). Overall, this data suggests that HuD regulates
cocaine CPP by inducing a regulatory program within the NAc associated with increased
expression of two selected targets involved in CPP behavior.
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Discussion
Overall, our study is the first to identify the neuronal RNA-binding protein HuD
as a post-transcriptional regulator of ARG expression and addiction-related behaviors.
HuD overexpression induced global alterations including multiple predicted direct HuDregulated transcripts containing HuD binding sequences in their 3’ UTRs. Many of these
targets were found to be enriched in the KARG and formed regulatory networks
associated with behavior. In agreement with these observations, we found that HuD was
upregulated by cocaine CPP training and overexpression caused increased cocaine CPP
behavior along with upregulation of two well-studied, direct HuD targets CaMKIIα and
BDNF. HuDOE animals that showed increased cocaine CPP behavior also were found to
have increased expression of these targets within the NAc, a critical brain region
associated with CPP and addiction in general. Since the encoding of cues indicative of
drug exposure are required for CPP behavior and are cited as a major cause of relapse in
human patients, post-transcriptional regulation involving HuD could play a role in
therapeutics targeting relapse to drugs of abuse.
Our data suggests that HuD regulates multiple networks of genes associated with
addiction-related behaviors. For example, ERK/MAPK signaling, which was a central
node in a network significantly regulated by HuDOE, has been found to be integral for
CPP to other drugs (Gerdjikov et al., 2004; Mizoguchi et al., 2004a; Miller et al., 2005).
Additionally, elevated ERK signaling within other brain regions, such as subregions of
the amygdala, have been found to be necessary for reactivity to cues that elicit drug
seeking during withdrawal (Lu et al., 2005, 2006; Thiel et al., 2012). Since cue-induced
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reinstatement of drug-seeking is proposed to model human drug-relapse behavior, this
suggests that HuD may be involved in reward reinstatement behavior.
To assess the regulatory impact of HuD on behavior, we analyzed the expression
of two direct targets of HuD (Tiruchinapalli, Ehlers, et al., 2008; Allen et al., 2013;
Sosanya, Peggy P.C. Huang, et al., 2013; Sosanya et al., 2015; Vanevski et al., 2015).
Both CaMKIIα and BDNF have been highly associated with behavioral and addictionrelated processes. For example, these two genes regulate molecular processes involved in
the learning and memory of discrete spatial cues (Silva et al., 1992; Falkenberg et al.,
1992; Linnarsson et al., 1997; Cho et al., 1998; Mu et al., 1999; Mizuno et al., 2000;
Gorski et al., 2003; Cirulli et al., 2004; Poulsen et al., 2007; McGauran et al., 2008;
Nakajo et al., 2008; Achterberg et al., 2014). Since visual spatial cues are critical in CPP
behavior (Cunningham et al., 2006), and these molecules have been associated with CPP
for other drugs of abuse, this suggested that HuD may regulate cocaine-CPP through
direct targeting of CaMKIIα and BDNF (Lu et al., 2000; Sakurai et al., 2007; Bahi et al.,
2008; Rosen et al., 2015).
Although overexpression of HuD was found to facilitate cocaine CPP learning,
previous work from our laboratory on the role of HuD in other learning associated
behaviors suggests that its constitutive overexpression disrupts more complex learning
and retention of spatial memories (Bolognani, Qiu, et al., 2007). This apparent
discrepancy may be due to the valence of the hedonic stimulus in drug-induced behaviors
versus stress-induced behaviors such as contextual fear conditioning (CFC) or Morris
water maze (MWM). Secondarily, this may be due to differences in the regions recruited
in these tasks. Indeed, researchers studying the role of NR2B containing NMDARs found
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that ifenprodil inhibition blocked the acquisition of morphine-induced CPP without
affecting the acquisition of MWM demonstrating a delineation between drug and nondrug associated spatial learning (Ma et al., 2011). Finally, temporal and spatial aspects of
HuD expression and activity may play an important role in these findings.
The influence of post-transcriptional regulators in spatial learning seems to follow
a bidirectional response, where both overexpression and knockout of a regulatory gene
impairs spatial learning, thus, suggesting that a specific expression pattern of downstream
plasticity-associated genes is required for proper learning and memory (Paradee et al.,
1999; Peier et al., 2000). Adding further complication, these plasticity-associated genes
themselves exhibit discretely regulated spatial and temporal expression. For example,
while hippocampal Bdnf mRNA was upregulated at specific time points of MWM
training (Kesslak et al., 1998), many drugs of abuse acutely and chronically upregulate
BDNF within the NAc (Filip et al., 2006; Graham et al., 2007; Bastle et al., 2017).
Additionally, BDNF is upregulated during abstinence from drug, which may contribute to
“incubation of craving” (Li and Marina E. Wolf, 2015). Thus, overexpression of
plasticity-associated genes such as BDNF and CaMKIIα may cause biphasic learning
responses as well (Mayford et al., 1996).
In conclusion, we have determined that HuD plays an important role in cocaine
CPP behavior, suggesting that regulation of mRNA stability and protein translation
mediated by this RBP is involved in controlling reward seeking. While further testing is
required to delineate the exact function of HuD in the molecular underpinnings of this
behavior, our work suggests that regulation of ARG expression mediated by HuD is a
novel regulatory pathway involved in addiction-related behaviors.
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Tables
Table 3.1. HuD regulated Addiction-related genes (ARGs)
Putative HuD

Acot12, Acot2, Adarb1, Adcy8, Adcyap1, Adrb2, Aff1, Ank1,

ARG target

Ap2a2, Apod, Arf4, Atp6v1b2, Atp6v1e1, Bche, Bcl2, Bcl2l11,

mRNA

Bdnf, Bmp7, Cacng1, Calm3, Camk2a, Ccl12, Cd44, Cdh1,

upregulated in

Cdkn1a, Cebpg, Chn2, Chrna3, Cnr1, Cnr2, Cpd, Creb1, Crem,

HuDOE

Csk, Ddhd2, Dld, Dnajb14, Dpysl2, Drd4, Dsc2, Dusp4, Edil3,
Egfr, Eif4e, Elavl4, Fgf2, Fkbp5, Foxp1, Fyn, Gap43, Gdnf, Gnaq,
Gnb5, Gpm6a, Gria2, Grip1, Gsn, H2-D1, Hhex, Hint1, Hmgb2,
Hspb1, Igf1, Ikbkb, Il10ra, Il16, Ipo11, Itgb1, Itpkb, Jun, Kalrn,
Kcmf1, Kcna1, Kcnc1, Kcnj6, Klk6, Kmo, Ldb2, Limk1, Lims1,
Lrch4, Mapk1, Mapk10, Mapk14, Mapk8, Matr3, Mbp, Mme,
Mpdz, Mrpl17, Myt1, Myt1l, Ncam1, Ndst1, Ndufs4, Nedd4, Nf1,
Nfasc, Nfia, Nfkbia, Nr4a3, Nsf, Ntrk3, Oprd1, Oprm1, Pdk4,
Pdxk, Phtf1, Pml, Ppm1b, Ppp1cc, Ppp1r14c, Ppp1r2, Ppp2cb,
Ppp2r2c, Ppp2r5c, Ppp3cb, Ppp3r2, Prkca, Prrx1, Psmb2, Ptdss2,
Pten, Ptk2b, Ptprk, Rac2, Rad23b, Rad51, Ran, Rb1, Rgs12, Rgs9,
Rhobtb3, Rhou, Rps6ka5, Sall3, Samhd1, Scn2b, Seh1l, Serpina3n,
Sesn2, Sfpq, Sh2d5, Slc6a1, Smarcd1, Sox9, Ssx2ip, Syn2, Syp,
Syt11,Tacr1, Tacstd2, Taf7, Thrb, Tiam1, Timp2, Tlk2, Tmed10,
Tmod2, Tmpo, Tmprss2, Tnfrsf9, Tph1, Trib2, Trim59, Trp53inp2,
Ubtf, Ugcg, Uqcrc2, Vamp3, Vnn1, Xpo1, Ywhaq, Zbtb16, Zwint
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HuD ARG

Adarb1, Adcy8, Adcyap1, Adrb2, Apod, Arf4, Bche, Bcl2, Bdnf,

targets associated

Camk2a, Cdkn1a, Chrna3, Cnr1, Cnr2, Creb1, Crem, Csk, Ddhd2,

with behavior

Drd4, Dusp4, Eif4e, Elavl4, Fgf2, Foxp1, Fyn, Gdnf, Gnaq, Gria2,
Hint1, Igf1, Ikbkb, Itgb1, Jun, Kalrn, Kcna1, Kcnc1, Kcnj6, Limk1,
Mapk1, Mapk10, Mapk14, Mapk8, Mme, Ncam1, Ndufs4, Nedd4,
Nf1, Nfasc, Nfkbia, Nr4a3, Ntrk3, Oprd1, Oprm1, Pml, Ppp1cc,
Ppp1r14c, Ppp3cb, Prkca, Pten, Rad23b, Rb1, Rgs9, Rps6ka5,
Sall3, Scn2b, Sfpq, Slc6a1, Syn2, Tacr1, Thrb, Timp2, Tmod2,
Tph1, Trib2

Top HuD

Adcy, Adrb, Adrb2, Bdnf, Calcineurin Protein(S), Camk2a, Cnr2,

regulated

Cofilin, Drd4, Erk1/2, F Actin, G Protein, G Protein Alphai, Gnaq,

network

Gpcr, Gria2, Kcnj6, L-type Calcium Channel, Limk1, Nmda

associated with

Receptor, Nr4a3, Oprd1, Oprm1, Pka, Pkg, Plc, Pp1 Protein

behavior

Complex Group, Pp2a, Ppp1cc, Ppp3cb, Prkca, Proinsulin, Syn2,
Tacr1, Trib2

Shown are candidate HuD target mRNAs that were significantly upregulated (fold
change ≥1.25 and p<0.05) in HuDOE animals containing potential HuD binding sites in
their 3’ UTR as defined by (Bolognani et al., 2010) and that were identified as ARG in
the KARG database, suggesting that they may play a role in addiction-related processes.
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Figures

Fig 3.1: HuD regulates addiction-associated molecular networks. Predicted HuD
targets were first determined by an in silico identification of mRNAs which contained ≥ 1
HuD binding motif(s) within the 3’UTR of mRNA from the entire mouse genome through
Perl Biomolecules assessing consensus motifs of HuD binding (shown below each data
set) as described by (Bolognani et al, 2010). (A) Predicted HuD targets were enriched
within the KARG datasets for genetic evidence and genetic and microarray evidence
compared to the entire mouse genome (*** p<0.001 two-tailed χ2 test). Next, in vivo
regulated, addiction-related targets were identified using microarrays. A set of transcripts
that a) were upregulated by a fold change of ≥1.25 in HuDOE compared to littermate control
forebrain tissue, b) were present in the KARG database and c) contained HuD binding sites
in the 3’ UTR as described in (A) were selected for future analyses. (B) Molecules fitting
these criteria were associated with functions and diseases, such as behavior in particular.
(C) Identified mRNAs associated were behavior were more clearly organized into
molecular pathways associated with addiction and formed a top network (D) heavily
implicated in addiction-associated behaviors.
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Figure 3.2: Cocaine CPP training is associated with elevated NAc HuD and two
validated HuD-targets. A) C57Bl/6J mice trained with 15 mg/kg cocaine show increased
preference for the cocaine-paired conditioned stimulus (Cs+) compared to animals that
received saline paired with both chambers (n = 20/treatment). Cocaine CPP training was
associated with an increase in NAc HuD mRNA B) and protein (C; n = 5-7/treatment).
Cocaine trained animals showed elevated Camk2a, Bdnf-L, and Bdnf-Pan mRNA (D, F,
H) as well as CaMKIIα, pro-BDNF, and mature-BDNF protein (E, G, I with representative
blots). n = 3-8/treatment. *p<0.05, **p<0.01, ***p<0.001, Student’s t-test cocaine versus
saline. Data are Means ±SEM.
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Fig 3.3: Naïve HuDOE animals show increased NAc HuD and validated HuD targets.
Male HuDOE mice and littermate controls were sacrificed around 2 mo. of age and the NAc
was dissected. HuDOE mice show increased NAc HuD mRNA (A) and protein (B)
compared to controls. Following elevated HuD expression, previously validated, direct
HuD targets were elevated in this region as well. Camk2a, Bdnf-L and Bdnf-Pan mRNA
was increased within the NAc (C, E, G) as well as CaMKIIα, pro-BDNF, and matureBDNF protein (D, F, H). n = 3-6/genotype. *p<0.05, **p<0.01, ***p<0.001 Student’s ttest cocaine versus saline. Error bars indicate ±SEM.
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Fig 3.4: HuDOE animals show increased cocaine CPP. Male HuDOE mice and littermate
controls trained with 15 mg/kg cocaine in the same CPP-induced protocol as Fig. 3.2
except both groups were trained with cocaine. HuDOE mice show increased preference for
the cocaine-paired Cs+ compared to littermate controls (n = 13-14/genotype). *p<0.05,
Student’s t-test HuDOE versus littermate control. Error bars indicated ±SEM.
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Fig 3.5: HuDOE animals show increased cocaine CPP-induced HuD target expression
within the NAc. The NAc was harvested 1hr following initiation of the test day in the CPP
protocol. HuDOE animals did not show an increase in HuD mRNA (A) but did show
elevated HuD protein within this region (B). HuDOE animals showed elevated Camk2a,
Bdnf-L, and Bdnf-Pan mRNA (C, E, G) as well as CaMKIIα, pro-BDNF, and matureBDNF protein (D, F, H with representative blots to the right). No significant change in
GAPDH mRNA or protein (I, J), which is not a predicted HuD target. n = 3-5/treatment.
*p<0.05, **p<0.01 Student’s t-test HuDOE versus littermate control. Error bars indicated
±SEM.
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CHAPTER 4: DISCUSSION
4a. Overview
Here we established NAc miR-495 and HuD as novel post-transcriptional
regulators of both ARG expression and motivation for cocaine. Initial bioinformatics
analyses identified miR-495 as a miRNA with predicted targets enriched in the KARG
database and with preferential expression in the brain reward and motivation pathway.
Similarly, many predicted HuD targets were found to be enriched in the KARG and
formed regulatory networks associated with behavior. (Everitt et al., 2005)
Among these, we validated that miR-495 and HuD targeted Bdnf and Camk2a
both in vitro and in vivo. Next, we found that cocaine decreased miR-495 expression
along with concomitant increases in ARG targets in the NAc. When the cocaine-mediated
miR-495 downregulation was blocked by lentiviral-mediated overexpression, cocaineinduced upregulation of ARG target mRNAs in the NAc was also prevented. From the
miR-495 overexpression microarray analysis, we found that several of the downregulated
target genes formed networks involved in receptor signaling, gene regulation, and
synaptic plasticity. Similarly, HuDOE induced global alterations including multiple
predicted direct HuD-regulated transcripts containing HuD binding sequences in their 3’
UTRs. Thus, both HuD and miR-495 regulate multiple networks of genes associated with
addiction-related behaviors. For example, ERK/MAPK signaling, which was a central
node in a network significantly regulated by HuDOE, has been found to be integral for
CPP to other drugs (Gerdjikov et al., 2004; Mizoguchi et al., 2004b; Miller et al., 2005).
Additionally, elevated ERK signaling within other brain regions, such as subregions of
the amygdala, have been found to be necessary for reactivity to cues that elicit drug
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seeking during withdrawal (Lu et al., 2005, 2006; Thiel et al., 2012). Since cue-induced
reinstatement of drug-seeking is proposed to model human drug-relapse behavior, this
suggests that HuD may be involved in reward reinstatement behavior.
In agreement with these observations, we found that HuD was upregulated by
cocaine CPP training and overexpression caused increased cocaine CPP behavior along
with upregulation of two well-studied, direct HuD targets CaMKIIα and BDNF.
Concurrently, NAc miR-495 was downregulated by cocaine CPP training. HuDOE
animals that showed increased cocaine CPP behavior also were found to have increased
expression of these targets within a critical brain region associated with CPP and
addiction in general, the NAc. In opposition, NAcSh LV-miR-495 OE in C57Bl/6J mice
and HuDOE blocked the cocaine CPP training induced upregulation in target mRNA and
protein, as well as diminished CPP. Furthermore, we found that NAc miR-495
overexpression reduced motivation to self-administer and seek cocaine, without effects
on food reinforcement, suggesting that NAc miR-495 selectively regulates genes
involved in motivation for cocaine. Since the encoding of cues indicative of drug
exposure are required for CPP behavior and are cited as a major cause of relapse in
human patients, post-transcriptional regulation involving HuD and miR-495 could play a
role in therapeutics targeting relapse to drugs of abuse.
Although overexpression of HuD was found to facilitate cocaine CPP learning,
previous work from our laboratory on the role of HuD in other learning associated
behaviors suggests that its constitutive overexpression disrupts more complex learning
and retention of spatial memories (Bolognani, Qiu, et al., 2007). This apparent
discrepancy may be due to the valence of the hedonic stimulus in drug-induced behaviors
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versus stress-induced behaviors such as contextual fear conditioning (CFC) or Morris
water maze (MWM). Secondarily, this may be due to differences in the regions recruited
in these tasks. Indeed, researchers studying the role of NR2B containing NMDARs found
that ifenprodil inhibition blocked the acquisition of morphine-induced CPP without
affecting the acquisition of MWM demonstrating a delineation between drug and nondrug associated spatial learning (Ma et al., 2011). Finally, temporal and spatial aspects of
HuD expression and activity may play an important role in these findings. The influence
of post-transcriptional regulators in spatial learning seems to follow a bidirectional
response, where both overexpression and knockout of a regulatory gene impairs spatial
learning, thus, suggesting that a specific expression pattern of downstream plasticityassociated genes is required for proper learning and memory (Paradee et al., 1999; Peier,
2000). Adding further complication, these plasticity-associated genes themselves exhibit
discretely regulated spatial and temporal expression. For example, while hippocampal
Bdnf mRNA was upregulated at specific time points of MWM training (Kesslak et al.,
1998), many drugs of abuse acutely and chronically upregulate BDNF within the NAc
(Filip et al., 2006; Graham et al., 2009; Bastle et al., 2017). Additionally, BDNF is
upregulated during abstinence from drug, which may contribute to “incubation of
craving” (Li and Marina E Wolf, 2015). Thus, overexpression of plasticity-associated
genes such as BDNF and CaMKIIα may cause biphasic learning responses as well
(Mayford et al., 1996).
To test further link miR-495 with other addiction-like behaviors, we examined
the effect of NAcsh miR-495 overexpression on cocaine self-administration and seeking
behavior. We observed that NAcsh miR-495 overexpression decreased responding and
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intake when cocaine was available on the high effort PR schedule, but did not alter intake
in the low effort FR5 schedule. PR schedules are believed to model an aspect of SUD
related to an individual increasing time and energy toward drug-seeking and -taking
behavior (Roberts et al., 2007), thus alterations in these behaviors closely model hallmark
symptoms of human addiction.
Furthermore, NAc miR-495 overexpression did not alter PR measures in a similar
procedure with a natural food reinforcer. This suggests that miR-495 specifically
influences motivation for cocaine likely without affecting the reinforcing value of
cocaine or food reinforcement/motivation. Conversely, HuD regulates the molecular
underpinnings of reinstatement to instrumental responding for an appetitive reward.
Although HuD appears to specifically regulate reinstatement, as acquisition and
extinction were not affected by upregulation of HuD. In our LV-miR-495 instrumental
food response experiment we only tested the acquisition of this behavior, thus it is a
possibility that HuD and miR-495 may regulate reinstatement to appetitive reward.
This behavioral effect may involve HuD-dependent stabilization of target
mRNAs. CaMKIIα and BDNF mRNAs are two HuD targets that have been implicated in
several forms of learning and memory. However, very little work has been done in the
role that they may play in instrumental learning for an appetitive reward. There is
evidence that Ser-831 on the GluR1, a CaMKIIα specific phosphorylation site, may be
important for the retrieval of instrumental learning for an appetitive reward (Crombag et
al., 2008). This points to a shared HuD and miR-495 regulatory pathway involving
CaMKIIα action in this behavior. Additionally, we found that NAcsh miR-495
overexpression reduced cocaine-seeking behavior during extinction and reinstatement,
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further supporting a selective reduction in motivation. We also confirmed that under
these conditions, miR-495 overexpression resulted in decreases in Bdnf and Camk2a
expression. Closely mirroring our effects, previous work has shown that NAcsh
knockdown of Camk2a and inhibition of NAcsh CAMKII reduces PR measures and
reinstatement, respectively (Anderson et al., 2008; Wang et al., 2010). Thus, CaMKIIα is
an important regulatory crux of many addiction-related molecular pathways (Wu et al.,
2001; Anderson et al., 2008; Jessica A. Loweth et al., 2010; Kourrich et al., 2012b;
Robison et al., 2013). Although we did not detect a statistically significant effect during
cue reinstatement (p = 0.06, one-tailed), the pattern is very similar. The lack of a more
robust effect on cue reinstatement may highlight the more prominent role of the NAc
core, rather than the shell, in regulating cue reinstatement (Fuchs et al., 2004). Although
HuD was not discretely studied in the context of self-administration, if miR-495 has an
effect on these targets, HuD may very well play a role in this behavior. Overall, our
results suggest that HuD and miR-495 preferentially regulates a network of ARG targets
involved in the incentive motivational properties of cocaine which are more critical for
sustaining behavior under the high-effort PR schedule of reinforcement than under the
low-effort FR5 schedule of reinforcement.
With this work, we have shown that HuD and miR-495 play a role in the regulation
of addiction-related gene expression and behavior. How drugs of abuse regulate HuD and
miR-495 to elicit these changes in gene expression and behavior remains a standing
question. Additionally, these ARGs have been associated with addiction-related behavior
but it is unclear how this is occurring. The general hypothesis put forth by the community
is that ARGs regulate features of neuronal plasticity, be it LTP or LTD, that drive
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compulsive behavior found in addiction. In the remaining sections, I will address the
evidence that HuD and miR-495 are regulated by factors that have been previously
associated with addiction. Finally, given the data provided and the current state of
literature, I will further discuss the evidence that the competition between HuD and miR495 regulates shifts in neuronal plasticity either towards LTD or LTP from the initial set
point of the neuron depending on connectivity, the neuronal genotype, and the stage of
behavior or drug exposure.

4b. Limitations of this study
In general, the main limitation of these studies in its translation to the human
condition is the fact that these behavioral studies have only assessed one theory of
addiction presented in pre-clinical behavior. All of these behavioral models have shown
that HuD and miR-495 regulate the incentive-salience of drugs, as in CPP. Though selfadministration itself is very similar to the human condition, our models of selfadministration only assessed the motivation to consume drugs of abuse in acquisition or
after withdrawal in cocaine and cue-induced reinstatement. Thus, we have shown these
behaviors are regulated by HuD and miR-495 but we have not assessed the role of these
factors in other theories of SUDs. For example, other theories of addiction take into
consideration the effects of intoxication compared to withdrawal states (Koob et al.,
2001). This idea suggests that the motivation to acquire drugs after repeated drug
exposure is driven by the negative internal states that develop during withdrawal. For
example, escalation of self-administration has been suggested to induce a state of
tolerance. This tolerance to the positive effects of the drug has been hypothesized to be
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counteracted by an increase in the negative effects of the withdrawal state. Thus far, we
have shown that miR-495 and HuD play a role in discrete drug presentation models such
as locomotor sensitization, CPP, and short-access self-administration procedures. We
could assess the role of miR-495 and HuD in escalation to determine if these factors may
also play a role in these other theories of SUDs.
A limitation in the use of HuDOE animals is the regional specificity of these
behavioral effects. In profiling of these animals, we found that HuD is overexpressed in
brain regions that show more regulated, lower expression of HuD. As such, cortical
regions and specific regions of the hippocampus that normally have with high baseline
expression of HuD have little to no elevation of HuD in transgenic animals. Conversely,
regions with low baseline expression of HuD, such as the NAc, show large upregulation
of HuD in transgenics. Although this may suggest that HuD is less important in these
regions, we found that HuD is upregulated in this region in response to acute cocaine and
cocaine CPP. Thus, this suggests that HuD in these regions have more specific, temporal
HuD expression pattern in response to specific events. Thus, we proposed that this is a
model to study the overexpression of HuD in regions that have low baseline expression.
However, HuD may be overexpressed in other regions that may play a role in addictionrelated behaviors. This could be overcome by lentiviral mediated overexpression of HuD
within the NAc specifically. This approach would be tenuous to study the competition of
miR-495 and HuD, since both would need to be overexpressed by a lentiviral vector. This
is due to lower levels of co-infection of both viruses at a similar level. In either case, we
believe our approach effectively assessed the region-specific effects of this competition,
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as miR-495 OE within the NAc of transgenic animals was sufficient to cause alterations
in cocaine CPP behavior.

4c. Regulation of HuD and miR-495
Although this work has delineated the various expression patterns of HuD and miR495 in response to cocaine and behavioral training, we have not determined the
mechanism for this regulation. HuD regulation through cocaine exposure can occur at
many steps. Transcriptionally, HuD mRNA induction has been found to be regulated by
Neurogenin2 in development (Ngn2; (Bronicki et al., 2012). This positive transcriptional
regulation appears to be neuronal specific, as it was not found in mesodermal cells, which
express HuD at lower levels compared to developing neurons. Since HuD is an early
marker of neuronal differentiation, it suggests that Ngn2 is activated early in
development to induce HuD mRNA expression.
SATB1 is another transcription factor/epigenetic regulator that may influence HuD
transcription. Satb1 null mice show signs that would suggest that it is an upstream
regulator of HuD. For example, Satb1 KO animals show diminished dendritic spines,
altered IEG expression in response to stimulation (Balamotis et al., 2012). Additionally,
this factor appears to bind to upstream regulatory sequences of HuD as well as some of
its targets (Balamotis et al., 2012). To further complicate this matter, we discovered that
Satb1 is a putative target of both miR-495 and HuD. Other studies from our laboratory
have also found this link and have suggested that may be part of a positive feedback loop
between SATB1 and HuD (Wang et al., 2015). In this study, it was found that this
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positive feedback loop was integral to neurogenesis further showing that this is
mechanism is essential to normal neuronal development and processes. Although
implicated in many neuronal-specific functions, there has not been any research into the
role of calcium in the regulation of SATB1. Thus, SATB1 plays a role in the transcription
of HuD but the role it may play in learning and memory associated with Ca++ transients
cannot be established as of now. In conclusion, the exact mechanism and timing of HuD
transcriptional regulation is uncertain, especially in the context of addiction-related
behaviors. However, multiple avenues for regulation are already associated with
addiction-related behaviors.
Once HuD is translated, the activation state of this protein can be modified by
post-translational modifications. The most well studied of this is an activating
phosphorylation site through Protein Kinase C (PKC; (Pascale et al., 2005; Lim et al.,
2012). As assayed by mRNA decay assays, activation of PKC stimulates HuD
phosphorylation leading to increased HuD/mRNA target association which was reversed
by a PKC inhibitor. Specifically, Lim & Alkon assayed neurotrophic factor mRNAs such
as BDNF. Not only does PKC phosphorylation of HuD induce its activation and
association with mRNAs, it also promotes HuR movement into the cytoplasm and likely
affects HuD localization as well (Schulz et al., 2013). This is integral to many of its
neuronal specific effects, as for example cytoplasmic localization is required for HuDdependent induction of neuronal differentiation (Kasashima et al., 1999). Thus, HuD
activation through PKC is necessary for many of its effects within the neuron.
In opposition to phosphorylation, HuD methylation causes inhibition of its
activity. This methylation is carrying out by Coactivator Associated Arginine
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Methyltransferase 1 (CARM1; (Fujiwara et al., 2006). In this study, Fujiwara and
colleagues found that active CARM1 prevented PC12 cells from differentiation into
neurons as well as processes such as neuritogenesis. This was rescued by expression of a
methylation-resistant HuD. CARM1 activity is negatively regulated by phosphorylation
(Higashimoto et al., 2007; Feng et al., 2009). In addition to their previous findings, Lim
& Alkon found that HuD methylation was diminished in response to PKC stimulation,
suggesting that PKC may also regulate CARM1 to disinhibit HuD as well as activating
HuD. As hypothesized, CARM1 phosphorylation was increased by PKC activation.
Overall, PKC appears to positively modulate HuD activity.
PKC itself has been associated with various forms of addiction-related behaviors,
suggesting PKC regulation of HuD may also be involved in this disorder. PKC inhibition
blocked the stereotypical acute cocaine induced locomotor response when infused into
the VTA (Steketee, 1993). Acute cocaine induces LTP, increased spine density, within
this brain region, suggesting it may do so through a PKC/HuD dependent process
(Borgland et al., 2006; Sarti et al., 2007). LTP within the VTA is required for later druginduced plasticity within the NAc and is dependent on a shared HuD/miR-495 target,
CaMKII (Mameli et al., 2009; Liu et al., 2014). PKC inhibitor infusion blocks
potentiated NMDAR-mediated early LTP which transitions into an AMPAR dependent
LTP (Borgland et al., 2006). This still suggests that PKC regulates these forms of
plasticity, potentially through downstream effects on HuD. Additionally, VTA PKC was
associated with the initiation of sensitization while PFC PKC was associated with the
expression of sensitization (Steketee et al., 1998). Pharmacological reversal of cocaine
sensitization through co-administration of pergolide/ondansetron was found to diminish
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total PKCζ and pPKCζ and λ within the NAcC and NAcSh, suggesting that PKC may be
necessary for the induction of plasticity within the NAc for sensitization (Chen et al.,
2007). Following this, a single, systemic infusion of a zeta inhibitory particle (ZIP)
blocked sensitization to cocaine (Howell et al., 2014). This treatment also decreased
whole brain membrane bound AMPAR suggesting it altered plasticity as well. The
specificity of this effect to specific brain regions or even the specificity of ZIP itself is in
question (Lee et al., 2013).
PKC has also been found to play a role in CPP. Intraventricular administration of
a PKC inhibitor immediately after each conditioning session blocked cocaine CPP (Cervo
et al., 1997). This effect was not found when infused immediately preceding the
conditioning session, leading these authors to hypothesize that PKC was involved in the
consolidation of the pairing between drug and environmental cues. Regional specificity
was assessed later by Aujla & Beninger, when they found NAc PKC inhibition blocked
amphetamine CPP (Aujla et al., 2003). Atypical PKC Mζ inhibition within the NAc, but
not the NAcSh, was found to block cocaine and morphine CPP expression (Li et al.,
2011). However, the specificity of ZIP is in question as knockout animals of PKCζ and
PKMζ show normal cocaine CPP but show reduced CPP when given ZIP (Lee et al.,
2013). ZIP may be influencing other PKCs or other PKCs may be upregulated in
response to KO. This is especially attractive as other studies focused on pan-PKC
inhibition through other means than ZIP (Cervo et al., 1997; Aujla et al., 2003). In either
case it appears that PKC inhibition blocks CPP, suggesting this effect may be due to HuD
inhibition.
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Finally, PKC plays a role in the SA of stimulants. D1 or D2 receptor specific
stimulation in the NAcC or Sh can cause reinstatement of SA. Using this model, Ortinski
and colleagues infused a PKC inhibitor within this region 10 mins before infusion of a
D1 or D2 specific agonist to stimulate reinstatement. D2 specific reinstatement was
blocked by infusion of a PKC inhibitor, suggesting that the downstream effects of PKC
must be involved in this behavior (Ortinski et al., 2015). This effect was also
accompanied by a diminished evoked excitatory post-synaptic potential (eEPSP),
specifically through decreased AMPAR currents, suggesting this may be due to
alterations in PKC mediated plasticity.
As for miR-495, very little is known regarding the mechanisms that may link its
expression to cellular events induced by cocaine and or behavioral training. In contrast to
other addiction-related miRNAs whose expression levels were shown to increase in
response to drugs of abuse (Chandrasekar et al., 2009; Nudelman et al., 2009; Hollander
et al., 2010; Schaefer et al., 2010), miR-495 expression in the NAc decreased shortly
after exposure to cocaine. This rapid downregulation could be due to several factors.
While miRNAs are stable in non-neuronal cell types, some miRNAs decay at faster rates
in neurons via activity-dependent processes (Krol et al., 2010), which could be triggered
by cocaine administration. The decrease in miR-495 expression may also be due to
transcriptional repression. miR-495 is part of a large cluster of imprinted genes between
delta-like homolog 1 and type III iodothyronine deiodinase genes, also known as the
Dlk1-Dio3 imprinted region (Lin et al., 2003; Seitz et al., 2004). Within this region, are
protein coding genes and non-coding RNA genes including miRNAs, small nucleolar
RNAs (snoRNAs), and long non-coding RNAs. The miRNAs found in this region are

103

clustered into polycistronic transcripts, or a single large precursor miRNA transcript
encoding several miRNAs. From this large precursor miRNA transcript, RNA processing
leads to discrete miRNA strands. This miRNA cluster has been associated with various
forms of neuronal function and dysfunction, suggesting that this region may play a role in
other neuropsychiatric disorders (Gardiner et al., 2012; I. Laufer et al., 2012; Laufer et
al., 2013; Hollins et al., 2014; Winter, 2015; Marty et al., 2016).
Since these miRNA clusters appear to be transcriptionally linked together, this led
many researchers to hypothesize that these miRNAs may show coordinated expression
patterns. To this end, it has been found that adjacent to the Glt2/Dio3 promoter region is a
site for differential methylation, suggesting that a methyl binding transcriptional regulator
may regulate this site (Kernohan et al., 2010). Wu and colleagues found that methylCpG-binding protein 2 (MeCp2) bound to methylated CpG islands upstream of these
miRNA clusters through chromatin immunoprecipitation (Wu et al., 2010). Using a
MeCp2 -/- mouse model of Rett Syndrome, they found that miRNA within these clusters
were upregulated, including miR-495. They posited this was due to the inhibitory
influence of MeCp2 on the transcription of these miRNA clusters. A salient feature of
Rett syndrome is the dysregulation of Bdnf expression, leading to cognitive disability.
Following our data, they found that many of these miRNAs directly targeted the 3’UTR
of Bdnf, including miR-495 (Wu et al., 2010). Further work into the mechanism of the
Mecp2 -/- mouse model of Rett syndrome has shown that these miRNAs may regulate
ERK signaling, a shared addiction-related pathway between HuD and miR-495 (Mellios
et al., 2017). Thus, the Mecp2 -/- mouse model of Rett syndrome recapitulates this
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dysregulation of BDNF through the removed inhibitory block on these miRNA clusters
leading to excessive miRNA-mediated downregulation of BDNF and ERK signaling.
If MeCP2 regulates the transcription of miRNAs associated with addiction, it
suggests that it may play a role in the disorder. The role of MeCP2 in addiction was first
studied in the context of escalation in the self-administration of cocaine (Im et al., 2010).
When animals are given extended access to drugs of abuse in a self-administration model,
they undergo a specific behavioral pattern termed escalation of drug use. Uncontrollable,
substantial amounts of drug use is an important facet in the human condition. With this,
researchers sought out a miRNA that may be increased by this behavior. They found that
miR-212, and activity-dependent miRNA regulated CREB, was upregulated in the dorsal
striatum of these animals after extended access (Hollander et al., 2010; Im et al., 2010).
This appeared to be corresponding to an increase in MeCP2, which appears to inhibit
miR-212 expression but contains a miR-212 binding site within the 3’UTR. Thus, if miR212 expression continues, it removes its own inhibitory block. These researchers found
that upregulation of miR-212 was associated with potentiated CREB signaling, possibly
through upstream cAMP pathways. RAF1 potentiates adenylyl cyclase activity, leading
to increased cAMP production. Various other factors can enhance or repress this action.
One of the targets of miR-212 is Sprout-related, EVH1 domain containing 1 (SPRED1), a
corepressor of RAF1. Thus, extended access to cocaine-induced upregulation of miR-212
led to decreased SPRED1 levels, leading to increased cAMP production and CREB
activity leading to increased miR-212 expression. When miR-212 was overexpressed
within the dorsal striatum, rats in extended access showed decreased levels of cocaine
infusions. With this, miR-212 upregulation was associated with an increase in CREB
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expression. Oppositely, blocking of miR-212 by a locked nucleic acid (LNA) caused an
increase in cocaine infusions. Another miRNA was found to have a similar effect on
MeCP2, which then led to inhibition of heroin-seeking behavior (Yan et al., 2017).
Overall, this suggests that Dorsal Striatal MeCP2 may elevate addiction-related behaviors
and inhibits the expression of miRNAs that block the induction of these behaviors.
MeCP2 can also be regulated by phosphorylation, leading to decreased
association of this factor with methylated DNA sites (Chen et al., 2003; Martinowich et
al., 2003; Zhou et al., 2006). Furthermore, this was found to be a CaMKII dependent
event and thus is associated with plasticity (Zhou et al., 2006). With this, it was found
that acute cocaine transiently increases the inhibitory phosphorylation of MeCP2 within
the striatum, 20 minutes post-injection but not 3h (Mao et al., 2011). This effect was
found to be NMDAR dependent within the Dorsal Striatum, but not in the NAc. This may
suggest that the mechanisms for MeCP2 regulation are different in various regions of the
striatum. Since MeCP2 is an inhibitory influence on miR-495 transcription, this suggests
that this effect of acute cocaine may play a role in the upregulation of miR-495.
Studies into the function of MeCP2 in addiction-related plasticity and behaviors
show a wide variety of results. NAc MeCP2 OE blocked normal amphetamine CPP
(Deng et al., 2010). However, NAc shMeCP2 increased low dose amphetamine CPP and
normal high dose CPP (Deng et al., 2010). To further study this effect, Deng and
colleagues utilized a hypomorphic, truncated MeCP2, MeCP2308. MeCP2308 mice
showed blocked CPP for amphetamine and sucrose. Additionally, MeCP2308 mice
showed blocked acute amphetamine induced structural plasticity, cFos/FosB/JunB
induction but increased acute amphetamine locomotor activity. This follows with the idea
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that miR-495 blocks addiction-related plasticity, thus an inhibited MeCP2 would lead to
disinhibited miR-495 expression and further blockade of new drug-induced plasticity.
Although MeCP2 regulation likely plays a role in the transcriptional regulation of
the polycistronic miRNA cluster containing miR-495, it would also similarly regulate the
expression of the other miRNAs within this cluster. Thus, if MeCP2 was to wholly
account for the cocaine-induced regulation of miR-495 then the expression of the other
miRNAs from this cluster would also be sensitive to cocaine. However, given that not all
of the miRNAs in this cluster are coordinately regulated (e.g., miR-376b vs. miR-495
after CPP, data not shown; (Wu et al., 2010; Lempiäinen et al., 2013), other regulatory
mechanisms such as pre-miRNA processing and/or mature miRNA stability may play a
role in controlling miRNA expression profiles(Joilin et al., 2014). It is curious that we
did not observe changes in miR-495 in any other addiction-related brain region,
especially in those that are also innervated by ventral tegmental dopamine neurons (e.g.,
dorsal striatum, mPFC). One possibility is that the relatively high basal expression levels
of miR-495 in the NAc allowed us to detect a decrease following cocaine administration.
Another possibility is that the NAc may have a more robust response to the acute and
chronic effects of cocaine resulting in decreases in miR-495 expression levels. In any
case, this suggests that miR-495 itself may be regulated post-transcriptionally in response
to cocaine.
Although this effect is novel to exposure of drugs of abuse, researchers have
found that other stimuli can induce similar, rapid shifts in the expression neuronal
miRNAs (Krol et al., 2010). This contrasts with slower decay rates found in non-neuronal
cell types, as Krol and colleagues found miRNA decay rates were much faster in neurons
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differentiated from ESCs as compared to undifferentiated control cells. This effect was
found to be activity dependent as blockade by tetrodotoxin diminished the quick decay
rates of selected miRNAs. Transcriptional effects could mediate activity-dependent
diminished expression of miRNAs, but the rapid time course of this effect suggests it is
mediated post-transcriptionally. One possibility is that specific endonucleases target
discrete miRNAs for destruction. Tudor domain staphylococcal/micrococcal-like
nuclease (Tudor-SN) is an evolutionarily conserved nuclease that initiates the decay of
human miRNAs (Elbarbary et al., 2017). The Tudor domain of Tudor-SN mediates
protein-protein interactions, suggesting it could be regulated by these interactions. In this
study, it was found that this domain allowed for interaction with RISC members such as
Ago2 and trinucleotide repeat-containing 6A (GW182) even after RNAse treatment. This
suggests that even an active miRNA, normally protected by incorporation into the RISC,
could still be targeted by this endonuclease. In conjunction with this, Tudor-SN appears
to target select miRNAs for destruction as opposed to any miRNAs. From personal
communication with Dr. Lynne Maquat and Dr. Nora Perrone-Bizzozero, miR-495
appears to contain the correct sequence for Tudor-SN mediated destruction. Dr. Maquat
also mentioned this endonuclease may Ca++ dependently initiate the decay of these
miRNAs. Taken together, this opens the possibility that Tudor-SN could be regulated in
response to plasticity-initiating events within the neuron to remove blocks to plasticity,
such as miR-495.
Another nuclease that may be involved in this rapid decay of miR-495 could be
the XRN exonucleases (Kai et al., 2010). Although understudied in mammals and even
more so in neurons, XRN exonucleases can degrade miRNAs at multiple steps of their
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biogenesis. Since we analyzed mature miR-495, an XRN specific for mature microRNAs,
such as XRN-2, may be mediating this effect (Chatterjee et al., 2009). The mechanisms
regulating miR-495 or other activity-dependently regulated neuronal miRNAs are
understudied.
Based on this evidence so far, HuD activity appears to be most directly regulated
first negatively by CARM1 methylation. This may hold HuD in an inactive state while
allowing for miR-495 to have more influence over shared targets. Upon neuronal
stimulation, PKC can phosphorylate CARM1 to inhibit HuD methylation as well as
phosphorylating HuD to stimulate its activity. On the other hand, miR-495 may be
rapidly degraded during neuronal activity by Tudor-SN, although other yet to be
determined post-transcriptional mechanisms may also be at play. Transcriptionally, HuD
is probably regulated by Ngn2 and Satb1 in response to drugs of abuse, but tying this
effect with neuronal stimulation is tentative at best. MeCp2 may regulate pre-miR-495
induction, but our evidence suggests that a post-transcriptional mechanism is most likely
at play. Overall, the potential regulators of HuD and miR-495 expression and function are
associated with addiction-related behaviors and various forms of plasticity (see Figure
4.1).
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4d. Downstream of HuD/miR-495: Plasticity?
Post-transcriptional regulation through RBPs and miRNAs play a role in finetuning gene expression involved in many cell signaling pathways (Schratt, 2009).
Although we have determined that miR-495 and HuD share a regulatory network
including many pathways associated with addiction, the consensus within the field is that
drug-induced long-term forms of plasticity drive the behavior characteristic of addiction.
Thus, since HuD and miR-495 are associated with addiction-related behavior, they must
play a role in long-term forms of plasticity.
However, within the hypothesis that circuit level changes in plasticity mediate
addiction-related behaviors is the notion that specific neuronal circuits are being
regulated differentially to cause changes in behavior. Region specific studies may
illuminate this prospect, but for the field to progress, neuronal specific studies are needed.
In our study, we have shown that HuD, miR-495 and shared targets are altered within
most of the mouse NAc. Although we try to target the NAcSh in viral studies and tissue
punches are centered on this region, it does not negate the fact that even within this
subregion is a several of neuronal phenotypes and specific afferents connecting to these
specific neurons. Thus, due to the region wide effects we find in CPP induced expression
(Figure 3.2) or genetic manipulation (Figures 3.4, 3.5, AA1-3), our data suggests that
HuD and miR-495 are altered within this entire region in many different cell types and
circuits. Furthermore, various forms of LTP and long term depression (LTD) are found
within this region and are associated with addiction-related behavior. Therefore, HuD and
miR-495 may not regulate a specific form of long term plasticity, either LTP or LTD but
both (Figure 4.1).
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From our in silico analyses informed by in vivo data, we found that many HuD
and miR-495 targets form networks involved in both LTP and LTD (Figures 2.4, 3.1;
(Kauer et al., 2007; Kasanetz et al., 2010; Russo et al., 2010), as well as other cell
signaling cascades relevant to addiction and plasticity, such as PKA signaling (Self et al.,
1998a; Boudreau et al., 2009). Therefore, HuD and miR-495 within the entire NAc may
act as a mechanism to fine tune the molecular response of multiple, interwoven pathways
involved in the development of addiction. Additionally, HuD is upregulated within whole
brain lysates after acute cocaine (Tiruchinapalli, Caron, et al., 2008). However, HuD and
miR-495 may not regulating whole brain LTP or LTD, as many of these are occurring
within specific regions and circuits after cocaine.
Within the framework of the idea that post-transcriptional regulation fine-tunes a
specific response, HuD and miR-495 competition could have divergent effects depending
on the specific neuronal phenotype and circuit, even if net effect is increased or decreased
ARG and Plasticity related gene (PRG) mRNA stability. The downstream effects of
shared HuD and miR-495 targets may be sensitive to the specific neuronal stimulation
that evoked HuD and miR-495 regulation as well as to initiate changes to plasticity
evoked by this neuronal stimulation. For example, LTP and LTD are both are calcium
sensitive processes that require similar protein machinery involved in either phenomenon
(Lüscher et al., 2012). Thus, instead of positing that HuD supports one form of plasticity
while miR-495 promotes another, it is more congruent with our current data to
hypothesize that HuD and miR-495 compete for the control of changes both forms of
long term plasticity (Figures 4.1B, C). This follows with our data as they both regulate
LTD and LTP through similar targets such as BDNF and CaMKIIα. With this, our data
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supports the hypothesis HuD regulation promotes changes to the plasticity found within
discrete neurons in response to their specific circuitry and phenotype, while miR-495 acts
as a block to these forms of plasticity. Here, this idea will be expanded upon by
examining the role that a selection of shared HuD and miR-495 targets associated with
both LTP and LTD could play in the formation of either of these forms of plasticity.
Although not tested for direct interaction, we found that Gria3 mRNA was
upregulated in the HuDOE microarray and sensitive to miR-495 OE (Figures 2.4 and 3.1).
Gria3 mRNA encodes the Ca++ permeable GluA3 AMPAR subunit. Although much
more research has been devoted to understanding the role of GluA1 and GluA2 in
hippocampal LTP and LTD, respectively, very little is known about GluA3 in these
processes. Especially since it was suggested from global KO studies that GluA3 has no
effect on basal synaptic properties, LTP, or LTD (Meng et al., 2003). Since it is Ca++
permeable, it suggests it must play some role in changes to neurotransmission.
Additionally, GluA3 is abundant in many hippocampal synapses and is associated with
synaptic dysfunction in disease states (Wu et al., 2007). Very recently it was found that
GluA3 promotes LTP in Purkinje cells during motor learning as well as in the
hippocampus (Gutierrez-Castellanos et al., 2017; Renner et al., 2017). In hippocampal
synapses, it was found that under basal conditions GluA2/3 containing AMPARs are lowconductance. During periods of stimulation and cAMP accumulation, GluA2/3 AMPARs
become high-conductance receptors and promote downstream synaptic potentiation. This
heightened cAMP production was stimulated by β-adrenergic receptors. However, this
does not preclude the possibility that other GPCRs, possibly DA receptors, could be
involved in a similar mechanism. Other research focused on synaptic pathologies, have
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found that GluA3 is a target of Aβ which removes it from the synapse leading to synaptic
and memory impairment (Reinders et al., 2016). GluA3, along with other receptor
mRNAs, were upregulated in the Hippocampal Dentate Gyrus region of human
alcoholics, suggesting a potential role in addiction (Jin et al., 2014). Supporting this,
findings from prenatal alcohol exposed (PAE) animals generally show a higher
propensity for addiction-related behaviors such as self-administration. Researchers found
that PAE exposed animals showed higher levels of amphetamine SA induced
upregulation of GluA3 in VTA neurons which was also associated with higher levels of
LTP in these neurons (Hausknecht et al., 2015). Thus while the potential role of GluA3 in
long-term plasticity is still under investigation it does appear that GluA3 regulation is
associated with LTP.
In addition to directly regulating AMPAR subunit mRNA stability, HuD and
miR-495 also regulate factors that can indirectly regulate the composition of AMPARs
within specific synapses. Arc is a well-studied PRG or, as termed by the synaptic tagging
hypothesis, Plasticity-related product (PRP, but will be discussed further as PRG;
(Redondo et al., 2011). Conventionally, it is hypothesized that Arc organizes actin, as it
was first discovered as a factor that co-fractionated with actin, and overexpression causes
actin dependent increases in thin spines (Lyford et al., 1995; Peebles et al., 2010).
Recently, other functions of Arc have been discovered. For example, Arc has been found
to mediate AMPAR cycling associated with LTD (Waung et al., 2008). Converging with
the hypothesis that HuD and miR-495 regulate plasticity through altering the translation
of specific PRGs, this same study found that mGluR1 dependent LTD required ARC
translation but not transcription. Thus, the local translation of pre-existing dendritic Arc
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mRNA was integral to the development of this form of long-term plasticity. Following
with the argument that HuD and miR-495 regulate both LTP and LTD, Arc KO animals
have deficits in both LTD and LTP (Plath et al., 2006). More distinctly, Arc has been
found to be required for late phase LTP (Guzowski et al., 2000; Plath et al., 2006;
Messaoudi et al., 2007). Additionally, Arc is required for LTP induced by BDNF, another
HuD and miR-495 shared target (Messaoudi et al., 2002, 2007). Therefore, HuD and
miR-495 regulation of Arc mRNA could cause alterations in both LTP and LTD in
response to different cellular stimuli.
Arc mRNA and protein expression has been found to be correlated with synaptic
activity, as well as learning and memory (reviewed in (Korb et al., 2011). As such, it has
been heavily implicated in addiction-related behaviors (Fosnaugh et al., 1995; Klebaur et
al., 2002; Freeman et al., 2008; Hearing et al., 2008, 2010, 2011, Lv et al., 2011, 2015;
Riedy et al., 2013; Alaghband et al., 2014; Salery et al., 2017; Gao et al., 2017). Acute
cocaine rapidly induces striatal Arc mRNA in a D1-dependent manner (Fosnaugh et al.,
1995). Arc expression has also been found to be potentiated in response to the pairing of
the drug to a specific environmental context, suggesting it may be involved in encoding
this pairing (Klebaur et al., 2002; Hearing et al., 2008, 2010). Arc may also be involved
in the motivation aspect of these cues, as cue-induced reinstatement increased Arc
mRNA in the orbitofrontal, prelimbic, and anterior cingulate regions of the prefrontal
cortex (Zavala et al., 2008). Additionally, following previous research that specific
ensembles of neurons are activated by addiction-related behaviors, striatal neurons
expressing cfos-lacZ in response to cocaine sensitization have been found to have
increased levels of Arc mRNA (Guez-Barber et al., 2011). The expression of Arc is
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altered within the striatum during active cocaine SA and withdrawal (Freeman et al.,
2008; Gao et al., 2017). Arc expression has also been associated with cocaine and
morphine CPP (Lv et al., 2011, 2015; Alaghband et al., 2014). Although well studied as a
marker of activity in the context of addiction-related behaviors, very little research has
gone into the downstream mechanism of Arc regulation in these behaviors. Even though
Arc-induced reorganization of synaptic AMPARs has focused on LTD, it was also found
that morphine CPP caused an Arc-induced increase in synaptic GluR1 associated with
LTP (Lv et al., 2015). Though nuclear reorganization has not well studied in plasticity,
Arc may also have a nuclear function and promotes promyelocytic leukemia nuclear
bodies (PML-NBs; (Irie et al., 2000; Bloomer et al., 2007). Recently, acute cocaine has
been found to cause Arc to accumulate within the nucleus (Salery et al., 2017).
Furthermore, Salery and colleagues instead studied the role it may play in chromatin
remodeling and it was found that Arc colocalizes with phosphorylated Ser10-histone H3.
Arc overexpression was found to diminish this phosphorylation while KO animals
showed decreased heterochromatin domains and enhanced pol II activity as well as cFos
expression. Behaviorally, these Arc KO animals showed increased cocaine-induced
sensitization and CPP, but was not directly linked to its nuclear activity. In either case,
this presents another possibility for Arc-induced regulation of plasticity and addictionrelated behaviors.
Another integral synaptic receptor, GluN2B or NR2B, is also regulated by HuD
and miR-495. Additionally, it has been associated with many forms of addiction-related
behaviors and cocaine exposure. It was first found to be upregulated during withdrawal
(Loftis et al., 2000). NR2B was found to interact with D2 receptors to inhibit D2 neuron
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circuits (Liu et al., 2006). NR2B synergistically activated ERK along with D1Rs, while
inhibition of this pathway prevented cocaine-induced sensitization and CPP (Pascoli et
al., 2011). Finally, it has been associated with cocaine-induced generation of silent
synapses within the NAc (Huang et al., 2009). As one of subunits in the NMDAR
complex, it has been hypothesized to regulate many forms of plasticity. Despite not being
well studied in addiction-related LTP, it has been found to be associated with forms of
LTP through its interaction with CaMKII (reviewed in (Coultrap et al., 2012).
Additionally, the ratio between NR2A/NR2B has been hypothesized to be involved in
determining the threshold for LTD/LTP with higher NR2A/NR2B associated with LTP
and lower with LTD (Yashiro et al., 2008). With this, NR2B is another shared target of
HuD and miR-495 that could play a dual role in LTD or LTP induction during addictionrelated behaviors.
In addition to these ARGs, we also established that HuD and miR-495 directly
targets and regulates the ARG Bdnf both in vitro and in vivo (HuD and miR-495 data
shown in Gardiner et al., In prep, only miR-495 in Figure 2.1). Additionally, Bdnf has
been a well characterized target of HuD (Allen et al., 2013; Vanevski et al., 2015).
BDNF have been highly associated with behavioral and addiction-related processes. For
example, BDNF regulates molecular processes involved in the learning and memory of
discrete spatial cues (Falkenberg et al., 1992; Linnarsson et al., 1997; Mu et al., 1999;
McGauran et al., 2008). Since visual spatial cues are critical in CPP behavior
(Cunningham et al., 2006), and these molecules have been associated with CPP for other
drugs of abuse, this suggested that HuD and miR-495 may regulate cocaine-CPP through
direct targeting of BDNF (Bahi et al., 2008). Additionally, Bdnf in the NAc has been
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linked to several drug abuse-related behaviors, where BDNF expression levels positively
correlate with cocaine reward and motivation (Horger et al., 1999; Hall et al., 2003;
Graham et al., 2007, 2009; Bahi et al., 2008). Thus, HuD and miR-495 regulation of
BDNF may play a role in these behavioral processes.
What is not well known is how BDNF can regulate these behavioral processes
through plasticity. As posited in the beginning of this section, addiction is a disorder of
neuroplasticity and thus, ARGs must affect plasticity. With this, BDNF has been
associated with various forms of plasticity. Bdnf KO animals were first found to have an
impairment in hippocampal LTP but was restored with recombinant BDNF or viralmediated expression (Korte et al., 1995, 1996; Patterson et al., 1996). Additionally,
BDNF appears to be released in response to LTP or immediately after its induction
(Aicardi et al., 2004). Additionally, its interaction with the TrkB receptor suggests that
this is the post-synaptic mediator of BDNF-induced LTP (Chen et al., 1999). Through
this receptor, BDNF appears to upregulate protein synthesis-dependent functional and
structural changes required for late phase LTP (reviewed in (Panja et al., 2014). This
direct effect of BDNF on LTP has led researchers to propose that TrkB receptors act as a
synaptic tag and BDNF as the PRP required in LTP and memory consolidation (Lu et al.,
2011). As with the other shared HuD and miR-495 ARGs, BDNF may also be involved
in LTD. In this case, it is that an unprocessed form of BDNF is associated with LTD,
rather than the mature BDNF usually studied. Through interaction and activation of the
p75NTR, Pro-BDNF has been associated with NMDAR-dependent LTD within the
hippocampus (Woo et al., 2005; Yang et al., 2014). Additionally, LTD-induction is
associated with an upregulation in proBDNF rather than BDNF through the secretion of
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proteases (Nagappan et al., 2009). This suggests that depending on the input, a neuron
can dictate whether BDNF or proBDNF acts on a synapse leading to LTP or LTD,
respectively. Finally, this LTD has been hypothesized to occur through the upregulation
of NR2B NMDARs, another shared HuD and miR-495 target (Woo et al., 2005). In terms
of Bdnf mRNA regulation, Bdnf-L has been proposed to be associated more with
proBDNF expression while Bdnf-S is more related to mature BDNF (Orefice et al.,
2013). Both HuD and miR-495 target these dual Bdnf mRNAs, thus could affect
expression of proBDNF and matBDNF leading to different forms of long term plasticity
associated with addiction-related behaviors.
Additionally, Camk2a has been a well characterized target of HuD (Sosanya,
Peggy P C Huang, et al., 2013; Sosanya et al., 2015) and has been associated with
behavioral and addiction-related processes. As with Bdnf, Camk2a also regulates
molecular processes involved in the learning and memory of discrete spatial cues and has
been found to play a role in CPP (Silva et al. 1992; Cho et al. 1998; Poulsen et al. 2007;
Sakurai et al. 2007; Rosen, Zunder, et al. 2015). Others have established that CaMKIIα
has a positive relationship between NAc levels and psychostimulant abuse-related
behavior (Anderson et al., 2008; J. A. Loweth et al., 2010; Wang et al., 2010; Kourrich et
al., 2012b). Furthermore, CaMKII has been identified in silico as a central node in
positive feedback gene regulatory pathways involved in addiction (Li et al., 2008).
Additionally, it has been associated with LTP and LTD, possibly through differential
phosphorylation (reviewed in (Coultrap et al., 2012). CaMKIIα also interacts with NR2B,
another HuD and miR-495 shared target ARG, to remain in an active state leading to
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many of its downstream effects. Therefore, regulation of CaMKIIα by HuD and miR-495
may coordinately affect several domains of addiction-related processes.
Given this evidence that miR-495 and HuD regulate many factors associated with
various forms of long term plasticity, our understanding of the effects that either of these
regulators have on long term plasticity is very limited. Previous work from our laboratory
found that HuDOE did not cause alterations in long term potentiation within mossy fiber
neurons in the hippocampus (Tanner et al., 2008). These neurons did show increased
paired pulse facilitation, a form of short-term pre-synaptic plasticity. Although a
presynaptic form of plasticity appears to discount that HuDOE regulated this, this mouse
shows increased HuD within most forebrain neurons, suggesting that this presynaptic
effect may have in fact been driven by HuDOE. These animals were naïve and not
subjected to any behavioral or drug challenges, suggesting that the effect of HuDOE may
require strong stimuli to cause changes to long term plasticity. The effects of miR-495 on
plasticity are unknown. With the help of Dr. Manuel Mameli’s group we attempted these
measures. After slicing the tissue for electrophysiology he found that LV-miR-495 OE
MSNs appeared to be damaged and thus were unable to determine electrophysiological
measures of the effect of miR-495. Furthermore, Kate Reinhardt in Dr. Bill
Shuttleworth’s laboratory, found a similar effect in Bdnf Val/Met mice. After preparation
of these brains for electrophysiological assays, she found that defective BDNF mice
neurons appeared damaged. To add to this, LV-miR-495 OE neurons appeared damaged,
missing many of their spines (data not shown). This might suggest that BDNF protects
against injury during electrophysiological slicing, and miR-495 induced knockdown or
defective Bdnf Val/Met variants may diminish the capacity of these neurons to survive
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this insult. In conclusion, it does in fact appear that the competition between HuD and
miR-495 putatively regulates plasticity but the actual effects of these molecules on
plasticity is unknown.
Collectively, we demonstrate a novel in silico method to identify potential
miRNAs that may be involved in SUD. Our findings suggest that miR-495 decreases
motivation for cocaine by targeting several ARGs and regulatory pathways in the NAc
involved in synaptic plasticity, PKA signaling, and other pathways associated with the
disorder. Conversely, we have determined that HuD plays a positive role in addictionrelated behaviors, suggesting that positive regulation of mRNA stability and protein
translation mediated by this RBP may counteract the effect of miR-495. These results
highlight the importance of moving drug abuse research from a single gene focus to
biological pathways to better understand the complexity of the molecular networks
associated with addiction. This discovery also opens new avenues for future research on
the specific factors controlling cocaine-induced regulation of miR-495 and HuD as well
as the the role of HuD and miR-495 in regulating different forms of synaptic plasticity in
the NAc. Most importantly, this study is the first to identify a miRNA that specifically
regulates the incentive motivational properties for cocaine both during active drug taking
and following a period of abstinence. The latter finding is particularly compelling, as
preventing relapse is a primary objective for addiction translational research. The
possibility of globally targeting drug-induced changes in gene expression via miRNAs,
such as miR-495, may lead to new therapeutics that shift the balance of gene regulation
toward alleviating, rather than promoting, SUD-related behavior.
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Fig. 4.1. miR-495 and HuD compete for the regulation of ARGs associated with both
forms of long-term plasticity. (A) miR-495 and HuD may compete for the regulation of
synaptic maintenance but they may also compete for the expression of either LTD (B) or
LTP (C) depending on the neuronal input. As discussed in the previous section, both LTP
and LTD processes are driven by Ca++ which can positively regulate HuD and negatively
regulate miR-495. This could lead to the increased mRNA stability and translation of
ARGs. Many of these genes have dual functions in either LTD or LTP. As such, I
propose that miR-495 and HuD compete for control of long-term plasticity depending on
the neuronal input.
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APPENDIX A: Effects of NAcsh LV-miR-495 OE in C57Bl/6 and
HuDOE mice on CPP behavior
First, using the same tissue processed in figure, we assessed the expression of
NAc miR-495 after cocaine CPP. We found that NAc miR-495 was significantly
downregulated in these same animals (data not shown, will be submitted as part of
Gardiner et al., In prep.; t(13) = 2.7, p<0.05). To assess whether this CPP induced
alteration in miR-495 expression was specific to miR-495 or generalized to other
miRNAs within the same transcriptional unit, we measured the expression of miR-376b.
NAc expression of miR-376b was not altered by CPP training (data not shown; t(9) = 0.7,
p = ns), suggesting that these alterations in miR-495 expression were specific to this
miRNA and possibly occur after transcription.
Next, we aimed to specifically delineate the role of NAc miR-495, in contrast to
HuD, in cocaine CPP behavior. To test this, we infused LV-miR-495 within the NAcSh
of C57Bl/6J male mice 2 weeks before cocaine CPP training. Since HuDOE potentiated
cocaine CPP, we hypothesized that miR-495 would diminish standard C57Bl/6J mouse
cocaine CPP. With this, we found that LV-miR-495 OE significantly decreased cocaine
CPP compared to LV-GFP (Figure AA.1A; t(7.2) = 2.6; p < 0.05, with Welch’s
Correction). As expected, miR-495 was upregulated nearly 1.5 fold within the LV-miR495 treated animals (Figure AA.1B; t(15) = 2.4; p < 0.05). Additionally, shared miR-495
and HuD target mRNA was significantly downregulated (Figure AA.C-E; Bdnf-L, t(6) =
2.8; p <0.05; Bdnf-Pan, t(7) = 2.5, p <0.05; Camk2a, t(10) = 3.3, p <0.01). This suggests
that NAc miR-495 negatively regulates the expression of ARGs associated with CPP as
well as motivation associated with CPP behavior itself. Together, both sets of data imply
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that NAc HuD and miR-495 have opposite effects on CPP-induced ARG expression and
CPP behavior.
Previously, we found that miR-495 and HuD compete for a shared
GUUUGUUUG region within the 3’UTR of ARGs in a luciferase assay. To test if HuD
and miR-495 compete for control of ARG expression within the NAc, we infused LVmiR-495 within the NAcSh of HuDOE animals. HuDOE + LV-miR-495 animals were
found to have increased NAc miR-495, as compared to HuDOE + LV-GFP controls
(Figure AA.2A; t(23) = 2.9, p < 0.01). Additionally, this was combined with a significant
decrease in shared ARG mRNA (Figure AA.2B-D; Bdnf-L, t(10.4) = 2.3, p <0.05 with
Welch’s Correction; Bdnf-Pan, t(13.8) = 2.3, p <0.05 with Welch’s Correction; Camk2a,
t(18) = 2.4, p <0.01). An alternative hypothesis for this effect may include miR-495
targeting of HuD, leading to diminished HuD mRNA and decreased stabilization of
shared ARG mRNAs. However, we found there was no significant difference HuD
mRNA in either viral conditions (data not shown, t(19) = 1, p = ns). This is in line with
our previous luciferase experiments detailing that miR-495 does not target HuD 3’UTR
luciferase reporters (data not shown, will be published in Gardiner et al., In Prep.) and
that miR-495 OE in SH-SY5Y cells does not decrease HuD mRNA (data not shown).
Together these results add to our previous luciferase reporter findings, suggesting that
HuD and miR-495 compete for expression of shared ARG mRNAs through the 3’UTR
within a region associated with addiction-like behaviors. This data also suggests that this
competition may be happening during addiction-related behaviors.
As found previously, cocaine CPP was associated with a decrease in NAc miR495 and a concomitant increase in HuD mRNA and protein, as well as shared ARG target
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expression (Figure 3.2). Additionally, we found that HuDOE caused an increase in CPP in
contrast to miR-495 OE, which diminished CPP (Figure 3.4, AA.1A). In combination
with our findings that HuD and miR-495 have a shared target GUUUGUUUG sequence
in ARG 3’UTRs, this data suggests that NAc HuD and miR-495 may compete for the
control of CPP-induced shared ARG expression and ultimately addiction-related
behaviors. To test this hypothesis, we infused LV-miR-495 within the NAcSh of HuDOE
animals before they were trained in cocaine CPP. HuDOE + LV-miR-495 animals showed
decreased cocaine CPP in comparison to LV-GFP controls (Figure AA.3A, t(12) = 6.8, p
< 0.0001). As expected, HuDOE animals infused with LV-miR-495 had increased miR495 within the NAc (Figure AA.3B, t(9) = 3.8, p < 0.01). Additionally, this alteration in
CPP behavior was associated with decreased shared HuD and miR-495 ARG target
mRNA (Figure AA.3C-E; Bdnf-L, t(13) = 3.6, p <0.01; Bdnf-Pan, t(8) = 2.8, p <0.05;
Camk2a, t(8) = 4.9, p <0.01). This suggests that HuD and miR-495 compete for the
expression of NAc shared ARGs in response to CPP as well as CPP behavior itself.
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Fig. AA.1. NAcSh LV-miR-495 OE animals show decreased cocaine CPP-induced
behavior and target expression within the NAc. Male C57Bl6/J mice were injected
with LV-miR-495 or LV-GFP control and trained with 15 mg/kg cocaine in the same
CPP-induced protocol as Figure 3.2 except both groups were trained with cocaine. LV127

miR-495 OE decreased preference for the cocaine-paired Cs+ compared to littermate
controls (n = 13-14/genotype). The NAc was harvested 1hr following initiation of the test
day in the CPP protocol. LV-miR-495 OE did in fact lead to increased miR-495 within
this region (B.) LV-miR-495 OE led to elevated Camk2a, Bdnf-L, and Bdnf-Pan mRNA
(C, D, E) n = 3-5/treatment. *p<0.05, **p<0.01 Student’s t-test LV-miR-495 versus LVGFP control. Error bars indicated ±SEM.
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Fig. AA.2. NAcSh LV-miR-495 OE in naïve HuDOE animals show decreased shared
target mRNA expression. Male HuDOE mice were injected with LV-miR-495 or LVGFP control within the NAcSh. The NAc was harvested 2 weeks following viral infusion
to allow for sufficient recovery and viral expression. HuDOE + LV-miR-495 OE did lead
to increased miR-495 within this region (A). HuDOE + LV-miR-495 OE diminished
Camk2a, Bdnf-L, and Bdnf-Pan mRNA (B, C, D) n = 3-5/treatment. *p<0.05, **p<0.01
Student’s t-test LV-miR-495 versus LV-GFP control. Error bars indicated ±SEM.
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Fig. AA.3. NAcSh LV-miR-495 OE in HuDOE animals show decreased cocaine CPPinduced behavior and target expression within the NAc. Male HuDOE mice were
injected with LV-miR-495 or LV-GFP control and trained with 15 mg/kg cocaine in the
same CPP-induced protocol as Figure 3.2 except both groups were trained with cocaine.
130

HuDOE + LV-miR-495 OE decreased preference for the cocaine-paired Cs+ compared to
littermate controls (n = 13-14/genotype). The NAc was harvested 1hr following initiation
of the test day in the CPP protocol. HuDOE + LV-miR-495 OE did in fact lead to
increased miR-495 within this region (B). HuDOE + LV-miR-495 OE led to diminished
Camk2a, Bdnf-L, and Bdnf-Pan mRNA (C, D, E) n = 3-5/treatment. *p<0.05, **p<0.01
Student’s t-test LV-miR-495 versus LV-GFP control. Error bars indicated ±SEM.
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APPENDIX B: Sensitization in C57 and HuDOE animals
To test the role of miR-495 and HuD in addiction-related behaviors, we initially
assayed the role of these factors in behavioral sensitization to cocaine. Additionally,
many of the shared HuD and miR-495 targets within the NAc are associated with
sensitization (Pierce et al., 1998; Guillin et al., 2000; Zhang et al., 2007; Bahi et al.,
2008; Crooks et al., 2010; J. A. Loweth et al., 2010; Brown et al., 2011; Kourrich et al.,
2012b; Robison et al., 2013; Salery et al., 2017). Mice were sensitized to cocaine (15
mg/kg, i.p.) by 5 single, daily injections of cocaine, followed by a 7-d withdrawal period
before receiving a challenge injection of either saline or cocaine (15 mg/kg, i.p.) on day
12. These mice received cocaine injections within locomotor monitoring chambers, a
novel environment. In contrast, we injected a separate group of animals in their home
cage with 5 single, daily injections of cocaine (15 mg/kg, i.p.) which served as a
subchronic home cage control group for molecular analyses. Mice given repeated
injections of either cocaine or saline exhibited differential locomotor activity across time
(Figure AB.1A; Day, F3, 12 = 15.6, p < 0.001; Day x Treatment, F3, 12 = 34.76, p < 0.001).
Cocaine treated mice exhibited an increase in locomotor behavior on days 1, 5, and 12
compared to baseline (Figure AB.1A; Day, F3, 5 = 21.93, p = 0.003; post-hoc pairedsamples t-tests, ps < 0.05), as well as an increase on day 12 compared to day 1 (p <
0.001), indicating locomotor sensitization had occurred. Saline controls exhibited a
decrease in locomotor behavior on days 5 and 12 compared to both their baseline and day
1 (Figure AB.1A; Day, F3, 5 = 12.855, p = 0.009; post-hoc paired-samples t-tests, ps <
0.05), suggesting these animals had habituated to the injections and/or activity
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monitoring chambers. Animals were sacrificed 1 hour following the challenge injection
and the NAc was dissected for molecular analyses. The mice treated subchronically
within their home cage had no altered changes in NAc miR-495 expression, with levels
that were comparable to saline-treated control mice (Figure AB.1B; p = 0.28). In
contrast, mice that received a sensitizing cocaine regimen had a decrease in NAc miR495 expression 1 h after the challenge cocaine injection, compared to saline controls
(Figure AB.1C, p = 0.02). Furthermore, we calculated scores for changes in locomotion
(i.e., sensitization in cocaine-treated mice and habituation in saline-treated mice) as a
ratio of day12/day 1 and found that NAc miR-495 expression significantly and negatively
correlated with these ratios in cocaine-treated mice, but not saline-treated mice (Figure
AB.1D, Cocaine: r(4) = 0.93, p = 0.02; Saline: r(4) = 0.36, p = 0.26). Additionally, we
found that shared HuD and miR-495 target mRNA were increased within the NAc
following behavioral sensitization to cocaine and concurrent with the decrease in NAc
miR-495 (Figure AB.1E-G; Camk2a t(6) = 2.3, p = 0.05; Bdnf-L t(11) = 2.3, p <0.05;
Bdnf-Pan t(10) = 2.8, p <0.05). Thus, miR-495 expression within the NAc may play a
role in the expression of behavioral sensitization to cocaine.
Next, we utilized HuDOE mice to determine the role that HuD may play within
sensitization. Since genotypes may not provide large effects for behavioral changes, we
used a submaximal sensitization dose (7.5 mg/kg) to determine how HuDOE may affect
sensitization. Comparatively, the rest of the sensitization protocol remained unchanged
from the original wild type experiment above. Since decreased NAc miR-495 was
associated with increased sensitization to cocaine, we hypothesized that HuDOE animals
would have elevated levels of sensitization to cocaine, despite the submaximal
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sensitization dose. There was a significant difference in locomotor activity across time
and genotype, as well as a significant interaction between the two (Figure AB.1H; Day,
F3, 18 = 16.6, p < 0.0001; Genotype, F1, 6 = 8.8, p < 0.05; Day x Genotype, F3, 18 = 4.8, p <
0.05). Wild-type mice did not exhibit an increase in locomotor behavior on day 1 or day 5
but did have significantly elevated levels of locomotor activity on day 12 compared to
baseline (Figure AB.1H; Day, F3, 12 = 20.1, p < 0.0001; post-hoc paired-samples t-tests,
baseline vs. day 5, Sidak’s ps < 0.05; baseline vs. day 12 ps < 0.001), as well as an
increase on day 12 compared to day 1 (Sidak’s p < 0.001), indicating locomotor
sensitization had occurred. As evidenced by the non-significant difference between
baseline and day 1, these animals did not exhibit elevated acute-cocaine induced
locomotor activity, as hypothesized by this submaximal dose of cocaine. In contrast,
HuDOE mice did exhibit an increase in locomotor behavior on day 1, in addition to days 5
and 12 compared to baseline (Figure AB.1H; Day, F3, 12 = 20.1, p < 0.0001; Sidak’s
post-hoc paired-samples t-tests baseline vs. day 1, ps < 0.01; baseline vs. day 5, ps <
0.05; baseline vs. day 12 ps < 0.001). However, there was not a significant difference
between day 12 and day 1 of cocaine treatment (p = ns). This suggests that although
HuDOE exhibited increased cocaine-induced locomotor activity in response to this
submaximal dose of cocaine, they did not sensitize to cocaine.
To compare these differing effects on sensitization without affecting cocaineinduced locomotor activity, we examined the significant interaction between genotype x
day (Day x Genotype, F3, 18 = 4.8, p < 0.05). There was no significant difference between
control or HuDOE in baseline locomotor measures, suggesting these mice show proper
basal activity measures (ps = ns). Additionally, there was no significant difference
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between genotypes in day 5 and day 12, suggesting that the behavioral plasticity induced
by this cocaine regimen appears normal in both genotypes (p = ns). However, there was a
significant difference between genotypes in the day 1 locomotor activity (p < 0.01). Thus,
HuDOE mice show an elevated locomotor response to acute cocaine. The HuDOE acute
cocaine locomotor response appears to be the maximal cocaine-induced locomotor
response, as their day 12 locomotor response is not different from the control animals. To
examine this difference further, we calculated scores for changes in cocaine-induced
sensitized locomotor activity as a ratio of day12/day 1. As expected, there was a
significant difference between genotypes in their sensitized response (t(6) = 2.5, p <0.05).
The mean ratio in the control group was 2.7, suggesting withdrawal induced behavioral
plasticity, as characteristic of this experimental setup, had occurred in these animals.
However, the mean ratio in the HuDOE group was 1.1, suggesting that no such behavioral
plasticity occurred in these animals. Although it is uncertain what plasticity may have
occurred within the brain, we believe that the HuDOE animals reached a maximal cocaineinduced locomotor activity level that could not be surpassed.
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Fig. AB.1. NAc HuD and miR-495 are associated with locomotor sensitization to
cocaine. (A) Challenge doses of saline or cocaine (15 mg/kg, i.p.,) in the context of an
initially novel environment cause stereotyped alterations in locomotor activity defined as
habituation and sensitization, respectively (* p < 0.05, ** p < 0.01, *** p < 0.001 versus
baseline; + p < 0.05, ++ p <0.001, +++ p < 0.0001 versus Day 1). (B) qRT-PCR analysis
of miR-495 expression in the NAc 1 h following 5 daily injections (subchronic) cocaine
(15 mg/kg, i.p.,) and saline treatments. Similar to sensitization dosing regimen without
pairing to the novel locomotor chamber and without withdrawal + challenge dose. In
contrast to acute cocaine administration, miR-495 levels did not decrease after subchronic
cocaine treatment. (C) qRT-PCR analysis of miR-495 levels in the NAc 1 h following the
final challenge dose of cocaine (15 mg/kg, i.p.,) and pairing with novel locomotor
chamber. (D) miR-495 expression significantly and negatively correlated with locomotor
sensitization scores expressed as day12/day 1 ratios. Line represents a best fit linear
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function for the cocaine and saline treated groups separately, *p < 0.05. (E-G)
Sensitization was associated with an increase in shared HuD and miR-495 targets. (H)
HuDOE mice and littermate controls underwent a similar locomotor sensitization
procedure as in (A), but both genotypes received cocaine but at a submaximal dose (7.5
mg/kg). *** p < 0.001 versus Wt at that day; ++ p <0.001 versus Day 1 vs Day x within
genotype). Error bars indicate SEM for (A-C, E-H).
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APPENDIX C: Supplementary Information from miR-495 manuscript
Materials and Methods
miRNA fluorescent in situ hybridization. Cryosections (12 µm) from adult mouse brains
were first fixed with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) to prevent
miRNA loss from the tissue followed by 4% paraformaldehyde (Pena et al., 2009). miR495 and scrambled locked nucleic acid (LNA) probes (3 pmol; LNA miRCURY probe,
Exiqon, Woburn, MA, USA) were labeled with digoxigenin (DIG Oligonucleotide
Tailing Kit, Roche Applied Sciences, Basel, Switzerland, cat # 3353583910) and
hybridized to the sections for 16 h at 55°C. After hybridization, sections were washed
and then incubated in the presence of peroxidase-conjugated anti-DIG antibodies,
followed by tyramide-Cy3 or fluorescein conjugates (TSA Plus Florescence Systems Kit,
PerkinElmer, Waltham, MA, USA, # NEL741001KT). After subsequent washes, slides
were mounted in Prolong Gold (Invitrogen, Grand Island, NY, USA, # P36930), and
images were acquired on an Olympus BX-60 microscope with a DP71 CCD-digital
camera (Olympus America, Center Valley, PA, USA).

Reverse transcription and qPCR. Mouse and rat brains were flash frozen and dissected
using a brain matrix. Regions of interest were dissected using a 1.25 and 2 mm brain
punch (Harris Unicore™). Tissue from one hemisphere was randomly chosen for RNA
processing and the contralateral side was processed for protein analyses. RNA was
isolated via standard Trizol® (Invitrogen, # 15596026) extraction followed by ethanol
precipitation in the presence of glycogen to recover both mRNA and small RNAs.
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Starting with 15 ng of purified RNA, cDNA was prepared using the Taqman®
MicroRNA Reverse transcription kit (Applied Biosciences, Grand Island, NY, USA, #
4366596) and Taqman® MicroRNA Assay primers (Life Technologies, Grand Island,
NY, USA) for miR-495 and U6. For mRNA qPCR, cDNA was prepared using the
SuperScript II First-Strand Synthesis system (Life Technologies, # 18064014) and
quantified using Power SYBR Green PCR Master Mix (Life Technologies, # 4367660)
with primers designed against selected targets (Mouse Bdnf-L: Forward
TGGCCTAACAGTGTTTGCAG, Reverse GGATTTGAGTGTGGTTCTCC; Rat BdnfL: Forward GCCACTGAAATGCGACTGAA, Reverse
CATTCCCCACCTCCATCTAGAC; Mouse/Rat Pan-Bdnf: Forward
GACTCTGGAGAGCGTGAAT, Reverse CCACTCGCTAATACTGTCAC; Mouse/Rat
Camk2a: Forward TATCCGCATCACTCAGTACCTG, Reverse
GAACTGGACGATCTGCCATTT; Mouse/Rat Arc: Forward
GGTAAGTGCCGAGCTGAGATG, Reverse CGACCTGTGCAACCCTTTC;
Mouse/Rat Gria3: Forward GCATACACCCCTCTGGAGAA, Reverse
TGAGAAGCCCTTCCATTTGA; Mouse/Rat Stmn2: Forward
GCTACAGCTGGACCCTTCTC, Reverse GCAGGAGCAGATCAGTGACA;
Mouse/Rat Cnr1: Forward ACCTCTTTCTCAGTCACGTTG, Reverse
TGTCATTTGAGCCCACGTAG) and compared to a reference transcript (Mouse Gapdh:
Forward TGTGATGGGTGTGAACCACGAGAA, Reverse
GAGCCCTTCCACAATGCCAAAGTT; Rat Gapdh: Forward
CCACAGTCCATGCCATCACT, Reverse GCCTGCTTCACCACCTTCTTG). Relative
expression was determined using the comparative 2-ΔCt method (Livak et al., 2001). A
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no reverse transcriptase (RT) reaction was run for each sample and none of the no-RT
controls amplified. qPCR experiments were replicated on 2-3 separate occasions. Data
collected from each run were averaged together.
Dual luciferase assays. HeLa cells were transfected with a pcDNA3 Firefly luciferase
reporter containing the 3’UTR of either the short or long form of Bdnf, termed pLucBdnfS and pLucBdnf-L, respectively. The pcDNA3 vectors, in which the Firefly luciferase
gene and the mouse Bdnf 3’UTRs were cloned, were a gift from Dr. Yue Feng (Allen et
al., 2013). Fragments of the 3’UTRs of Camk2a and Arc containing miR-495 bindingsites were cloned into the pIS0 Firefly luciferase reporter using SacI and XbaI restriction
sites. The primers used were as follows: Camk2a 3’UTR: Forward
CCGTGCTGGCTTCTTTGTTAC and Reverse CCAATCCATAGGACCAGGACTT;
Arc 3’UTR: Forward AAGATTACAGAGAGGAGGTG and Reverse
ATAAGTTTCATAGTTTTATTAACA. The pIS2 Renilla vector was co-transfected with
the Firefly reporter. Pre-miR-495, anti-miR-495, and pre-miR™ miRNA precursor
negative control #2 (Ambion) were obtained from Life Technologies™ and transfected at
20nM. Luciferase activity was determined using the Dual- Luciferase® Reporter Assay
System (Promega Corporation, Madison, WI, USA, # E1910) and the Infinite® 200 plate
reader (Tecan, Maennedorf, Switzerland).

Acute cocaine administration. C57BL/6J mice were randomly assigned to receive one
injection of either saline or cocaine hydrochloride (15 mg/kg, i.p.) and were sacrificed
either at 0.5 (saline: n = 3; cocaine: n = 5), 1 (saline: n = 3; cocaine: n = 10), 2 (saline: n
= 3; cocaine: n = 4), 4 (saline: n = 3; cocaine: n = 6), 24 (saline: n = 3; cocaine: n = 6), or
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48 h (saline: n = 3; cocaine: n = 5) post-injection. Brains were harvested, frozen in 2methylbutane (-500C), and stored at -800C until processing.

Western blotting. NAc tissue was homogenized with lysis buffer (50 mM Tris-HCl pH
8.0, 150 mM NaCl, 1 mM EDTA, 0.1% Nonidet P-40-) supplemented with fresh protease
inhibitors (cOmplete™ Mini, Roche, Indianapolis, IN, # 4693159001). Lysates were precleared by centrifugation at 14,000 x g and then used for protein determination. Aliquots
containing 20 µg of total protein were diluted 1:1 in 2x Laemmli Sample Buffer (Sigma,
# S3401) and run on 4-15% SDS polyacrylamide gels (Bio-Rad, #4568086). Western
blots were performed as previously described (Tanner et al., 2008) using antibodies to
either CaMKIIα (1:2000; Santa Cruz, Dallas, TX, USA, # sc-13141), mature BDNF
(1:1000; Icosagen, Õssu, Ülenurme, Tartumaa, Estonia, #327-100), or proBDNF (1:1000;
Alomone, Jersusalem, Israel, #AGP-032). Membranes were then incubated for 1 h in
either secondary goat anti-mouse HRP (1:5000; Santa Cruz, # sc-2005) or goat antiguinea pig HRP (1:5000; Santa Cruz, # sc-2438), respectively, and were developed with
standard chemiluminescent reagents and procedures (NEL103001EA, Perkin Elmer,
Waltham, MA, USA). Each sample n is exactly one animal with both hemispheres pooled
together. Specific bands that correspond to the correct molecular weight of the target
(~14 kDa for mature BDNF, ~38 kDa for proBDNF, ~50 for CaMKIIα) were quantified
using densiometric analysis in ImageJ and then standardized by pixel density to the
Coomassie Brilliant Blue stain of total protein as described previously (Tanner et al.,
2008). Westerns were replicated 2-3 times and data was averaged together.
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Intracranial viral injections. As described previously (Pentkowski et al., 2012), virus
was infused bilaterally through guide cannula aimed at the nucleus accumbens shell;
(NAcsh; +1.6 mm AP, ±1.1 mm ML, -6.8 mm DV from Bregma) while rats were under
isoflurane anesthesia (2-3%). Lentiviral vectors contained either green fluorescent protein
(GFP; LV-GFP; 8.28 x 108 IUF/mL), which also expresses a non-targeting sequence, or
GFP + pri-miR-945 (LV-miR-495; 1.32 x 109 IUF/mL; System Biosciences Inc.
Mountain View, CA, USA). The infusions (2 µl/side) were given at a rate of 0.2 µL/min
through a 30-gauge injector (Plastics One, Roanoke, VA, USA) connected via Tygon
microbore tubing (Norton Performance Plastics, Akron, OH, USA) to a 25-µL syringe
(Hamilton Co., Reno, NV, USA) housed in an infusion pump (CMA Microdialysis, North
Chelmsford, MA, USA). Injectors extended 1 mm below guide cannula and were left in
place for 10 min post-infusion to allow for virus diffusion. For in vivo virus validation
and microarray experiments, brains were harvested 7 days later under deep anesthesia,
frozen in 2-methylbutane (-500C), and stored at -800C until processing.

NAcsh miR-495 overexpression and acute cocaine. Rats were implanted with guide
cannula aimed at the NAcsh and randomly assigned to receive an infusion of either LVGFP or LV-miR-495 (see Intracranial viral injections). Two weeks later, rats were
randomly assigned to receive one injection of either saline or cocaine (15 mg/kg, i.p.;
LV-GFP-saline: n = 3; LV-miR-495-saline: n = 5; LV-GFP-cocaine: n = 8; LV-miR-495cocaine: n = 6) and were sacrificed two hours later. Brain tissue was rapidly collected as
described previously.
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Microarray analysis. We used Affymetrix® Rat Gene 2.0 ST arrays (Santa Clara, CA,
USA) to determine changes in gene expression in the NAc from LV-miR-495 vs. LVGFP infused rats (n = 3). Data were normalized using Robust multi-array average (RMA)
and significant changes in expression were determined with MeV4_9_0 software
(Boston, MA, USA) using a t-test with Bonferroni corrections and permutation
validations. Predicted targets of miR-495 that were downregulated by miR-495
overexpression were used for Ingenuity Pathway Analysis (Qiagen, Lenlo, Limburg,
Netherlands). Results were deposited on NCBI with a deposition number GSE85500.

NAcsh miR-495 expression following cocaine self-administration. Adult, male Sprague
Dawley rats (200-225g upon arrival) were used for the self-administration experiments
because catheter patency can be maintained for longer periods of time compared to mice,
and therefore, rats were better suited for the self-administration experiments. The rats
were handled ~2 min daily for 7 days before receiving surgery for implanting intravenous
(i.v.) jugular catheters as previously described (Pockros et al., 2011; Pentkowski et al.,
2012). Briefly, the free end of the catheter had a bent metal cannula attached (Plastics
One, Roanoke, VA, USA) that was bored subcutaneously and exited out an incision on
top of the skull. The cannulae were affixed on top of the skull using screws and dental
acrylic. The incisions were sutured and treated with a topical antibiotic. Catheters were
flushed daily with a 0.1 mL solution containing heparin sodium (70 U/mL; APP
Pharmaceuticals, Schaumburg, IL, USA) and Timentin (66.7 mg/mL; GlaxoSmithKline,
Research Triangle Park, NC, USA). Catheter patency was tested periodically by
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administering 0.05 mL of methohexital sodium (Brevital, 16.6 mg/mL, Jones Pharma,
Inc., St. Louis, MI, USA), which results in rapid anesthetic effects when administered i.v.
Self-administration began 7 days post-surgery and two days prior to the first
session, rats were placed on mild food restriction (16 g/day). Rats were then randomly
assigned to receive either 1 or 22 d of self-administration (e.g., SA1, SA22). In order for
the SA1 group (n = 6) to receive a comparable number of cocaine infusions as the SA22
group (n = 7), we established a criterion where rats were only included in the experiment
if they received at least 12 infusions during the first 2-h session. Cocaine was delivered
on a fixed ratio (FR) 1 schedule of cocaine reinforcement (0.9375 mg/kg/0.1mL infusion)
throughout the first session, with the relatively high cocaine dose chosen to increase rates
of acquisition during the first session. Completion of the required schedule resulted in
activation of both a cue light above the active lever and a tone stimulus and 1 s later the
infusion pump was activated for 6 s. The cues and infusion pump were then terminated
concurrently with illumination of the house light for a 20-s timeout period during which
lever presses were recorded but had no consequences. Lever presses on an inactive
control lever were also recorded but had no consequences. Controls in both the SA1 and
SA22 groups received saline infusions and cues yoked to a cocaine partner, but lever
presses produced no consequences (n = 7 total controls). Following the first session, the
SA22 group went on to continue self-administration training, which consisted of daily 2h sessions (6 days/week; 0.9375 mg/kg/infusion) that began on an FR1 schedule and
progressed to a VR5 schedule of cocaine reinforcement across sessions depending on
individual performance. Criteria for advancing to a higher ratio at the start of a session
were <15% variance in the number of infusions received across 3 consecutive days. Once
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rats started and stabilized on a VR5 for 3 consecutive days, they received gradual
increases in daily food (i.e., 18, 20, then 22g/day for the remainder of the experiment).
Based on the NAc miR-495 expression time course following acute cocaine in mice, rats
in both the SA1 and SA22 groups were sacrificed one hour following the last session.
One hour post-session represents 3 h from their first infusion, as well as 1 h from their
last infusion, well within the 1-4 h time frame of the miR-495 decrease observed after
acute cocaine administration. Brains were rapidly extracted, frozen in 2-methylbutane,
and stored at -800C until processing.

NAcsh miR-495 overexpression and cocaine self-administration, extinction, and
reinstatement. Adult, male Sprague Dawley rats (200-225g upon arrival; n=28) received
surgery and initial self-administration training as previously described (see above, NAc
miR-495 expression following cocaine self-administration), with the following
exceptions: they received NAcsh intracranial guide cannulae along with jugular vein
catheters, they were given food ad libitum once they stabilized on an FR5 schedule, and
the cocaine training dose was 0.75 mg/kg/infusion. Once stability was reached under
unrestricted food conditions, rats were infused with either LV-GFP (n = 12) or LV-miR495 (n = 10) while under isoflurane (2-3%) anesthesia (see Intracranial viral injections).
Total cocaine intake prior to receiving viral infusions was counterbalanced across groups.
One week later, when lentiviral-mediated miR-495 overexpression is known to occur
(Fig. 4C), rats received six daily FR5 sessions (0.75 mg/kg/infusion, i.v.). Once their
intake was stable across 3 consecutive sessions on the training dose, rats were tested on a
progressive ratio (PR) schedule of reinforcement at the same dose. The response demand
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in the PR sessions increased exponentially according to the formula 5*e^(0.2n)-5
(Richardson et al., 1996), with n representing the number of reinforcers the rat received
in the session (i.e., the progressive response requirement was 1, 2, 4, 6, 9, 12, 15, 20, 25,
32, 40, 50, 62, 77, 95, 118, 145, 178, etc). The last ratio achieved after failing to attain a
reinforcer in 1 h was defined as the break point. After completion of PR testing, the rats
were switched to the next dose and the same steps were taken to stabilize on an FR5
schedule and then test on a PR schedule at the respective cocaine dose. The doses were
administered in a pseudorandom order: 0.75, 0.375, 1.5, and 0.1875 mg/kg/infusion.
Following the final PR test, rats were placed on the training dose (0.75
mg/kg/infusion) on an FR5 schedule of reinforcement for at least 3 sessions. Then rats
received daily 1-h extinction sessions for at least 10 days, where lever presses produced
no consequences. Once each rat achieved a low extinction baseline (<20% of highest
response during extinction or <20 responses in a session for 3 consecutive sessions), they
were tested for cue reinstatement in a 1-h test session. Cues were presented responsecontingently on an FR1 schedule and were presented non-contingently only if the rat did
not press the active lever within the first 5 min of the test session. Rats were then restabilized under extinction conditions before testing for cocaine-primed reinstatement.
The day before testing, rats were injected with saline (1 mL/kg) to acclimate to injections.
Rats did not reinstate lever pressing following saline injections (data not shown). The
next day rats were tested for cocaine-primed reinstatement by receiving a cocaine
injection (10 mg/kg, i.p.) prior to being placed in the operant chamber. Lever pressing
resulted in no consequences.
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NAcsh miR-495 overexpression and food reinforcement. Rats (n=20) were handled
daily for 1 week prior to receiving training to lever press for food reinforcement (45 mg
pellet, BioServ, Frenchtown, NJ, USA, # F0021) in 30-min daily sessions. Advancement
of reinforcement schedule was identical to the cocaine SA experiment, however rats were
maintained on 16 g of rat chow/day until stabilized on an FR5 schedule, at which point
they received 18 g/day (i.e., restricted). Once stable on an FR5 schedule, rats were
infused with their assigned virus (LV-GFP or LV-miR-495; see Intracranial viral
injections), where group assignment was counterbalanced for previous total food intake
during training (n = 8/group). Rats were given one week of recovery, followed by one
week of FR5 sessions, and then received a PR test. Following testing, rats received food
ad libitum for the remainder of the experiment. To demonstrate varying degrees of
motivation for food, rats were tested one week later on a PR schedule following daily
exposure to food ad libitum (i.e., unrestricted).
Histology. To visualize cannula placement and spread of virus, rats were perfused
transcardially with 4% paraformaldehyde (PFA) following behavioral testing and their
brains were post-fixed in PFA for 24-h, followed by serial increases in sucrose solutions
(15%, then 30%). Brains were then frozen at -80°C until sectioned at 40 μm using a
microtome. Sections were mounted on gel-coated glass slides using Vectashield+DAPI
mounting medium (Vector Labs, Burlingame, CA, USA, # H-1200). Images of the
sections were captured using a Hamamatsu Digital Camera (Hamamatsu City, Japan)
attached to an Olympus BX53 microscope at 20x magnification and automated stitching
software (cellSens Dimension, Olympus, Center Valley, PA, USA). GFP and DAPI
staining were overlayed using Adobe Photoshop (Adobe Systems, Inc., San Jose, CA,
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USA). Either no GFP expression or >50% of GFP expression outside of the target region
were considered misplaced. Six rats from the cocaine self-administration experiment and
four rats from the food experiment were excluded from the study.
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Figures
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Fig AC.1. Predicted miR-495 targets from the KARG have more evidence for their
involvement in addiction than the total KARG. The entire mouse KARG dataset was
searched for miR-495 targets as in Fig. 1A, B and Table S1. Each gene in the dataset
included a score for how many pieces of evidence linked the gene to addiction. Average
evidence scores from the entire dataset in comparison to predicted miR-495 targets were
compared. Mann-Whitney U, ** p < 0.01.
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Fig AC.2. Fluorescent in situ hybridization of miR-495 in the mouse brain
demonstrating probe-specific labeling. Sections were hybridized with miR-495 specific
LNA (top panel) or scrambled (bottom panel) probes. Both images were acquired using
the same exposure time.
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Fig AC.3: Controls for luciferase experiments. HeLa cells were transfected with a
firefly luciferase reporter pcDNA3Luc empty vector (A) or pISOluc empty vector (B). A
Renilla vector was co-transfected with the firefly vectors. Pre-miR-495 and anti-miR-495
were transfected at 20nM. Pre-miR™ miRNA precursor negative control #2 was used as
a negative control. Error bars indicate SEM.
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Fig AC.4. NAc Bdnf mRNA isoform expression 2 h following acute cocaine
administration. qRT-PCR analysis of Bdnf-L and Bdnf-Pan mRNA levels in the NAc 2 h
following acute saline or cocaine administration (15 mg/kg, i.p.; n = 8/group) in male
C57Bl/6 mice. Although both Bdnf-L and Bdnf-pan mRNA within the NAc were
significantly increased 2 h post-injection, the relative upregulation of Bdnf-was about 2fold higher than the total Bdnf (Bdnf-pan). Error bars indicate SEM. **p < 0.01 vs. saline.
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Fig AC.5: Cocaine intake during the final 2-h session in rats given either 1 or 22
sessions of cocaine self-administration. Rats were trained to lever press for cocaine
(0.9375 mg/kg/0.1mL) and either received 1 (SA1; n = 6) or 22 (SA22; n = 7) 2-h
sessions of cocaine self-administration. Bars indicate mean number of infusions received
on the last day of self-administration. Error bars indicate SEM.
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Fig AC.6: No difference in NAc shell vs. core miR-495 expression in saline-yoked
animals.
Rats received saline infusions yoked to a cocaine partner who had access to cocaine
(dose) on an FR5 schedule of reinforcement. NAc tissue was collected 1 h following the
test session and was processed using qRT-PCR with Taqman probes for miR-495 and U6
snRNA. Bars indicate mean miR-495 levels normalized to U6. n = 7/group. Error bars
indicate SEM.
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Fig AC.7: No change in NAc core miR-495 expression following cocaine selfadministration. Rats were trained to lever press for cocaine (0.9375 mg/kg/0.1mL) and
either received 1 (SA1; n = 6) or 22 (SA22; n = 7) days of cocaine self-administration.
Controls (n = 7) received saline infusions yoked to a cocaine partner. NAc tissue was
collected 1 h following the test session to determine changes in miR-495 levels as a result
of cocaine self-administration. The tissue samples were processed using qRT-PCR with
Taqman probes for miR-495 and U6 snRNA. Bars indicate mean miR-495 levels
normalized to U6. Error bars indicate SEM.
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Fig AC.8: NAcsh miR-495 overexpression did not alter cocaine self-administration
on a FR5 schedule. Total responses (A) and infusions (B) during 2-h sessions across
cocaine doses on an FR5 schedule. LV-GFP: n = 12, LV-miR-495: n = 10. Error bars
indicate SEM. FR = fixed ratio.
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Fig AC.9: NAcsh miR-495 overexpression did not alter inactive lever presses on a
PR schedule or during extinction and reinstatement of cocaine-seeking behavior. (A)
Total inactive lever presses/session across several cocaine doses on a PR schedule. (B)
Inactive lever presses during extinction in rats initially trained on an FR5 schedule of
cocaine self-administration. During the 1-h daily extinction sessions, lever presses
produced no consequences. (C) Inactive lever presses during the cue reinstatement test.
After meeting criteria for extinction of cocaine-seeking behavior (Baseline), rats
underwent cue reinstatement where cues that were previously presented responsecontingently during self-administration we available on an FR1 schedule for 1 h. (D)
Inactive lever presses during the cocaine-primed reinstatement test. After re-establishing
an extinction baseline, rats received a priming injection of cocaine (10 mg/kg, i.p.) and
were immediately placed into the operant conditioning chamber. They were then allowed
to lever press under extinction conditions for 1 h (i.e., responses produced no scheduled
consequences). LV-GFP: n = 12, LV-miR-495: n = 10. Error bars indicate SEM. PR =
progressive ratio.

157

C u e R e in s t a t e m e n t

A c tiv e L e v e r P r e s s e s

200
L V -G F P

+

150

L V -m iR -4 9 5

+

100

50

0
B a s e lin e

Test

Fig AC.10: NAcsh miR-495 overexpression did not alter cue reinstatement. After
meeting criteria for extinction of cocaine-seeking behavior (Baseline), rats underwent cue
reinstatement where cues that were previously presented response-contingently with
cocaine during self-administration sessions were available on an FR1 schedule for 1 h.
LV-GFP: n = 12, LV-miR-495: n = 10. Error bars indicate SEM. + p < 0.05 vs. Baseline.
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Fig AC.11: NAcsh miR-495 overexpression did not alter responses or intake of food
on an FR5 schedule. Total responding (A) and intake (B) for food reinforcement on an
FR5 schedule across 7 sessions. Lentiviruses were infused one week prior to the first FR5
session. n = 8/group. Error bars indicate SEM. FR = fixed ratio
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Fig AC.12: NAcsh miR-495 overexpression did not alter food intake on a PR
schedule. Total responding (A) and infusions (B) for food reinforcement on a PR
schedule. Rats were initially tested on restricted feeding conditions (18g/day) and then
tested one week later on unrestricted feeding conditions. n = 8/group. Error bars indicate
SEM. PR = progressive ratio

160

Tables
Table AC.1. In silico identification of miR-495 target mRNAs in the KARG
database
Identification Method

miR-495 target mRNAs

KARG &TargetScan (TS)

Actn2, Arc, Bcl2l1, Bdnf, Bmp7, Cacna1d, Camk2a, Cask, Cdh1, Clock, Cnbp,
Cnr1, Crebbp, Ctnnd2, Ddhd2, Ddit4, Dedd, Eif5a, Fkbp5, Foxg1, Gabbr2, Gad2,
Gap43, Gosr1, Hnrnph2, Hspa5, Htr2c, Igf1, Igf1r, Kat2b, Kcmf1, Mapk10, Myt1,
Myt1l, Nacc2, Ndst1, Nfib, Nkx2-1, Npas2, Nptxr, Nr4a3, Per2, Pgk1, Pibf1,
Ppargc1a, Ppme1, Ppp1cb, Prkar1a, Prosc, Prrc2a, Pten, Ptpra, Pura, Rab11b,
Ran, S1pr3, Scg2, Sgk1, Slc14a1, Slc2a1, Snca, Sox9, Sptbn1, Srsf6, Ssx2ip, Stmn2,
Tfap4, Timp2, Ube2n, Wnk1

KARG, TS, miRanda

Bdnf, Camk2a, Cnr1, Ctnnd2, Dusp6, Fkbp5, Hspa5, Jun, Atxn1, Sgk, Per2, Clock, Fusip1,
Tmed10, Ddit4

Shown are candidate miR-495 target and Knowledgebase of Addiction related Genes (KARG) mRNAs that have been
identified through in silico analyses by overlapping predicted miR-495 targets found in TargetScan (TS) with genes
found in the KARG database. To more stringently identify predicted miR-495 targets, we also utilized miRanda,
considering the free energy of the RNA duplex ΔG ≤ -15 kcal/mol.
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Table AC.2. miR-495 target mRNAs downregulated by LV-miR-495 overexpression
within the NAcSh
Down <0.75 and TS targets

Adrbk2, *Arc, Arhgap5, Atp2b2, Bcl11a, *Bdnf, Cacna1d, *Camk2a, Camk2g, Clmn,
Cnr1, Cpeb2, Cpne4, Dcaf6, Dlgap2, Dmd, Dpp10, Drp2, Dyrk2, Ephb2, Fat4,
Gabbr2, Gpr22, Gpr3, *Gria3, Hivep2, Kctd16, Lancl2, Large, Lhx2, Limch1, Lrrc57,
Mapk10, Mast4, Mcf2l, Nacc2, Nat8l, Ncam2, Neurod6, Nfib, Nmt2, Nptxr, Nr4a3,
Nrxn1, Ntm, Pcdh9, Pde4d, Per2, Pgr, Pitpnm3, Pou6f1, Ppargc1a, Ppme1, Prickle1,
Psme3, Ptprd, Pura, R3hdm2, Rap1gap2, Rimbp2, Rims4, Satb1, Satb2, Scn8a,
Shank2, Slit1, Smad9, Sox5, *Stmn2, Tcf4, Tgfb2, Tmeff2, Tox, Usp32, Xylt1, Zfhx4

Down <0.75, TS targets,

*Arc, *Bdnf, Cacna1d, *Camk2a, Cnr1, Gabbr2, Mapk10, Nacc2, Nfib, Nr4a3, Per2,

KARG

Ppargc1a, Ppme1, Pura, *Stmn2

Shown are candidate miR-495 target mRNAs found within TargetScan that were significantly downregulated (fold
change ≤0.75 and p<0.05) by miR-495 overexpression in NAcsh. These mRNA targets are expressed within the NAcSh
and many are found within the KARG, suggesting that they may play a role in addiction-related processes.
*downregulation confirmed by qRT-PCR.
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Table AC.3. Molecular network highly regulated by miR-495
miR-495 targets

*Arc, Atp2b2, *Bdnf, Cacna1d, *Camk2a, Camk2g, Dlgap2, Dmd, Ephb2, *Gria3,
Lhx2, Ncam2, Neurod6, Nr4a3, Nrxn1, Per2, Rap1gap2, Rimbp2, Satb2, Shank2,
Tmeff2

Interacting molecules

Actin, AMPARs, Calcineurin proteins, Calmodulin, CaMKII, CREB, Cytochrome C,
ERK1/2, HDACs, L-Type Calcium Channels, mGluR1, NMDARs, PIAS, Proinsulin

Shown are miR-495 target mRNAs found within TargetScan that were significantly downregulated (fold change ≤0.75
and p<0.05) by miR-495 overexpression in NAcsh and were found to form an interacting molecular network. These
mRNA targets are expressed within the NAcSh and many are found within the KARG, suggesting that they may play a
role in addiction-related processes. Also shown are molecules or classes of molecules that interact with miR-495
targets. *downregulation confirmed by qRT-PCR.
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